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ABSTRACT  
STRUCTURAL  STUDIES  ON  CALCIUM/CALMODULIN-­DEPENDENT  ACTIVATION  OF  EUKARYOTIC  




Advisor:  Dr.  Ranajeet  Ghose  
  
Eukaryotic  elongation  factor  2  kinase  (eEF-­2K)  is  a  key  modulator  of  the  rate  of  protein  synthesis.  
Activated  by  calcium-­loaded  calmodulin  (Ca2+-­CaM),  eEF-­2K  phosphorylates  its  only  known  physiological  
substrate,  eEF-­2,  on  a  specific  threonine  residue  (Thr-­56).  Phosphorylated  eEF-­2  has  reduced  affinity  for  
the  ribosome,  and  results  in  a  significant  decrease  in  the  rate  of  translation  elongation.  Modulation  of  the  
rate  of  translation  elongation  plays  a  crucial  role  in  proteostasis  –  adequate  regulation  of  protein  synthesis,  
protein  folding,  and  protein  degradation  that  greatly  influences  cellular  growth  and  survival.  Binding  of  Ca2+-­
CaM  triggers  activation  of  eEF-­2K  and  remains  intact  to  facilitate  the  substrate  phosphorylation,  acting  as  
a  cofactor  of  the  enzyme.  Despite  its  importance,  how  the  binding  of  Ca2+-­CaM  leads  to  activation  remains  
poorly  understood.  
We  employed  various  biophysical  tools,  such  as  nuclear  magnetic  resonance  (NMR)  spectroscopy  
and  isothermal  titration  calorimetry  (ITC),  coupled  with  mutational  strategies  to  characterize  structural  and  
thermodynamic  nature  of  the  binding  of  Ca2+-­CaM  onto  eEF-­2K.  Our  data  clarify  the  roles  of  Ca2+  and  each  
lobe   of   CaM   that   provide  mechanistic   insight   into   the   structural   regulation   of   eEF-­2K  mediated   by   the  
binding  of  Ca2+-­CaM.  In  addition,  our  discovery  suggests  that  one  of  the  main  eEF-­2K  regulators,  pH,  could  
regulate  the  activity  of  eEF-­2K  by  controlling  the  binding  of  CaM.    
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Chapter  1  –  Introduction  
The  contents  of  this  chapter  will  be  submitted  as:  
Kwangwoon  Lee,  Kevin  N.  Dalby,  and  Ranajeet  Ghose  
The  Variable  Interaction  Modes  of  Calmodulin  
1.1  Abstract  
Calmodulin   (CaM),  a  ubiquitous  Ca2+   sensor,   is  an  essential   regulator  of  proteins   involved   in  a  
multitude   of   physiological   processes   in   eukaryotic   cells.  Capable   of   binding   up   to   four  Ca2+   ions,  CaM  
decodes   Ca2+-­pulses   through   Ca2+-­dependent   conformational   changes   to   selectively   modulate   its  
interactions  with  a  host  of  target  proteins.  Structures  of  CaM  in  complex  with  peptides,  with  protein  domains,  
and  recently,  with  near-­full-­length  or  full-­length  proteins  have  served  to  provide  atomistic  insight  into  how  
CaM  recognizes  and  regulates  its  targets.  The  large  library  of  structures  of  CaM  complexes  available  in  the  
PDB  has  allowed   the   identification  of   “canonical”  modes   through  which  CaM  engages   its   targets   in   the  
presence  or  in  the  absence  of  Ca2+.  In  addition,  the  PDB  also  provides  examples  of  unique,  “non-­canonical”  
binding  modes  employed  by  CaM  in  a  significant  number  of  cases.  This  large  variability  in  Ca2+-­dependent  
and  Ca2+-­independent  interactions  allows  CaM  not  only  to  regulate  a  variety  of  cellular  targets  but  to  alter  
these  interactions  in  response  to  fluctuations  in  cellular  Ca2+  levels.  Here,  we  briefly  review  the  structural  
universe  that  provides  mechanistic  insight  into  the  CaM-­dependent  regulation  of  a  large  class  of  proteins  
ranging  from  channels  to  protein  kinases.    
1.2  Introduction  
Eukaryotic  cells  utilize  calcium  (Ca2+)  as  a  second  messenger   to  orchestrate  a   large  number  of  
critical  cellular  process1,2.  This  is  achieved  by  the  use  of  specific  Ca2+-­sensing  proteins  to  respond  to  the  
temporally  regulated  fluctuation  of  intracellular  Ca2+  concentration  over  two  orders  of  magnitude  (~100  nM  
to  ~10  µM)3,1.  These  Ca2+-­sensing  proteins  typically  contain  two  distinct  types  of  Ca2+-­binding  modules  -­  a  
helix-­loop-­helix  EF-­hand  motif  (present  in  calmodulin,  S100,  parvalbumin,  troponin-­C,  calbindin,  etc.)  or  a  
C2-­domain  (present  in  protein  kinase  C,  phosphatidylinositol  3-­kinase,  synaptotagmin  I-­VIII,  rabphilin-­3A,  
etc.)1,2.  Calmodulin  (CaM),  that  is  ubiquitously  expressed  in  eukaryotic  cells,  constitutes  one  of  the  most  
versatile  Ca2+  sensors  given  its  ability  to  regulate  interactions  with  a  large  number  of  proteins  in  response  
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to  cellular  Ca2+  fluxes,  thereby  influencing  a  host  of  critical  processes,  including  cell  proliferation,  motility,  
apoptosis,  autophagy  and  gene  expression4-­8.  
   Structurally,  CaM  comprises  of   two  modular  domains  or   lobes  (N-­lobe  and  C-­lobe)   that  share  a  
high  degree  of  similarity  (43%  identity  in  human  CaM)  in  their  amino  acid  sequences.  Each  lobe  bears  two  
EF-­hand  motifs  (EF1,  EF2  on  the  N-­lobe  and  EF3,  EF4  on  the  C-­lobe)  that  can  each  bind  a  single  Ca2+  ion  
for  a  total  of  four  Ca2+  ions  in  the  fully  Ca2+-­saturated,  (Ca2+)4-­CaM  state  (Figure  1.1A).  The  two  lobes  of  
CaM  are  connected  by  a   linker   that   forms  a   long  helix   in   the  crystal   structure  of   (Ca2+)4-­CaM9,10.  NMR  
evidence  suggests  that  the  central  part  of  this  linker  (encompassing  residues  K77  through  S81  in  human  
CaM;;  in  this  paper  we  will  use  single-­letter  codes  for  CaM  residues  and  three-­letter  codes  for  residues  on  
the  CaM-­binding   targets)   remains  disordered   in   solution  and  enables  a   significant   amount   of   inter-­lobe  
flexibility11.  This  inter-­lobe  flexibility  is  also  characteristic  of  CaM  in  the  Ca2+-­free  state  (apo-­CaM,  Figure  
1.1B)12.  In  addition  to  significant  inter-­lobe  dynamics,  each  lobe  displays  a  substantial  amount  of  intra-­lobe  
plasticity.  This  local  and  global  flexibility  facilitates  the  promiscuity  of  (Ca2+)4-­CaM  towards  a  large  number  
of  distinct  protein  targets  as  described  below13.  
The   ability   of  CaM   to   selectively   interact  with   a   large   number   of   partners   allows   it   to   precisely  
decode  Ca2+  signals  and  drive  specific  physiological  processes13.  This  selectivity  is  achieved  through  Ca2+-­
dependent  structural  changes  in  CaM.  The  binding  of  Ca2+  on  each  EF-­hand  leads  to  an  adjustment  of  the  
inter-­helical  angles/distances  (Figure  1.1C,  Table  1)14,  resulting  in  the  exposure  of  hydrophobic  residues  
of  the  amphipathic  helices  therein  and  facilitating  the  formation  of  docking  platforms  for  the  CaM-­binding  
“domains”   (CBD)   of   the   target   proteins.  While   the  EF-­hand  motifs   in   various  Ca2+-­binding   proteins   are  
largely  conserved  structurally14,   the  composition  and  the   length  of   the  Ca2+-­binding   loops  as  well  as  the  
helices   show   significant   variability15,   allowing   CaM   and   other   EF-­hand   containing   proteins   to   be  
promiscuous  and,  at  the  same  time  selective,  for  their  natural  targets  in  a  Ca2+-­dependent  fashion.  
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Figure  1.1.  The  structures  of  CaM  in  the  Ca2+-­loaded  and  Ca2+-­free  states.  (A)  The  structure  of  (Ca2+)4-­
CaM  showing  the  N-­lobe  (green)  and  the  C-­lobe  (blue).  For  the  N-­lobe,  the  helices  A  and  B  form  the  first  
EF-­hand  (EF1),  helices  C  and  D  form  the  second  EF-­hand  (EF2).  For  the  C-­lobe,  helices  E  and  F  form  the  
third  EF-­hand  (EF3),  helices  G  and  H  form  the  fourth  EF-­hand  (EF4).  The  central  part  of  the  inter-­lobe  helix  
(shown  in  black)  seen  in  the  crystal  structure  (PDB:  1CLL)  is  found  to  be  disordered  in  solution.  Ca2+  ions  
are  shown  as  yellow  spheres,  in  this  and  all  successive  figures.    (B)  The  structure  of  CaM  in  the  absence  
of  Ca2+  (apo-­CaM)  showing  the  Ca2+-­free  N-­  (pink)  and  C-­lobes  (gold)  connected  by  a  flexible  linker  (black)  
(PDB:  1CFC).   (C)  Chelation  of  Ca2+  changes   the  conformation  of   the   inter-­helix   linkers,  alters   the   inter-­
helical   angles   within   the   EF-­hands   and   leads   to   increased   exposure   of   the   hydrophobic   patches   that  
comprise  the  docking  platforms  for  target  proteins.  This  results  in  a  Ca2+-­bound  “open”  state  (green)  of  the  
EF-­hands  compared  to  a  “closed”  state  (pink)  in  the  absence  of  Ca2+.  
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The  principal  CBDs  in  various  CaM-­target  proteins  are  typically  linear  motifs  that  are  15–25  residues  long  
with  low  overall  sequence  homology16.  A  CBD  generally  engages  (Ca2+)4-­CaM  in  helical  form  using  two  or  
more  variably  spaced  hydrophobic  residues  (usually  bulky  hydrophobic  residues  such  as  Phe,  Ile,  Leu,  Val,  
Trp,  Tyr)  as  primary  anchors  to  the  hydrophobic  patches  on  CaM17.  These  contacts  are  often  supplemented  
by  additional   interactions  e.g.  electrostatic   interactions  between   the  basic   residues  on   the  CBD  and   the  
acidic  residues  on  CaM.  As  mentioned  earlier,  the  ability  of  CaM  to  engage  a  variety  of  CBD  sequences  is  
enabled  both  by  the  intra-­lobe  plasticity  of  the  hydrophobic  surfaces  and  also  by  the  flexibility  of  the  inter-­
lobe  linker  that  can  variably  orient  each  lobe  to  tailor  the  relative  configuration  of  the  hydrophobic  surfaces  
presented  to  various  CBDs.  The  overall  result  is  a  specific,  high-­affinity  interaction  with  (Ca2+)4-­CaM  with  
dissociation  constant  (KD)  values  typically  ranging  from  100  nanomolar  (nM)  to  10  picomolar  (pM)17.  
The  intracellular  concentration  of  CaM  ranges  from  ~2-­25  µM  depending  on  tissue  type18,  yet  less  
than  1%  of  CaM  exists   in   the  Ca2+-­saturated  state  (~50  nM)5,19,20.  This   is  not  unexpected  given  that   the  
intracellular  concentration  of  free  Ca2+  in  the  resting  state  of  an  eukaryotic  cell  is  ~100  nM1  and  its  affinity  
for  CaM  is  in  the  µM  range  (KD  for  the  C-­  and  N-­lobes  are  ~1  and  ~10  µM,  respectively)5,19-­21.  Given  this  
scenario,  it  is  important  for  CaM  to  retain  the  ability  to  interact  with  a  variety  of  partners  in  the  absence  of  
Ca2+  (or  in  certain  cases,  for  Ca2+  occupancies  of  less  than  4,  as  described  below).    Interactions  with  Ca2+-­
free  i.e.  apo-­CaM,  generally  involve  CBDs  containing  a  so-­called  “IQ  motif”  that  encodes  a  [Ile/Leu/Val]-­
Gln-­(Xxx)3-­Arg-­Gly-­(Xxx)3-­[Arg/Lys]  sequence22,23,   that  principally  engages  the  Ca2+-­free  CaM  C-­lobe.  In  
some  cases,   IQ-­containing  CBDs  alter   their  mode  of   interaction  with  CaM24   in   response   to   increases   in  
cellular   Ca2+   concentration   and   subsequent   Ca2+   occupancy   of   the   CaM   EF-­hands.   The   resultant  
conformational  changes  within  the  complex,  that  could  be  substantial  in  some  instances,  provides  a  means  
for  CaM  to  modulate  its  interactions  with  target  proteins  in  a  Ca2+-­dependent  fashion  and  to  perform  its  role  
as  an  efficient  intracellular  Ca2+-­sensor.  
   The  literature  is  replete  with  structures  of  CaM  bound  to  its  targets  (summarized  in  Table  A.1  that  
is  current  as  of  12/2018)  providing   the  opportunity   to  explore   the  structural  universe  populated  by  CaM  
complexes.  While  complexes  involving  short  peptides  encoding  the  CBDs  of  CaM  targets  comprise  a  large  
majority   of   these   entities,   structures   involving   CaM   partners   in   full-­length   or   near   full-­length   forms   are  
beginning  to  appear  in  the  PDB.  In  order  to  facilitate  our  discussion  of  insights  obtained  from  the  structures  
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of  CaM  complexes,  we  will  classify  them  into  two  broad  structural  groups  each  in  the  presence  or  in  the  
absence   of   Ca2+.   We   term   these   structural   classes   “canonical”   and   “non-­canonical”.   The   canonical  
interactions  in  the  presence  of  Ca2+  and,  to  some  extent,  those  in  its  absence,  are  well-­represented  in  the  
PDB.  Some  CaM  complexes  also  present  unique  interaction  modes  that  cannot  be  classified  as  canonical  
in  the  presence  or  the  absence  of  Ca2+.  We  term  this  latter  subset,  that  comprises  roughly  38%  (70  of  186)  
of  the  structures  of  CaM  complexes  available  in  the  PDB,  as  “non-­canonical”.  Our  definition  of  canonical  
and  non-­canonical  modes  is  illustrated  schematically  in  Figure  1.2.  While  the  interactions  involving  CaM  
and   its   target   proteins   have   profound   functional/physiological   consequences,   in   this   review   we   focus  




Figure  1.2.  Schematic  representation  of  the  classification  of  the  interactions  of  CaM  as  Ca2+-­dependent  
and  Ca2+-­independent  canonical  and  non-­canonical  modes  used  here.  
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1.3  Canonical  interactions  
1.3.1  Canonical  interactions  in  the  presence  of  Ca2+  
In  the  canonical  Ca2+-­dependent  binding  mode  illustrated  by  a  significant  fraction  of  the  structures  
of  CaM  complexes  available  in  the  PDB  (see  Table  A.1),  (Ca2+)4-­CaM  wraps  around  a  helical  region  of  the  
CBD  peptide  by  utilizing  the  exposed  hydrophobic  patches  (“open”  state)  of  both  lobes.  The  CBD  helix,  that  
utilizes  two  or  more  hydrophobic  residues  to  anchor  onto  the  CaM  hydrophobic  patches,  is  fully  encircled  
by  its  two  lobes  in  a  fashion  reminiscent  of  a  “hot-­dog  in  a  bun”25-­27,13.  This  binding  mode  greatly  reduces  
the   exposed   surface   area   of   the   CBD   and   leads   to   significant   conformational   changes   and   overall  
compaction  of  the  structure  of  CaM  compared  to  its  (Ca2+)4  peptide-­free  state.  The  overall  magnitude  of  
these  changes  depends  on  the  positions  of  the  flanking  anchor  residues  on  the  CBD  that  engage  the  CaM  
hydrophobic  patches.  Ataman  et  al.28  noted  that  it  is  possible  to  define  the  critical  hydrophobic  patches  on  
the  N-­  and  the  C-­lobes  of  CaM  by  a  set  of  four  residues  on  each  lobe  -­  F19,  L32,  M51,  M71  for  the  N-­lobe  
(FLMMN)  and  F92,  L105,  M124,  M144  for  the  C-­lobe  (FLMMC)  in  human  CaM  (Figure  1.3).  The  “FLMM  
tetrads”  are  almost  completely  conserved  in  eukaryotic  CaMs  (the  last  M  of  FLMMN  may  sometimes  be  an  
L;;  the  last  M  of  FLMMC  may  sometimes  be  an  L  or  a  V).  As  shown  in  Table  A.1,  a  large  majority  of  partners  
that  target  (Ca2+)4-­CaM  contact  this  tetrad.  To  systematize  our  classification  of  the  nature  of  engagement  
of   (Ca2+)4-­CaM   by   key   hydrophobic   residues   on   the   target,   we   used   the   following   approach:   (1)   First,  
missing  hydrogen  atoms  were  added  to  the  structures  without  further  minimization.  (2)  The  Ala,  His,  Ile,  
Leu,  Met,  Phe,  Trp,  Tyr  or  Val  residues  on  the  target  that  were  within  3  Å  of  the  CaM  FLMMN  or  FLMMC  
tetrads  were  selected  and  visually   inspected.  (3)  The  first  residue  that   inserted  (sidechain  facing   inside)  
into  the  hydrophobic  pocket  defined  by  FLMMN  or  FLMMC  was  labeled  as  the  1-­position.  (4)  Subsequent  
residues  (from  the  list  above)  that  contact  the  tetrads  were  chosen  in  sequence,  and  those  that  do  not  show  
insertion,  but  only  peripheral  contact,  were  shown  in  parentheses;;  residues  for  which  the  target  hydrophobic  
sidechain   faced   away   from   the   pocket   were   not   considered.   This   classification   leads   to   engagement  
patterns  that  in  most  cases,  but  not  all,  are  consistent  with  those  suggested  by  others17.  Using  this  approach,  
we   found   that   the  most   common  spacing  of   these   “anchor”   residues   is   such   that   the   last   anchor   is   13  
residues  away  from  the  first  in  the  primary  sequence  of  the  CBD  leading  to  a  1-­14  pattern.  Variations  include  
	  
	   7	  
the   involvement   of   intermediate   anchors   leading   to   patterns   such   as   1-­10-­14,   1-­(5)-­10-­14,   etc.   A   few  
representative  examples  of  these  interactions  are  shown  in  Figure  1.4.    
First  structurally  characterized  in  1992,  the  architecture  of  (Ca2+)4-­CaM  in  a  high  affinity  complex  
(KD  ~1  nM)  with  a  CBD  derived  from  skeletal  muscle  light  chain  myosin  kinase  (skMLCKCBD,  Figs.  4A,  5)  
provides  an  excellent  example  of  a  canonical  interaction  in  the  Ca2+-­saturated  state25  (PDB:  2BBM).  (Ca2+)4-­
CaM  (the  bun)  wraps  around  skMLCKCBD  (the  hot-­dog)  with  the  latter  forming  a  helix  that  embeds  deep  into  
the  hydrophobic  patches  of  the  Ca2+-­bound  N-­  and  C-­lobes,  both  of  which  assume  an  open  state,  in  a  1-­14  
binding  mode  (Figure  1.5A).  The   first  of   the   two  hydrophobic  anchors  on  skMLCKCBD,  Trp580  at   the  1-­
position,  docks  into  the  hydrophobic  patch  on  the  CaM  C-­lobe  formed  by  residues  F92,  I100,  L105,  M124,  
I125,  A128,  V136,  F141,  M144,  and  M145  (FLMM  tetrad  residues  underlined;;  Figure  1.5B);;  the  second  
hydrophobic  anchor,  Phe593  at  the  14-­position,  docks  into  the  CaM  N-­lobe  hydrophobic  patch  formed  by  





   Apo-­CaM   (Ca2+)4-­CaM  
   Angle  (º)   Distance  (Å)   Angle  (º)   Distance  (Å)  
N-­lobe  
A/B  (intra-­EF1)   128±3   12.3±0.2   86   18.5  
C/D  (intra-­EF2)   130±4   12.3±0.3   86   16.2  
B/C   130±4   11.2±0.3   113   11.3  
A/D   121±2   10.7±0.2   108   10.7  
C-­lobe  
E/F  (intra-­EF3)   137±3   11.9±0.2   101   15.1  
G/H  (intra-­EF4)   132±5   12.3±0.2   94   14.4  
F/G   144±3   11.8±0.1   112   11.0  
E/H   144±3   11.2±0.3   116   10.3  
  
Table  1.1.  Inter-­helical  angles  and  distances  in  CaM  
The  helices  have  been  defined  as  A  (5-­19),  B  (29-­38),  C  (45-­54),  D  (65-­74),  E  (82-­92),  F  (102-­111),  G  (118-­
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Figure  1.3.  FLMM  Tetrads.  The  N-­lobe   (green)  and  C-­lobe   (blue)  FLMM   tetrads,   that  define   the  major  
hydrophobic  pockets  of  CaM  (indicated  by   the  shaded  oval),  are  shown  on   the   top  and  bottom  panels,  
respectively.  Constituent  residues  F19,  L32,  M51,  M71  (FLMMN)  and  F92,  L105,  M124,  M144  (FLMMC)  are  
shown  in  ball-­and-­stick  representation  in  yellow  and  labeled.  The  mesh  around  each  moiety  represents  the  
corresponding  van  der  Waals  surface.  
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Figure  1.4.  Illustrative  examples  of  canonical  Ca2+-­dependent  interactions.  (A)  NMR  structure  of  (Ca2+)4-­
CaM  in  complex  with  a  CBD  peptide  derived  from  skeletal  muscle  myosin  light  chain  kinase  (skMLCKCBD;;  
PDB:  2BBM).  Trp580  and  Phe593  are  inserted  into  the  hydrophobic  patches  formed  by  the  Ca2+-­bound  
C-­lobe  and  the  Ca2+-­bound  N-­lobe,  respectively,  in  a  1-­14  binding  mode.  (B)  Crystal  structure  of  (Ca2+)4-­
CaM  in  complex  with  a  CBD  peptide  derived  from  calmodulin-­dependent  protein  kinase  II  (CaMKIICBD;;  
PDB:  1CDM).  Leu299  (C-­lobe),  Ile303  (C-­lobe),  and  Leu308  (N-­lobe)  constitute  a  1-­5-­10  binding  mode.  
(C)  NMR  structure  of  (Ca2+)4-­CaM  in  complex  with  a  CBD  peptide  derived  from  calmodulin  dependent  
protein  kinase  kinase  (CaMKKCBD;;  PDB:  1CKK).  Trp444  (N-­lobe),  Met453  (C-­lobe)  and  Phe459  (C-­lobe)  
comprise  the  1-­10-­16  binding  mode.  (D)  Crystal  structure  of  (Ca2+)4-­CaM  in  complex  with  a  CBD  peptide  
derived  from  alpha-­II  spectrin  (αIIspCBD;;  PDB:  2FOT).  Trp1192  (C-­lobe)  and  Phe1205  (N-­lobe)  enable  a  1-­
14  binding  mode.  In  all  cases,  the  CBD  peptide,  N-­  and  C-­lobes  of  CaM  and  the  inter-­lobe  linker  are  
colored  in  orange,  green,  blue  and  black,  respectively.  The  sidechains  of  the  FLMMN  and  FLMMC  
residues  are  shown  as  sticks  and  colored  yellow  in  all  cases. 
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The  hot-­dog   in  a  bun  mode  of   interaction  seen   in  canonical   (Ca2+)4-­CaM  complexes  provides  a  
clear  regulatory  advantage.  This  mode  of  binding  enables  the  efficient  disengagement  and  sequestration  
of  CBDs   away   from   functional   sites  within   the  CaM-­regulated   target   protein   allowing   the   generation   of  
functionally  important  states  in  response  to  Ca2+  fluxes.  An  excellent  illustration  of  this  process  is  provided  
by  the  so-­called  “release  of  inhibition”  mechanism30  that  is  operative  in  many  CaM-­regulated  protein  kinases  
(Ca2+/calmodulin-­dependent  protein  kinases  I/II/IV,  myosin  light  chain  kinases,  inositol  1,4,5-­trisphosphate  
3-­kinase   etc.)31-­40,   in   phosphatases   (calcineurin)41,42   and   in   the   Ca2+-­ATPase   pump   (PMCA)43.   In   this  
mechanism,  an  auto-­inhibitory  segment,  e.g.  a  substrate  mimic  (pseudo-­substrate)  as  in  the  case  of  CaM-­
regulated  kinases,  encoding  a  CBD  forms  a  high-­affinity  complex  with  CaM  in  the  presence  of  Ca2+  thus  
releasing  the  constraints  that  hold  it  in  its  inhibitory  conformation  allowing  activation44  (Figure  1.6).  
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Figure  1.5.  Key  interactions  seen  in  NMR  structure  of  (Ca2+)4-­CaM  in  complex  with  the  skMLCKCBD  peptide  
(PDB:  2BBM;;  also  see  Figure  1.4A)  (A)  skMLCKCBD  (orange)  that  engages  CaM  in  a  1-­14  binding  mode  is  
shown   fully   encircled  by   the  Ca2+-­saturated  N-­   and  C-­lobes  of  CaM   (shown   in   surface   representation).  
Details  of  the  critical  interactions  with  the  CaM  C-­lobe  (B)  and  the  N-­lobe  (C)  are  shown.  Trp580  (position  
1)  and  Phe593  (position  14)  are  deeply  inserted  into  the  C-­lobe  and  N-­lobe  hydrophobic  patches  (shown  in  
yellow  with  key   residues   labeled),   respectively.  The  helical   region  of   skMLCKCBD   is   threaded   through  a  
hydrophobic  channel  created  by  the  closure  by  the  two  lobes  of  CaM  in  a  “hot-­dog  in  a  bun”  configuration.  
FLMM  tetrad  residues  for  the  C-­lobe  (B)  and  N-­lobe  (C)  are  underlined.  
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Figure  1.6.  Schematic  illustration  of  the  release  of  inhibition  mechanism  operative  in  CaMKII.  The  binding  
of  the  CBD  (orange)  to  (Ca2+)4-­CaM  disengages  it  from  the  auto-­inhibitory  site  on  CaMKII  resulting  in  the  
exposure  of  the  substrate  binding  site  and  allowing  phosphorylation  of  Thr286.  Adapted  from  Stratton  et  
al.44  
  
1.3.2  Canonical  Interactions  with  CaM  in  the  Ca2+-­free  state  
Unlike  in  the  case  of  (Ca2+)4-­CaM  where  both  lobes  adopt  an  open  form,  the  N-­lobe  of  apo-­CaM  
adopts  a  closed  conformation  that  is  characterized  by  increased  angles  and  significantly  reduced  distances  
between  the  helices  that  form  EF1  and  EF2  (Table  1).  This  conformation  is  also  characterized  by  a  largely  
buried  hydrophobic  patch.  Similar   trends  are  also  seen   for  EF3  and  EF4   that  comprise   the  C-­lobe  also  
indicating  a  more  closed  state  in  the  absence  of  Ca2+  (Table  1).  However,  NMR  studies  have  shown  that  
the  Ca2+-­free  C-­lobe  displays  a  greater  degree  of  plasticity  than  the  N-­lobe  on  the  microsecond-­millisecond  
timescale12,45   suggesting   that   additional   rare   conformers   exist   for   this   lobe.   This   observation   has   been  
reinforced   by   recent   computational   studies   that   suggest   that   the   C-­lobe   of   apo-­CaM   samples  multiple  
distinct  topologies  to  promote  conformational  selection  for  a  range  of  CBDs46.  This  conformational  flexibility  
likely  enables  the  Ca2+-­free  CaM  C-­lobe  to  interact  with  target  IQ  motifs  utilizing  a  novel  “semi-­open”  state  
(Figure  1.7).  We  classify   this   type  of   interaction  as   the  canonical  Ca2+-­independent   interaction  mode  of  
CaM  (Figure  1.2).  For  interactions  involving  IQ  motifs,  the  CaM  N-­lobe  is  either  free,  e.g.   in  the  voltage  
gated  sodium  channels  (e.g.  in  NaV1.5  shown  in  Figure  1.8A)  or  in  the  small  conductance  calcium-­activated  
potassium  channels47,  or  participates  in  minimal  electrostatic  interactions  with  the  CBD  or  other  parts  of  the  
target   protein   as   in   myosin   Va48   (Figure   1.8B).   Interactions   involving   IQ   motifs   occasionally   lead   to  
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structural  rearrangements  in  the  Ca2+-­binding  loops  that  in  some  cases  alter  the  ability  to  engage  Ca2+.  In  
most  cases  these  conformational  changes  are  the  indirect  effect  of  the  engagement  of  the  IQ  motif  by  the  
Ca2+-­free  CaM  C-­lobe.  However,  it  has  been  reported  that  IQ  motif-­containing  sequences  are  also  capable  
of  directly  interacting  with  the  Ca2+-­binding  loops.  A  structural  model  of  the  Ca2+-­free  C-­lobe  in  complex  with  
the   calponin   homology   (CH)   domain   from   the   smoothelin-­like   1   (SMTNL1)   protein,   generated   by  
computational  docking  using  NMR  data,  suggests  a  direct  interaction  between  the  acidic  residues  of  the  
Ca2+-­binding  loops  with  the  basic  residues  of  the  CH  domain  IQ  motif  (PDB:  2K3S)49.  
	  
	   14	  
  
Figure  1.7.  Closed,  semi-­open  and  open  states  of  the  CaM  C-­lobe.  The  conformation  of  the  CaM  C-­lobe  
in  absence  of  Ca2+  (left;;  PDB:  1CFC),  in  the  semi-­open  state  characteristic  of  Ca2+-­independent  interactions  
with  IQ  motif  containing  targets  (middle;;  PDB:  2IX7)  and  in  the  Ca2+-­loaded  open  state  (right;;  PDB  :1CLL;;  
Ca2+  ions  not  shown).  The  residues  of  the  FLMMC  tetrad  are  shown  in  stick  representation  and  labeled.  
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Figure  1.8.   Illustrative  examples  of  canonical  Ca2+-­independent   interactions.   (A)  NMR  structure  of  apo-­
CaM  in  complex  with  a  Nav1.5-­derived  IQ  motif  peptide  (orange,  NaV1.5CBD,  PDB:  2L53).  Ile1908  of  the  IQ  
motif  interacts  with  the  CaM  C-­lobe  (grey);;  no  significant  interactions  are  seen  with  the  CaM  N-­lobe  (pink)  
that   remains   dynamic   in   solution.   The   semi-­open   state   of   the   C-­lobe   EF-­hands   is   stabilized   by   the  
electrostatic/polar   interactions   between   E114   (sidechain   in   red)   of   CaM   with   Gln1909   and   Arg1913  
(sidechain  in  blue)  of  the  IQ  motif.    (B)  Crystal  structure  of  apo-­CaM  in  complex  with  an  IQ  motif  containing  
peptide  derived  from  Myosin  Va  (Myo5aCBD,  orange)  (PDB:  2IX7).  Ile773  of  Myo5aCBD  docks  into  the  semi-­
open  C-­lobe  while  Gln774  and  Arg778   (sidechain   in  blue)  makes  polar/electrostatic  contacts  with  E114  
(sidechain  in  red)  of  CaM.    The  Ca2+-­free  N-­lobe  adopts  a  closed  form  and  shows  only  a  few  contacts  with  
Myo5aCBD;;  one  of  these  contacts  being  an  interaction  of  the  CaM  helix  A  with  Tyr786  near  the  C-­terminus  
of  Myo5aCBD.  In  both  cases,  the  key  interactions  involve  the  first  part  of  the  canonical  IQ  motif  with  the  Ile,  
Gln  and  Arg  in  the  first,  second  and  fifth  positions  of  [Ile/Leu/Val]-­Gln-­(Xxx)3-­Arg-­Gly-­(Xxx)3-­[Arg/Lys].  
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An  excellent  example  of  a  canonical  Ca2+-­independent  interaction  is  provided  by  the  complex  of  
apo-­CaM  with  a  peptide  derived  from  myosin  Va  (Myo5aCBD,  PDB:  2IX748)  encoding  its  first  two  IQ  motifs  
(Figs.   8B,   9A).   This   structure   represents   the   first   high-­resolution   structural   information   on   a   complex  
involving  apo-­CaM  and  an   IQ  motif.   In   this  structure,  Gln774  (the  Q  of   the   IQ  motif)  and   the  conserved  
Arg778  within  the  consensus  sequence  interact  with  E114  on  the  linker  connecting  EF3  and  EF4  on  the  
CaM  C-­lobe   (Figure   1.9B).   This   promotes   partial   exposure   of   the   hydrophobic   patch   to   accommodate  
Ile773  (the  I  of  the  IQ  motif)  in  addition  to  Ile777  and  Trp780.  Interactions  with  the  N-­lobe,  that  remains  in  
a  closed  form,  are  less  numerous,  and  largely  involve  the  first  helix  of  CaM  (helix  A)  that  contacts  Tyr786  
belonging  to  the  C-­terminal  region  of  the  first  IQ-­motif  within  Myo5aCBD  (Figure  1.8B).  Interactions  within  
apo-­CaM  involving  the  sidechain  of  E114  on  the  C-­lobe  and  the  backbone  of  the  N-­lobe  residues  E45  and  
A46  serve  to  generate  the  closed  topology  without  use  of  the  N-­lobe  hydrophobic  patch,  in  a  manner  that  
is  distinct   from  the  canonical  (Ca2+)4-­CaM/target   interactions  (described  above).   In  contrast,   in   the  NMR  
structure   of   apo-­CaM   in   complex   with   the   Nav1.5   IQ  motif   (Nav1.5CBD;;   PDB:   2L53)   (Figure   1.9A),   the  
interaction  is  limited  to  the  C-­lobe  of  CaM  without  any  observable  engagement  of  the  N-­lobe  that  remains  
dynamic  in  solution47.     
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Figure  1.9.  Key  interactions  seen  in  the  crystal  structure  of  apo-­CaM  in  complex  with  Myo5aCBD  (PDB:  2IX7;;  
also  see  Figure  1.8B).  (A)  The  peptide,  that  forms  a  helix,  is  sandwiched  between  the  Ca2+-­free  N-­  (pink)  
and  C-­lobes  (grey)  of  CaM.  (B)  The  Myo5aCBD  IQ  motif  engages  the  hydrophobic  patch  (shaded  yellow)  of  
the  Ca2+-­free  C-­lobe  of  CaM  using  Ile773  of  the  IQ  motif  as  an  anchor,  supplemented  by  additional  contacts  
involving  Ile777  and  Trp780.  This  interaction  is  supplemented  by  polar/electrostatic  interactions  Gln774  and  
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1.3.3  IQ-­motif  Interactions  Serve  as  Efficient  Sensors  of  Cellular  Ca2+    
   Complexes   involving   apo-­CaM   and   IQ  motif-­containing   targets   function   as   efficient   sensors   of  
cellular   Ca2+   levels,   achieving   this   goal   through   a   variety   of   mechanisms50-­52,48,53,8,54.   In   some   cases,  
engagement   of   target   IQ   motifs   alters   the   Ca2+   affinity   of   CaM   or   leads   to   modified   Ca2+  
association/dissociation  kinetics.  In  the  case  of  the  interaction  of  CaM  with  a  peptide  encoding  the  Nav1.2  
IQ  motif,  Ca2+  saturation  of  the  N-­lobe,  that  normally  has  a  lower  Ca2+  affinity  than  the  C-­lobe55,  occurs  first,  
leading  to  the  formation  of  a  (Ca2+)2-­CaM•Nav1.2  intermediate.  Ca2+  occupancy  of  the  N-­lobe  appears  to  
induce  the  engagement  of  the  C-­terminal  flanking  region  of  the  Nav1.2  IQ  peptide  (PDB:  4JPZ)56.  In  contrast,  
the  association  of  a  peptide  encoding  the  first  IQ  motif  of  myosin  Va  with  CaM  significantly  alters  the  kinetics  
of  the  association  and  dissociation  of  Ca2+  from  each  of  the  lobes  of  CaM,  the  largest  effects  noted  for  the  
N-­lobe,  but  results  in  only  a  ~3-­fold  enhancement  in  the  overall  Ca2+  affinity24.  Conversely,  the  affinity  of  
CaM  towards  IQ  motif-­containing  targets  may  also  be  altered  in  response  to  changes  in  Ca2+  concentration.  
For  example,  the  affinity  of  a  peptide  encoding  the  IQ  motif  of  the  Nav1.2  α-­subunit  is  reduced  from  a  KD  ~3  
nM  towards  apo-­CaM  to  a  KD  ~85  nM  towards  the  (Ca2+)4-­CaM54.  In  contrast,  a  peptide  encoding  the  sixth  
IQ  motif  of  myosin  IXa  has  a  far  lower  affinity  for  the  apo  state  of  CaM  (KD  ~8  µM)  compared  to  its  Ca2+-­
bound  state  (KD  ~30  nM)57  
   Some  IQ-­containing  proteins  undergo  large  structural  rearrangements  altering  their  binding  modes  
under   high   Ca2+   conditions   when   one   or   both   of   their   lobes   become   Ca2+-­saturated.   This   scenario   is  
illustrated  by  the  crystal  structure  of  the  Ca2+-­CaM  in  complex  with  the  motor  domain  of  myosin  Va  (PDB:  
4ZLK)24.  The  CaM  C-­lobe  undergoes  a  transition  from  its  semi-­open  (described  in  the  previous  section)  to  
a  fully-­open  state  upon  Ca2+  binding,  altering  the  mode  of  engagement  of  the  ligand  compared  to  that  in  
the  Ca2+-­free  state  (Figure  1.10).  The  C-­lobe  EF-­hands,  EF3  and  EF4,  exchange  their  positions  relative  to  
the   ligand  by  rotating  180˚  about   the  I-­residue  (Ile773)  of   the  IQ  motif   (from  a  NEF3-­EF4C  “polarity”   to  a  
NEF4-­EF3C  polarity;;  the  N-­terminus  of  the  CBD  sequence  contacts  EF3  and  EF4  in  the  former  and  latter  
cases,  respectively).  This  reverse  polarity  binding  is  enabled  by  a  set  of  hydrophobic  residues,  encoded  
within  the  IQ  motif,  that  results  in  a  canonical  engagement  in  the  Ca2+-­loaded  state  with  the  hydrophobic  
residues  Ile773,  Ile777  and  Leu787  engaging  the  CaM  FLMM  tetrads  in  a  1-­5-­15  fashion  (according  to  our  
classification  of  canonical  interactions  based  on  FLMM  contacts  described  above).  Note  that  the  original  
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authors  classify   this  altered  mode  as  1-­5-­8-­14  (involving  Ile773,   Ile777,  Trp780  and  Tyr786;;  see  Figure  
1.10).  The  latter  two  residues  do  make  hydrophobic  contacts  but  not  with  residues  of  the  FLMM  tetrads.  A  
similar  Ca2+-­induced  change  in  polarity  from  NEF3-­EF4C  to  NEF4-­EF3C  is  evident  upon  comparing  the  NMR  
structures  of  the  Ca2+-­free  (PDB:  2KXW)58  and  Ca2+-­bound  (PDB:  2M5E)54  C-­lobe  of  CaM  in  complex  with  
an  IQ  motif  peptide  derived  from  NaV1.2  (Figure  1.11).  As  in  the  case  of  myosin  Va,  the  change  in  polarity  
is  effected  through  a  rotation  about  the  I-­residue  (Ile1912)  of  the  IQ  motif.  Chemical  shift  perturbation  data  
suggests   that   the  Ca2+-­loaded  N-­lobe  of  CaM  appears   to  have   little  contact  with   the  peptide  perhaps   to  
enable  additional  intramolecular  or  intermolecular  engagement  in  the  context  of  full-­length  Nav1.2.  A  point  
to  mention   here   is   that   the   crystal   structure   of  CaM   in   complex  with   a   longer  Nav1.2-­derived   construct  
encoding  the  IQ  motif  (PDB:  4JPZ)  suggests  no  change  in  polarity  in  a  Ca2+-­loaded  state.  However,  the  
authors  of  that  structure  indicate  that  the  Ca2+  occupancy  of  the  C-­lobe  for  this  structure  is  not  completely  
clear56,  likely  resolving  an  apparent  contradiction  with  the  NMR  studies54.  
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Figure  1.10.  Ca2+-­dependent  changes  in  the  orientation  of  the  CaM  C-­lobe  in  complex  with  the  first  IQ  motif  
from  myosin  Va  (PDB:  2IX7  without  Ca2+;;  PDB:  4ZLK  with  Ca2+).  In  the  absence  of  Ca2+,  EF3  (gray)  of  the  
Ca2+-­free  C-­lobe  engages   the  N-­terminal   part   of   the   IQ  motif   (orange)   using   a   NEF3-­EF4C  polarity   (left  
panel).  When  both  lobes  are  Ca2+-­saturated  (right  panel),  EF4  (shown  in  dark  red  for  both  Ca2+-­free  and  
Ca2+-­bound  states  to  orient  the  eye)  engages  the  N-­terminal  region  of  the  IQ  motif  in  a  NEF4-­EF3C  polarity.  
This  orientation  allows  the  Ca2+-­bound  N-­lobe  (blue)  to  additionally  engage  Tyr786,  yielding  a  canonical  
Ca2+-­dependent  1-­5-­15  binding  mode  where   Ile773   (of   the   IQ  motif,   1-­position),   Ile777   (5-­position)  and  
Trp780  act  as  the  hydrophobic  anchors  to  the  Ca2+-­loaded  C-­lobe.  Tyr786  and  Leu787  (15-­position)  make  
hydrophobic  contacts  with  the  N-­lobe.  Both  lobes  of  CaM  display  a  Ca2+-­induced  open  form.  The  sidechains  
of  the  FLMM  tetrads  are  shown  in  yellow.  
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Figure  1.11.  Ca2+-­dependent  changes  in  the  orientation  of  the  CaM  C-­lobe  in  complex  with  the  Nav1.2  IQ  
motif.  When  CaM  interacts  with  the  IQ  motif   in  the  absence  of  Ca2+  (left  panel)  (PDB:  2KXW)  the  NEF3-­
EF4C   polarity   allows   Ile1912   to   be   inserted   in   the   C-­lobe   hydrophobic   pocket   and   promotes  
polar/electrostatic  interactions  of  Gln1913  (orange)  and  Arg1917  (red)  of  the  IQ  motif  with  E114  (red)  on  
CaM,  the  latter  being  positioned  in  the  linker  connecting  EF3  (gray)  to  EF4  (shown  in  dark  red  in  all  cases).  
Upon  Ca2+-­saturation  (right  panel)  (PDB:  2M5E),  the  C-­lobe  adopts  an  NEF4-­EF3C  polarity  (the  Ca2+-­bound  
EF3  shown  in  blue).  Due  to  the  polarity  change,  the  EF3-­EF4  linker  no  longer  makes  contacts  with  Gln1913  
and  Arg1917.  
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1.4  Non-­canonical  Interactions  
   By  our  definition  of  Ca2+-­dependent  canonical  interactions  (Figure  1.2),  each  Ca2+-­saturated  lobe  
of  CaM,  in  open  form,  encircles  the  target  CBD;;  for  Ca2+-­independent  canonical  interactions,  the  semi-­open  
Ca2+-­free  C-­lobe  engages  the  conserved  target  IQ-­motif.  In  case  of  non-­canonical  interactions,  it  is  far  more  
difficult  to  classify  non-­canonical  interactions  as  purely  Ca2+-­dependent  or  purely  Ca2+-­independent.  These  
non-­canonical  interactions  involve  CBDs  that  do  not  share  significant  similarity  to  those  predicted  to  engage  
either  apo-­CaM  (non-­IQ)  or  (Ca2+)4-­CaM  with  reasonable  affinity27  nor  interact  with  CaM  using  modes  that  
are  distinct   from  the  Ca2+-­dependent  or  Ca2+-­independent  canonical  modes  described  above.  For  some  
non-­canonical   interactions,   target   proteins   are   able   to   engage   apo-­CaM   leading   to   partial   activation   of  
function  with  full  activation  occurring  in  the  Ca2+-­saturated  state.  Examples  include  the  inducible  nitrogen  
oxide  synthase  (iNOS)59  and  the  small  conductance  Ca2+-­activated  potassium  channel  protein  (SK  channel)  
(PDB:  1G4Y,  1QX7,  6CNM,  3SJQ)60,61,6,62.  In  other  cases,  targets  engage  apo-­CaM  weakly,  but  achieve  
sufficient  activation  under   the   influence  of  CaM  that   is  partially  Ca2+-­saturated.  Examples  of  such  cases  
include  the  A-­kinase  anchoring  protein  79  (AKAP79)  (PDB:5NIN)63,  the  adenylyl  cyclase  (AC)  domain  of  
anthrax  edema  factor  (PDB:1K93)64,  and  the  mammalian  homolog  of  C.  elegans  unc-­13p  (Munc13-­1)  (PDB:  
2KDU)65.   The   CaM-­regulated   eukaryotic   elongation   factor   2-­kinase   (eEF-­2K)   is   able   to   conditionally  
modulate  its  affinity  for  CaM  in  response  to  post-­translational  modifications  and  apparently  to  pH  changes  
(unpublished   observations   in   the   Dalby   group)   to   ensure   appropriate   activation   under   a   variety   of  
conditions66,67.  In  the  description  below,  we  classify  interactions  as  Ca2+-­dependent  or  Ca2+-­independent  
based  on  whether  the  CaM  lobe  where  the  primary  interaction  occurs  contains  the  full  complement  of  2  
Ca2+  ions  or  not.  
1.4.1  Ca2+-­dependent  Non-­canonical  Interactions  
Many  protein  targets  that  require  partial  Ca2+-­saturation  of  CaM  to  enable  the  interaction  utilize  the  
Ca2+-­bound  C-­lobe  as  a  principal  docking  site  and  the  N-­lobe  as  a  Ca2+-­sensor  that  can  tune  activity/function  
by  undergoing  conformational  changes  in  response  to  Ca2+  levels.  When  bound  to  these  target  proteins,  
the  Ca2+-­loaded  CaM  C-­lobe  adopts  an  open  form  as  illustrated  in  the  structures  of  the  complexes  with  the  
edema   factor  AC  domain64  and  AKAP7963   (Figure  1.12A)  and  as   implied   from   the   results  of   the  NMR-­
based  Ca2+  titration  of  the  complex  with  Munc13-­165.    
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   The  crystal  structure  of  the  CBD  of  AKAP79  (AKAP79CBD,  PDB:  5NIN)63  shows  that  the  Ca2+-­free  
N-­lobe  adopts  a  closed  form  and  makes  van  der  Waals  contacts  and  hydrogen  bonds  with  the  helical  region  
of  AKAP79CBD  that  is  docked  onto  the  Ca2+-­bound  C-­lobe  (Figure  1.12A).  This  interaction  is  enabled  by  the  
hydrophobic  residues  Trp79,  Leu82,  Leu85  and  Val86  on  AKAP79CBD  and  characterized  by  the  authors  as  
a   non-­canonical   1-­4-­7-­8  mode.   The   interesting   feature   about   this   interaction   is   that   it   is   enabled   by   a  
distortion  of  the  AKAP79CBD  helix  from  α-­helical  to  310-­helical  at  the  C-­terminus  to  enable  this  unique  mode  
of  binding.  Based  on  our  classification  of  hydrophobic  contacts  (described  for  the  canonical  Ca2+-­dependent  
interactions  described  above)   this  would  comprise  a  1-­4  mode  since  Trp79  and  Leu82  at   the  1-­  and  4-­
positions  make  contact  with  a  FLMM  tetrad  (FLMMC  in  this  case)  while  the  other  two  residues  do  not.  
A  completely  different  mode  of  interaction  is  seen  in  the  crystal  structure  of  the  anthrax  edema  factor  AC  
domain  in  complex  with  CaM  (PDB:  1K93;;  Figure  1.12B)64.  The  interactions  of  the  Ca2+-­bound  CaM  C-­lobe  
with  the  AC  domain  appears  to  be  mediated  by  a  set  of  hydrophobic  interactions  with  helix  H  of  the  latter,  
supplemented  by  additional  contacts  with  surrounding  helices  via  polar  residues  of  the  amphipathic  helices  
that  constitute  the  CaM  EF-­hands.  The  Ca2+-­free  N-­lobe  remains  in  the  closed  state,  and  is  stabilized  by  
several  polar/electrostatic   interactions  with  the  helices  of  the  AC  domain.  This  large  network  of  contacts  
leads  to  the  burial  of  a  significant  surface  area  (5900  Å2)  and  results  in  a  tight  association  (KD  ~20  nM)64.  
Interestingly,   when   the   Ca2+   levels   are   high,   the   N-­lobe   binds   Ca2+,   but   continues   to   adopt   a   closed  
conformation  that  is  somewhat  similar  to  that  in  the  Ca2+-­free  state  (PDB:  1XFZ)68.    
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Figure  1.12.  Ca2+-­dependent  non-­canonical  interactions  in  CaM.  (A)  Crystal  structure  of  CaM  in  complex  
with  a  CBD  peptide  derived  from  A-­kinase  anchoring  protein  79  (AKAP79CBD;;  PDB:  5NIN).  Trp79,  Leu82,  
Leu85,  and  Val86  of  AKAP79CBD  (orange)  serve  as  hydrophobic  anchors  that  dock  into  the  Ca2+-­bound  C-­
lobe  (blue),  while  Arg84  (blue)  makes  electrostatic  interactions  with  E11  (red)  of  the  Ca2+-­free  N-­lobe  (pink).  
Trp79  (1)  and  Leu82  (4)  contact  FLMMC  (sidechains  of  the  latter  residues  are  shown  in  stick  representation  
and  colored  yellow).  (B)  Crystal  structure  of  CaM  in  complex  with  the  anthrax  edema  factor  adenylyl  cyclase  
domain  (PDB:  1K93).  The  helix  H’  of  edema  factor  constitutes  the  principal  binding  site  of  the  Ca2+-­bound  
CaM   C-­lobe.   Although   the   edema   factor   contains   predicted   canonical   CaM-­binding   motifs,   specific  
hydrophobic   anchoring   interactions   are   difficult   to   ascertain.   Instead,   numerous   interactions   among   the  
edema  factor  helices  and  CaM  contribute  to  formation  of  the  high  affinity  complex.  Lys525,  that  participates  
in  electrostatic   interactions  with  E114  on  CaM,  appears   to  crucial  since  a  Lys525Ala  mutation  weakens  
binding  to  CaM  by  ~200-­fold.  
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1.4.2  Ca2+-­independent  Non-­canonical  Interactions  
Some  proteins  that  that  lack  IQ  motifs  are  also  able  interact  to  with  apo-­CaM  and  attain  their  active  
states  when  the  bound  CaM  is  partially  Ca2+-­saturated.  Unlike  in  the  two  non-­canonical  cases  described  
above  where  occupancy  of  Ca2+  in  one  lobe  is  necessary  for  binding,  the  CBDs  described  below  are  able  
to  utilize  a  Ca2+-­free  CaM  lobe  as  the  primary  interaction  site.  An  example  of  this  type  of  interaction  can  be  
seen  in  the  recent  cryo-­electron  microscopy  (cryoEM)  structure  of  CaM  in  complex  with  SK4,  one  of  the  
four   members   of   the   small-­conductance   Ca2+-­activated   K+   (SK)   channel   family   (PDB:   6CNM).   In   the  
absence  of  Ca2+,  helix  HA  of  SK4  engages  the  C-­lobe  of  CaM  via  hydrophobic  interactions  utilizing  residues  
Trp323,  Leu319  and  Ala316;;  of   these  only  Leu319  contacts  FLMMC.  These  are  supplemented  by  polar  
interactions   of   the   nearby  HB   helices  with   the  CaM  C-­lobe  which   remains   in   a   semi-­open   form   and   is  
engaged  using   a   NEF3-­EF4C   polarity   (Figure   1.13A,   left   panel).   In   this   state,   the  CaM  N-­lobe   remains  
dynamic  without  engaging  any  specific  part  of  the  channel.  The  semi-­open  conformation  of  the  bound  Ca2+-­
free  C-­lobe  resembles  that  seen   in   the  previously  published  structure  of  CaM  in  complex  with  construct  
derived  from  the  closely  related  SK2  channel  encoding  helix  HA,  helix  HB,  and  a  part  of  helix  HC.  In  that  
complex,  the  Ca2+-­free  C-­lobe  engages  HA  utilizing  Trp432,  Leu428  and  Ala425  in  a  NEF3-­EF4C  polarity  
(of  these  only  Leu428  interacts  with  the  FLMMC  tetrad;;  Figure  1.14A)  and  the  Ca2+-­bound  N-­lobe  engages  
the  HC  of  another  protomer,  resulting  in  a  dimer  of  dimers  (PDB:  1G4Y)60.  In  the  complex  involving  SK4,  
elevated   Ca2+   levels   lead   to   the   recruitment   of   one   Ca2+   ion   by   the   CaM  C-­lobe   through   EF3   without  
significant  conformational  changes  and  maintenance  of  the  NEF3-­EF4C  polarity  (PDB:  6CNN,  6CNO).  The  
Ca2+-­saturated   N-­lobe,   that   was   dynamic   in   the   absence   of   Ca2+,   now   engages   the   helical   linker   that  
connects  helices  S4  and  S5  (S45A;;  Figure  1.13A,  right  panel;;  Figure  1.13B,  middle  panel)  of  a  neighboring  
subunit.  This  latter  interaction  involving  the  Ca2+-­saturated  CaM  N-­lobe  triggers  rearrangement  of  the  helix  
S6  in  each  subunit  of  the  tetrameric  assembly  (each  associated  with  one  CaM  for  a  total  of  four)  leading  to  
the  opening  of  the  pore62  (Figure  1.13B,  right  panel).    
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Figure  1.13.  Ca2+-­independent  non-­canonical  interactions  in  CaM.  (A)  Close-­up  of  the  cryo-­EM  structures  
of  CaM  in  complex  with  the  full-­length  SK4  channel  (orange)  in  the  absence  (PDB:  6CNM,  left  panel)  and  
presence  (PDB:  6CNN,  right  panel)  of  Ca2+.  In  the  absence  of  Ca2+,  the  semi-­open  form  of  the  C-­lobe  (EF3  
in  gray  and  EF4  in  dark  red)  makes  hydrophobic  contacts  with  SK4  residues  Ala316,  Leu319  and  Trp323  
(of   these   only   Leu319   contacts   FLMMC;;   the   resolved   sidechains   of   the   latter   are   shown   in   stick  
representation   and   colored   yellow;;   note   that   some   sidechains   of   FLMMC   are   not   resolved   in   the   EM  
structure)  and  additional  polar  contacts  with  the  SK4  HA’  and  HB’  helices  resulting  in  a  NEF3-­EF4C  polarity.  
In   the  presence  of  Ca2+,   the  CaM  C-­lobe  bound  to  one  Ca2+   ion  still  engages   the  HA’  helix  without  any  
polarity   changes  and   the  Ca2+-­saturated  N-­lobe   (green)  engages   the  S45A  helix   (purple)   from  a  nearby  
subunit  causing  it  to  be  displaced  downward.  In  the  context  of  the  tetrameric  SK4  channel,  binding  of  four  
CaM  molecules  leads  to  the  engagement  of  four  sets  of  S45A  helices  and  promotes  rearrangement  of  the  
S6  transmembrane  helices  and  results  in  opening  of  the  channel.  This  process  is  shown  schematically  in  
(B);;  adapted  from  Lee  et  al.62  with  permission.  
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At  first  it  is  somewhat  curious  that  the  Ca2+-­free  CaM  C-­lobe  is  able  to  recognize  CBDs  that  lack  IQ  
motifs.  However,  comparison  of  a  canonical   IQ  motif   interaction  and  a  non-­IQ  motif   interaction  with   the  
Ca2+-­free   C-­lobe   suggests   that   the   some   of   the   structural   features   of   the   former   are   reasonably  
approximated   in   the   latter.   The   Ca2+-­free   C-­lobe   in   complex   with   the   SK2   channel-­derived   construct  
maintains  a  semi-­open  structure  in  the  presence  of  the  Ca2+-­bound  N-­lobe  resembling  in  part  the  C-­lobe  
conformation  in  the  complex  with  the  Myo5a  IQ  motif,  described  above  (Figure  1.14).  E114  of  the  inter-­EF  
linker  of  the  Ca2+-­free  C-­lobe  forms  a  bifurcated  hydrogen-­bond  with  Arg429  (on  helix  HA)  and  Lys455  (on  
helix  HB)  to  stabilize  the  semi-­open  form  and  to  expose  the  hydrophobic  patch,  while  maintaining  a  NEF3-­
EF4C  polarity  (Figure  1.14A).  This   interaction   is   further  stabilized  by  the  burial  of  a  hydrophobic  anchor  
Leu428.  For  the  Myo5a  IQ  motif-­bound  CaM  C-­lobe,  the  interaction  between  E114  with  Arg778  and  Gln774  
of  the  IQ  motif  (Figure  1.14B)  is  what  maintains  the  Ca2+-­free  CaM  C-­lobe  in  a  semi-­open  conformation.  
Inspection   of   these   two   structures   reveals   the   apparently   similar   roles   of   Leu428   and   Asn426   of   SK2  
compared  with  Ile773  (the  I  of  the  IQ  motif)  and  Gln774  (the  Q  of  the  IQ  motif),  respectively,  of  the  Myo5a  
IQ  motif.  
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Figure   1.14.   Interactions   resembling   those   seen   in   IQ  motifs   are   present   in   some   noncanonical   Ca2+-­
independent  interactions.  (A)  Ala425,  Leu428  (engages  FLMMC),  and  Trp432  form  the  three  hydrophobic  
prongs  of  the  HA  helix  for  the  SK2  channel  (orange,  PDB:  1G4Y)  that  interacts  with  the  Ca2+-­free  C-­lobe  of  
CaM.  Arg429  and  Lys455  (blue)  take  part  in  electrostatic  interactions  with  the  sidechain  of  E114  on  CaM  
keeping  its  C-­lobe  in  a  semi-­open  configuration.  (B)   In  the  structure  of  apo-­CaM  in  complex  with  the  IQ  
motif  of  Myo5a  (PDB:  2IX7),  Ile773  (I  of  the  IQ  motif)  of  Myo5a  takes  part  in  hydrophobic  interactions  with  
the  Ca2+-­free  C-­lobe   (and   is   in  a   somewhat   similar   conformation  as  Leu428   in  SK2),   the   sidechains  of  
Gln774  (Q  of  the  IQ  motif)  and  Arg778  (R  of  the  IQ  motif;;  sidechain  in  blue)  participate  in  polar/electrostatic  
interactions   with   the   sidechain   of   CaM   E114   (sidechain   in   red).   Both   C-­lobes  maintain   an   NEF3-­EF4C  
polarity  in  a  semi-­open  form.  The  Q  (Gln774)  of  the  Myo5a  IQ  motif  is  in  a  similar  spatial  position  as  Asn426  
of  SK2.  
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A  similar,  yet  subtly  different  type  of  non-­IQ  motif   interaction  with  the  Ca2+-­free  CaM  C-­lobe  has  
been  demonstrated  by  the  structural  studies  of  CaM  in  complex  with  a  CBD  peptide  (eEF-­2KCBD)  derived  
from  eEF-­2K.  eEF-­2KCBD  interacts  with  apo-­CaM  with  weak  affinity  and  with  (Ca2+)2-­CaM  with  a  significantly  
higher  affinity69.  Biochemical  data  suggest  that  the  Ca2+  requirement  for  the  activation  of  eEF-­2K  can  be  
substantially   reduced,   in   spite   of   the   absolute   requirement   of   CaM,   by   specific   post-­translational  
modifications66,67.  The  NMR  structure  (PDB:  5J8H,  Figure  1.15)  of  the  complex  between  eEF-­2KCBD  and  
Ca2+-­CaM  reveals   that   the  eEF-­2KCBD-­bound  C-­lobe   remains  Ca2+-­free   in  a  semi-­open   form  under  Ca2+  
saturating   conditions,  while   the  N-­lobe  participates   in   the   interaction   in   a  Ca2+-­dependent  manner.  The  
structure  illustrates  that  the  Ca2+-­free  C-­lobe  engages  eEF-­2KCBD  that  forms  a  helix  and  utilizes  Trp85,  Ile89  
and  Ala92  as  hydrophobic  anchors.  The  Ca2+-­loaded  N-­lobe  takes  part  in  weak  interactions  with  Pro98.  Of  
these  hydrophobic  anchors,  Trp85  and  Ile89  directly  contact  FLMMC  and  Pro98  contacts  FLMMN  leading  to  
a  1-­5-­14  mode  of  engagement   (described  originally  as  1-­5-­869  but  Ala92  does  not  contact  either  FLMM  
tetrad)  that  is  normally  restricted  to  the  Ca2+-­saturated  state  of  CaM.  The  overall  interaction  is  supplemented  
by   an   electrostatic   contact   between   Lys91   of   eEF-­2KCBD   and  E114   on   the  CaM  C-­lobe,   that   serves   to  
stabilize   the   inter-­EF   linker   in   the   C-­lobe   in   the   semi-­open   form,   somewhat   resembling   the   mode   of  
stabilization   utilized   by   IQ  motifs   and   the  SK   channels,   as   described   above.   In   addition,   unique   to   the  
interaction   involving   eEF-­2KCBD,   a   salt   bridge   between   Lys93   of   eEF-­2KCBD   and   E87   of   CaM   further  
stabilizes  the  semi-­open  form  of  the  CaM  C-­lobe  (Figure  1.15).  In  this  configuration,  the  C-­lobe  bound  to  
eEF-­2KCBD  is  unable  to  bind  Ca2+.  Recent  native  mass  spectrometry  data  on  a  near  full-­length  construct  of  
eEF-­2K  has  validated  the  presence  of  only  two  Ca2+  ions  in  its  complex  with  CaM70.    
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Figure  1.15.  Ca2+-­independent  non-­canonical  interactions.  (A)  NMR  structure  of  CaM  in  complex  with  eEF-­
2KCBD  (orange)  in  the  presence  of  Ca2+  (PDB:  5J8H).  The  Ca2+-­free  C-­lobe  (EF3  in  gray  and  EF4  in  dark  
red)  engages  the  helical  region  of  eEF-­2KCBD,  making  hydrophobic  contacts  with  Trp85,  Ile89,  and  Ala92  
in  a  NEF4-­EF3C  orientation.  The  Ca2+-­bound  N-­lobe  (green)  further  engages  the  disordered  C-­terminal  tail  
of  eEF-­2KCBD  through  weak  interactions  with  Pro98.  The  interactions  are  reminiscent  of  a  canonical  1-­5-­14  
mode  seen  when  both  N-­  and  C-­lobes  of  CaM  are  Ca2+-­saturated.  The  semi-­open  C-­lobe  is  stabilized  by  
the   electrostatic   contacts   between   Lys91   (sidechain   colored   blue)   of   eEF-­2KCBD   and   E114   (sidechain  
colored   red)   of   CaM,   somewhat   similar   to   that   seen   in   an   interaction   involving   IQ-­motifs.   Additional  
electrostatic  interactions  between  Lys93  (sidechain  colored  blue)  of  eEF-­2KCBD  and  E84  (sidechain  colored  
red)  of  CaM  further  stabilize  the  conformation.  The  sidechains  of  the  FLMMN  and  FLMMC  tetrads  are  shown  
in  stick  representation  in  yellow.  Close-­up  views  of  the  interactions  between  eEF-­2KCBD  with  the  CaM  C-­
lobe  (shown  in  a  surface  representation  in  grey)  (B)  and  the  CaM  N-­lobe  (shown  in  a  surface  representation  
in  green)  (C).  The  sidechains  of  eEF-­2KCBD  residues  Lys91  and  Lys93  are  shown  in  stick  representation  
and   colored   blue;;   the   surface   patches   corresponding   to  CaM   residues  E84  and  E114  are   colored   red.  
Hydrophobic  patches  are  shaded  yellow,  key  hydrophobic  residues  are   labeled  and  residues  of  FLMMN  
and  FLMMC  are  underlined.  
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Figure  1.16.  Number  of  structures  of  CaM  complexes  plotted  against   their  PDB   release  year.  The   total  
number  and  the  number  of  non-­canonical  complexes  are  shown  as  black  and  red  bars,  respectively.  The  
cumulative  number  in  each  case  is  shown  in  the  inset.  
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1.5  Concluding  Remarks  
Here,  we  have  surveyed  the  structural  landscape  populated  by  CaM  complexes  parsing  these  into  
canonical  and  non-­canonical  modes  of  interaction  in  the  presence  and  the  absence  of  Ca2+.  We  realize  that  
other   rational   means   of   classifying   these   structures   in   eminently   possible.      We   also   note   that   the  
classification  used  here   is  biased  by   the   fact   that  most  of  structures  available   in   the  PDB   involve  short  
peptides  from  CaM  targets.  Given  the  fact  more  and  more  structures  of  CaM  bound  to  full-­length  or  near  
full-­length   targets   that   demonstrate   unique   binding  modes   are   being   deposited   into   the  PDB   (31   of   47  
structures   deposited   since   2016   are   classified   as   non-­canonical;;   Figure   1.16),   it   is   likely   that   a  
reassessment   of   the   present   definitions   will   be   required   in   the   near   future.   The   availability   of   CaM   in  
complexes   with   full/near-­full-­length   constructs   of   its   partners   also   suggests   caution   in   over-­interpreting  
results  from  peptide-­based  structural  studies  that  have  largely  been  the  norm  till  date.  For  example,  in  the  
case  of  death-­associated  protein  kinase  (DAPK),  while  the  key  hydrophobic  interactions  are  similar  in  the  
complexes   involving   the   catalytic   domain   of   DAPK   and   a   short   CBD   peptide   derived   from   it,   the  
conformation  of   the  CaM  lobes  was   found  to  be  quite  different   in   the   two  cases71.  Preliminary  chemical  
cross-­linking   data   on   the   CaM-­regulated   kinase   eEF-­2K   also   suggest   differences   in   the   inter-­lobe  
orientation   of   CaM   in   complex   with   a   near   full-­length   construct   compared   to   one   that   involves   a   CBD  
peptide70.    
In  this  review,  we  also  attempted  to  systematize  the  numbering  of  the  hydrophobic  anchors  that  
engage  the  hydrophobic  patches  on  CaM  in  the  canonical  Ca2+-­dependent  interactions.  We  based  this  on  
the  observation  that  two  sets  of  four  residues  each  on  the  N-­lobe  (FLMMN)  and  C-­lobe  (FLMMC)  of  CaM  
may  be  used  to  classify  the  major  hydrophobic  grooves.  This  classification  results   in  some  engagement  
patterns  that  are  somewhat  different  from  those  defined  by  others  (e.g.  we  define  the  engagement  mode  in  
PDB  ID:  2BCX  as  1-­(13)-­17  as  opposed  to  1-­17  by  Tidow  and  Nissen17)  in  a  small  number  of  cases.  We  
have  explicitly  described  these  differences  (or  those  when  our  classification  differs  from  that  of  the  original  
authors;;   e.g.   PDB   ID:   5J8H,   classified   as   1-­5-­14   here   and   1-­5-­8   in   the   original   publication69)   when  
specifically  discussing  the  relevant  structures.  
As  noted  above,  recent  biochemical,  biophysical  and  structural  studies  have  continued  to  provide  
new  insights  into  a  variety  of  CaM-­mediated  regulatory  mechanisms  in  many  CaM-­binding  proteins.  While  
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Ca2+-­signaling  appears  to  be  a  primary  mode  of  modulation  of  the  interactions  of  CaM  with  its  partners,  it  
is  becoming  apparent  that  additional  modes  of  regulation  exist  e.g.  through  post-­translational  modifications  
on   CaM72,73   and   on   its   target   proteins   66,67.   In   addition   to   structural   and   biochemical   studies,   novel  
biophysical  studies  are  beginning  to  provide  insight  into  the  mechanisms  of  substrate  recognition  by  CaM.  
NMR   studies   that   utilize   paramagnetic   relaxation   enhancement   (PRE)   measurements   have   revealed  
transient  states  of  apo  and  Ca2+-­saturated  CaM  that  could  be  crucial   in   the  CBD  recognition74,75.  These  
experimental  studies  of  target  recognition  have  been  reinforced  by  complimentary  in  silico  analyses  of  CaM  
complexes76  in  the  effort  to  obtain  a  comprehensive  spatio-­temporal  view  of  the  interactions  of  CaM  with  
its   targets.      In   addition   to   obtaining   structural   insight   into   the  CaM-­mediated   activation  mechanisms   of  
several  classes  of  proteins  including  kinases  and  channels,  described  above,  protein  interactions  involving  
CaM   are   beginning   to   be   exploited   in   the   field   of   protein   engineering   and   biotechnology.   CaM-­based  
intracellular   Ca2+-­sensors   are   being   utilized   in   neurobiology77-­79,   and   various   Ca2+-­mediated   gene  
expression   systems   have   been   developed   to   expand   the   chemical   biology   toolkit80-­82.   Furthermore,  
engineered  CaM  variants  have  been  created  with  specific  enzymatic  functionalities83-­85.  Now  that  we  are  
approaching  a  half  century  since  the  discovery  of  CaM  as  a  phosphodiesterase  activator86,87,  this  ubiquitous  
Ca2+  sensor  appears  to  be  still  capable  of  providing  many  more  surprises.  
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1.6  Background  -­  eukaryotic  elongation  factor  2  kinase  
Protein  synthesis  constitutes  a  fundamental  process  in  all  living  cells.  Tight  regulation  of  the  rates  
of   protein   synthesis   and   protein   degradation   is   critical   in   maintaining   homeostasis.   The   eukaryotic  
elongation   factor   2   kinase   (eEF-­2K,   82   kDa,   725   residues)   is   a   key   gatekeeper   of   this   regulation88-­92.  
Activated  by  Ca2+-­loaded  calmodulin  (CaM)  and  regulated  by  a  variety  of  phosphorylation  events,  eEF-­2K  
regulates   the   protein   synthesis   by   inhibiting   its   only   known   target,   elongation   factor   2   (eEF-­2)   via  
phosphorylation  (Thr-­56).  Phospho-­eEF-­2  (pThr-­56)  is  impaired  in  its  ability  to  dock  onto  the  ribosome  to  
initiate  GTP-­dependent  translocation  of  peptidyl-­tRNA  and  mRNA  from  the  A-­site  to  the  P-­site93.    
eEF-­2K  is  an  atypical  serine/threonine  kinase  ubiquitously  expressed  in  the  cytosol  of  all  tissues  of  
vertebrates94.  eEF-­2K  belongs  to  the  6-­member  α-­kinase  family  and  shares  no  homology  with  canonical  
protein   kinases95.  Adding   to   its   unique  nature,   eEF-­2K   is   the   only   known  α-­kinase   to   be  activated  and  
regulated  by  Ca2+-­CaM89,96   through  a  mechanism   that  appears   to  be  distinct   from  other  CaM-­regulated  
kinases.   While   structural   information   on   eEF-­2K   is   currently   unavailable,   extensive   biochemical   and  
functional  analyses  have  identified  its  domain  organization97-­99;;  these  include  an  N-­terminal  putative  Ca2+-­
CaM-­binding  domain  (eEF-­2KCBD,  ~77-­96),  an  atypical  kinase  domain  (~138-­318)  that  is  separated  from  a  
set   of   three   Sel-­1-­like100   repeats   (~523-­563,   ~565-­609,   ~665-­700)   by   a   regulatory   loop   (R-­loop)   that  
contains  multiple  phosphorylation  sites   including   the  autophosphorylation  site,  Thr-­348101,   that   is  key   to  
kinase  activation.  The  extreme  C-­terminus  of  eEF-­2K  (~711-­725)  appears  to  be  critical  for  the  recognition  
of  eEF-­299.  
The  first  step  in  eEF-­2K  activation  involves  the  binding  of  Ca2+-­loaded  CaM.  This  leads  to  a  104-­
fold  enhancement  in  rate  of  autophosphorylation  on  Thr-­348  and  concurrent  103-­fold  increase  in  the  rate  of  
substrate  phosphorylation101.  While  biochemical  analyses  suggest  a  two-­step  kinetic  mechanism  of  eEF-­
2K  activation  (Figure  1.15),  the  precise  mechanism  of  the  process  is  as  of  yet  unknown.  
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Figure   1.17.   Current   model   of   eEF-­2K   activation.   Ca2+-­CaM   binds   to   the   kinase   in   the   inactive   state  
inducing  a  conformational  transition  at  its  active  site  This  change  allows  rapid  autophosphorylation  on  Thr-­
348.  A  second  conformational  transition  involving  the  R-­loop  follows  and  enhances  the  activity  of  the  kinase  
towards  eEF-­2.  This  proposal   involves   the  structural  characterization  of   the  conformation  of  CaM  in   the  
state  shown  with  the  black  outline.  
  
1.7  Role  of  eukaryotic  elongation  factor  2  kinase  in  essential  hypertension    
Recent  studies  have  shown  that  eEF-­2K  regulation  is  involved  in  hypertensive  vascular  remodeling  
(VR)  during  vascular  smooth  muscle  cell  (VSMC)  differentiation  in  response  to  biochemical  abnormalities  
and/or  mechanical  changes   in   the   local  environment102-­104.  During  essential  hypertension,   the  molecular  
regulation   of   VR   directs   mature   VSMCs   to   undergo   morphogenesis,   adopt   pathogenic   structures   and  
acquire  contractility  altering  hemodynamics  and  aggravating  oxidative  stress,  inflammation,  and  vascular  
injury105,106.  Elevated  eEF-­2K  expression  levels  and  modulation  of  its  activity  have  been  observed  during  
extensive  VR  in  spontaneously  hypertensive  rat,  an  animal  model  of  essential  hypertension102.  Inhibition  or  
knockdown   of   eEF-­2K   halts   disease   progression,   suggesting   that   eEF-­2K   could   be   an   attractive  
pharmaceutical  target  for  the  prevention  of  hypertensive  cardiovascular  diseases103,104.  
A   structural   analysis   of   the  Ca2+-­CaM-­eEF-­2K   interaction  will   not   only   help   in   elucidating,  what  
appears  to  be,  a  unique  mode  of  association  between  CaM  and  eEF-­2K,  providing  selectivity  and  specificity  
for  targeted  therapeutics,  but  also  provide  a  starting  point  for  understanding  eEF-­2K  activation  mechanism  
involved   in  hypertensive  VR   in  essential  hypertension.  Mechanistic  and  structural  studies  of  pathogenic  
eEF-­2K  activation  will  also  further  contribute  to  understanding  of  the  mechanisms  of  hypertension-­driven  
diseases   (stroke,  myocardial   infarction,   heart   failure,   renal   failure   etc.),107,108   as  well   as   atherosclerosis  
(eEF-­2K  molecular  regulation  in  angiogenesis  and  plaque  formation)109-­111.    
eEF-2K Ca2+-CaM•eEF-2K Ca2+-CaM•eEF-2K Ca2+-CaM•eEF-2KpThr-348 Ca2+-CaM•eEF-2KpThr-348
Ca2+-CaM Conf. change Mg2+•ATP Conf. change
Activated
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1.8  Project  goal  
The  long-­term  goal  of  this  research  is  to  determine  structurally,  mechanistically,  and  functionally,  
the  role  of  Ca2+-­CaM  in  activating  eEF-­2K.  A  critical  step  towards  this  goal,  addressed  in  Chapter  2  and  3  
through  two  specific  aims,  is  to  establish  the  structural  basis  of  how  CaM  recognizes  and  activates  eEF-­
2K:  1)  Establish   the  structural  basis   for   the   interaction  of  CaM  with  a  predicted  CaM-­binding  sequence  
located  at  the  eEF-­2K  N-­terminus;;  2)  Determine  the  conformation  of  Ca2+-­CaM  bound  to  eEF-­2K.    
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Chapter  2  -­  Structural  Basis  for  the  Recognition  of  Eukaryotic  Elongation  Factor  2  Kinase  by  
Calmodulin  
The  contents  of  this  chapter  were  published  as:  
Lee,  Kwangwoon,  Sébastien  Alphonse,  Andrea  Piserchio,  Clint  DJ  Tavares,  David  H.  Giles,  
Rebecca  M.  Wellmann,  Kevin  N.  Dalby,  and  Ranajeet  Ghose.  "Structural  basis  for  the  recognition  
of  eukaryotic  elongation  factor  2  kinase  by  calmodulin."  Structure  24,  no.  9  (2016):  1441-­1451.  
©  2016  Cell  Press    
*3-­letter  amino  acid  code  for  eEF-­2K  and  1-­letter  amino  acid  code  for  CaM  were  used  
2.1  Abstract  
Binding  of  Ca2+-­loaded  calmodulin  (CaM)  activates  eukaryotic  elongation  factor  2  kinase  (eEF-­2K)  
that  phosphorylates  eEF-­2,  its  only  known  cellular  target,  leading  to  a  decrease  in  global  protein  synthesis.  
Here,   using   an   eEF-­2K-­derived   peptide   (eEF-­2KCBD)   that   encodes   the   region   necessary   for   its   CaM-­
mediated  activation,  we  provide  a  structural  basis  for  their  interaction.  The  striking  feature  of  this  association  
is  the  absence  of  Ca2+  from  the  CaM  C-­lobe  sites,  even  under  high  Ca2+  conditions.  eEF-­2KCBD  engages  
CaM  largely  through  the  C-­lobe  of  the  latter  in  an  anti-­parallel  1-­5-­8  hydrophobic  mode  reinforced  by  a  pair  
of  unique  electrostatic  contacts.  Sparse  interactions  of  eEF-­2KCBD  with  the  CaM  N-­lobe  results  in  persisting  
inter-­lobe   mobility.   A   conserved   eEF-­2K   residue   (Trp85)   anchors   it   to   CaM   by   inserting   into   a   deep  
hydrophobic   cavity   within   the   CaM   C-­lobe.   Mutation   of   this   residue   (Trp85Ser)   substantially   weakens  
interactions  between  full-­length  eEF-­2K  and  CaM  in  vitro  and  reduces  eEF-­2  phosphorylation  in  cells.  
2.2  Introduction  
Eukaryotic  elongation  factor-­2  kinase  (eEF-­2K),  a  member  of  the  atypical  α-­kinase  family96,94,112,  
inhibits  eukaryotic  elongation  factor  2  (eEF-­2),  its  only  known  physiological  substrate,  by  phosphorylating  
it  on  a  specific  threonine  (Thr56)89,113,114.  Phosphorylated  eEF-­2  has  impaired  ability  to  bind  the  ribosome  
resulting  in  an  overall  reduction  in  the  rate  of  protein  synthesis115-­117.  The  regulation  of  protein  synthesis  by  
eEF-­2K  is  critical  in  a  variety  of  cellular  processes,  ranging  from  the  control  of  cell  cycle  progression118  to  
driving  the  synthesis  of  proteins  necessary  for  synaptic  plasticity119-­122.  Aberrant  eEF-­2K  activity  is  thought  
to   contribute   to   several   disease   states,   including   a   variety   of   cancers123-­125,   Alzheimer’s   disease126,127,  
depression128,129,  and  heart  disease130,131,103.    
	  
	   38	  
Utilizing  a  variety  of  steady  and  pre-­steady  state  kinetics  measurements  combined  with  in  vitro  and  
cell-­based  assays,  Tavares  et.  al  demonstrated  that  eEF-­2K  is  activated  through  a  unique  two-­step  process  
initiated  by   the  binding  of  Ca2+-­loaded  calmodulin  (CaM)101.  This  mode  of  activation  does  not  appear   to  
occur  through  a  “release  of  inhibition”  mechanism132,133  and  sets  eEF-­2K  apart  from  other  CaM-­dependent  
kinases.   In   the   first   step,   the   inactive   kinase   undergoes   a   conformational   transition   within   its   catalytic  
domain  induced  by  Ca2+-­CaM  binding.  This  leads  to  a  more  than  a  103-­fold  enhancement  in  its  ability  to  
auto-­phosphorylate   on   a   key   threonine   (Thr348,   eEF-­2K   residues   are   italicized   throughout   the   text   to  
distinguish  them  from  CaM  residues)  in  the  regulatory  (R-­loop)  immediately  C-­terminal  to  the  kinase  domain  
(Figure   2.1).      The   engagement   of   a   basic   allosteric   binding   pocket   within   the   kinase   domain   by  
phosphorylated  Thr348  enables  a  second  conformational  transition  of  the  R-­loop  to  generate  a  state  with  
the  highest  activity  towards  substrate.  Thus,  the  fully  active  conformation  of  eEF-­2K  is  attained  through  two  
sequential  conformational  transitions  initiated  by  Ca2+-­CaM  binding,  which  represents  a  critical  step  in  the  




Figure  2.1.    Schematic  representation  of  the  domain  organization  of  eEF-­2K.  The  catalytic  domain  (CD,  
cyan),  the  basic  allosteric  pocket  (yellow)  and  the  critical  auto-­phosphorylation  site  Thr348  (green)  on  the  
regulatory  loop  (R-­loop)  are  shown;;  the  C-­terminal  domain  (CTD,  red)  contains  multiple  Sel1  like  repeats  
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The   absence   of   an  N-­terminal   segment   (75-­100)   on   eEF-­2K   prevents   its  Ca2+-­CaM-­dependent  
activation,  suggesting  that  a  CaM-­binding  site  is  localized  within  this  segment97.  On  the  basis  of  sequence  
analysis  together  with  biochemical  studies,  eEF-­2K  has  been  proposed  to  engage  CaM  in  a  1-­5-­8-­14  mode  
(numbers  indicate  spacing  of  critical  hydrophobic  anchors)134  within  the  fragment  encompassing  residues  
Phe79   through  Met9597.  However,   this  sequence   in  eEF-­2K  contains  a  histidine  rather   than  a  canonical  
hydrophobic   residue   at   the   14th   position,   suggesting   that   the   overall   binding   mode   deviates   from   this  
predicted  topology.  Thus,  as  a  necessary  step  towards  determining  the  structural  and  mechanistic  basis  of  
the  regulation  of  eEF-­2K  by  Ca2+-­CaM,  we  determined  the  structure  of  CaM  in  complex  with  a  27-­residue  
peptide  (eEF-­2KCBD)  encompassing  residues  Ser74-­Ala100  of  eEF-­2K.  
Our  results  indicate  that  eEF-­2KCBD  interacts  with  CaM  largely  through  the  C-­lobe  of  the  latter,  in  a  
fashion  reminiscent  of  a  1-­5-­8  mode,  with  several  unique  features,  most  importantly,  the  absence  of  Ca2+  
ions  in  the  C-­lobe  metal  binding  sites  even  at  high  Ca2+  concentration.  NMR  data  suggest  little  difference  
in  the  conformation  of  the  C-­lobe  between  the  apo  and  Ca2+-­loaded  states  of  CaM  when  peptide-­bound.  
Interactions  between  eEF-­2KCBD  and  the  N-­lobe  of  CaM  are  enhanced  with  the  occupancy  of  the  N-­lobe  
Ca2+-­sites,  but  are  absent  when  Ca2+  is  not  present.  These  interactions,  though  weak  in  isolation,  combined  
with  those  involving  the  C-­lobe  lead  to  a  ~240-­fold  increase  in  affinity.  Based  on  the  structure  of  the  Ca2+-­
CaM•eEF-­2KCBD  complex,  disruption  of  the  key  hydrophobic  anchoring  interaction  involving  Trp85  on  eEF-­
2KCBD  by  substitution  with  a  polar   residue  (Trp85Ser)   leads   to  a  ~80-­fold  reduction   in   the  affinity  of   full-­
length  eEF-­2K  towards  CaM  and  in  its  ability  to  phosphorylate  eEF-­2  in  cells.    
2.3  Materials  and  methods  
2.3.1  Cloning,  expression  and  purification  
DNA  fragments  encoding  full-­length  human  calmodulin  (CaM)  and  a  predicted  calmodulin  binding  
segment  of  human  eEF-­2K   (residues  74-­100;;  eEF-­2KCBD;;   codon-­optimized  and  synthesized,  Genscript)  
were  cloned  separately  into  pET28b  vectors  (Novagen)  containing  an  N-­terminal  His6-­SUMO-­tag  between  
the   BamHI   and   XhoI   sites.   The   C-­terminal   Ser   of   the   SUMO   tag   was   subsequently   mutated   to   Ala  
(GGSàGGA)  for  the  CaM  construct  using  In-­Fusion  HD  Cloning  Kit  (Clontech)  to  allow  production  of  wild-­
type  CaM   (A1   to  K148)  after   removal  of   the  His6-­SUMO-­tag   in   the  overexpressed  protein  as  described  
below.  
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Plasmids  encoding  His6-­SUMO-­CaM  or  His6-­SUMO-­eEF-­2KCBD  were  transformed  into  E.  coli  BL21  
(DE3)   cells.   Fresh   colonies   were   inoculated   into   starter   Luria-­Bertani   (LB)   media   supplemented   with  
kanamycin  (50  mg/L),  grown  overnight  at  37  °C,  and  centrifuged  (4000  g  for  15  min  at  4  °C).  The  cell  pellet  
was  re-­suspended  in  1  L  LB  or  M9  media  supplemented  with  1  g/L  15NH4Cl  and  2  g/L  [U-­13C]  glucose  for  
the  production  of  unlabeled  or  uniformly  15N,  13C-­labeled  protein,  respectively,  and  grown  at  37  °C  until  the  
OD600  reached  0.8.  To  induce  expression,  1  mM  isopropyl  β-­D-­1-­thiogalactopyranoside  (IPTG)  was  added,  
followed  by  3.5  hours  of  incubation  at  37  °C.  Cells  were  harvested  by  centrifugation  (4000  g  for  30  min  at  
4  °C).  The  cell  pellets  were  re-­suspended  in  lysis  buffer  containing  50  mM  Tris  at  pH  8.0,  500  mM  NaCl,  5  
mM  2-­mercaptoethanol,  8  M  urea,  and  1  protease  inhibitor  cocktail  tablet  (Roche),  lysed  by  sonication,  and  
heat  shocked  at  80  °C  for  15  minutes.  After  centrifugation  (15,000  g  for  30  min  at  4  °C),  the  supernatant  
was  extracted  and  incubated  with  Ni-­NTA  beads  (Qiagen)  for  30  min  at  room  temperature.  The  beads  were  
poured   into  an  Econo-­Column   (Bio-­Rad),  washed  with  10  column  volumes  of   lysis  buffer   and   refolding  
buffer  (50  mM  Tris  at  pH  8.0,  150  mM  NaCl,  and  5  mM  2-­mercaptoethanol),  and  eluted  with  elution  buffer  
(refolding  buffer  containing  250  mM  imidazole).    The  eluents  were  dialyzed  against  4  L  refolding  buffer  at  
4  °C  for  16  hours.  Ulp1  (1:1000  Ulp1  to  fusion  mass  ratio)  protease  was  added  to  the  dialyzed  samples  and  
incubated  at  30  °C  for  2  hours.  Cleaved  eEF-­2KCBD  was  concentrated  and  exchanged  into  Ca2+-­NMR  buffer  
(20  mM  Bis-­Tris  at  pH  6.8,  150  mM  KCl,  and  10  mM  CaCl2)  or  apo-­NMR  buffer  (Ca2+-­free)  (20  mM  Bis-­Tris  
at  pH  6.8,  150  mM  KCl,  and  10  mM  EGTA)  using  a  3  kDa  MWCO  centrifugal  concentrator  (EMD  Millipore).  
eEF-­2KCBD   was   then   purified   using   a   gel   filtration   column   (Superdex   75   10/300   GL,   GE   Healthcare  
Biosciences)  pre-­equilibrated  with  the  Ca2+-­  or  apo-­NMR  buffer.  Cleaved  CaM  was  passed  over  a  Ni-­NTA  
column  and  washed  with  wash  buffer  (50  mM  Tris  at  pH  8.0,  150  mM  NaCl,  and  10  mM  imidazole).  After  
adding  2  mM  CaCl2  into  the  flow-­through  and  wash  fractions,  Ca2+-­CaM  was  further  purified  over  a  phenyl  
sepharose  column  (HiTrap  Phenyl  Sepharose  FF,  GE  Healthcare  Biosciences)  and  a  size  exclusion  column  
(Superdex  75  10/300  GL).  
Recombinant   full-­length  human  eEF-­2K  (wild-­type  and   the  Trp85Ser  mutant)  was  co-­expressed  
with  λ-­phosphatase  in  E.  coli,  and  purified  as  described  earlier135,66,101.  However,  the  Trp85Ser  mutant  was  
purified  by  anion-­exchange  chromatography   (Mono  Q)   instead  of  CaM-­agarose  affinity  chromatography  
described  previously.      
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2.3.2  NMR  sample  preparation  
To   prepare   NMR   samples   of   the   1:1   Ca2+-­CaM•eEF-­2KCBD   complex,   U-­[15N,13C]-­CaM   and  
[unlabeled]-­eEF-­2KCBD   or   [unlabeled]-­CaM   and   U-­[15N,13C]-­eEF-­2KCBD   were  mixed   at   1:2   CaM   to   eEF-­
2KCBD  ratio.  The  resulting  complex  containing  an  excess  of  eEF-­2KCBD  was  passed  through  a  gel  filtration  
column  (Superdex  75  10/300  GL)  pre-­equilibrated  with  the  Ca2+-­NMR  buffer  (20  mM  Bis-­Tris  at  pH  6.8,  150  
mM  KCl,  and  10  mM  CaCl2).  The  fractions  containing  the  complex  were  pooled  and  concentrated  using  a  
3  kDa  MWCO  centrifugal  concentrator  (EMD  Millipore).    
Apo-­CaM•eEF-­2KCBD  NMR  samples  were  prepared  by  directly  mixing  U-­[15N/13C]-­apo-­CaM  with  
[unlabeled]-­eEF-­2KCBD  at  1:3  molar  ratio  in  the  apo-­NMR  buffer  (20  mM  Bis-­Tris  at  pH  6.8,  150  mM  KCl,  
and  10  mM  EGTA).  All  NMR  samples  (300  µL)  were  prepared  in  Ca2+-­NMR  or  apo-­NMR  buffers  in  either  
95  %  H2O,  5%  D2O  mixture  or  >99%  D2O  with  final  CaM  concentrations  ranging  between  ~300  and  ~600  
µM.    The  identities  and  purity  of  the  samples  were  confirmed  using  Tris-­tricine  gels  and  MALDI-­TOF  mass  
spectrometry  (Figure  2.16).    
  
Figure  2.16.  Quality   inspection  of   eEF-­2KCBD.   (A)  Three-­layer  Tris-­tricine  gel   image  of   eEF-­2KCBD  after  
ULP1-­cleave.  No  degradation  or  impurity  is  observed  in  the  lane  of  “eEF-­2KCBD”.  The  protocol  for  casting  
the  gel  was  incorporated  from  Ref136  (B)  MALDI-­TOF  spectrum  of  eEF-­2KCBD.  A  major  peak  containing  eEF-­
2KCBD  in  a  +1  charged  state  at  3159.7  m/z  is  shown,  while  its  +2  charged  state  is  located  at  1580.8  m/z.    
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2.3.3  Isothermal  titration  calorimetry  
The  affinity  of  eEF-­2KCBD  for  Ca2+-­CaM  was  determined  using  isothermal  titration  calorimentry  (ITC)  
measurements.   Three   sets   of   experiments   were   performed   under   identical   conditions   to   confirm  
reproducibility.  eEF-­2KCBD  samples  were  dialyzed  against  4  L  Ca2+-­NMR  buffer  for  24  hours  at  25  °C  using  
a  1  kDa  MWCO  dialysis  bag  (Spectrum  Labs).  All  samples  and  solutions  were  filtered  and  degassed  prior  
to  measurements.  Calorimetric  titrations  were  carried  out  at  35  °C  using  MicroCal  iTC200  (Malvern).  17.5  
µM  CaM  and  253  µM  eEF-­2KCBD  were  filled  in  the  injection  syringe  and  the  sample  cell,  respectively.  After  
a  0.4  µL  preliminary  injection,  1  µL  Ca2+-­CaM  was  injected  into  the  sample  cell  38  times  every  180  s,  while  
being  stirred  at  600  rpm.  As  control,  Ca2+-­CaM  was  injected  into  the  sample  cell  filled  with  Ca2+-­NMR  buffer.  
The  normalized  data  were  analyzed  using  the  Origin  software  ligand-­in-­cell  module  and  the  one-­site  binding  
model.    
2.3.4  Resonance  assignment  
All  NMR  experiments  were  performed  at  35  °C  on  Varian  Inova  (600  MHz)  or  Bruker  Avance  (500,  
600,  800  and  900  MHz)  spectrometers  equipped  with  cryogenic  probes  capable  of  applying  pulsed  field  
gradients  along  the  z-­axis.  Spectra  were  processed  using  NMRPipe137  and  analyzed  using  NMRViewJ138.  
Assignment  of  1H,  13C,  and  15N  resonances  of  Ca2+-­CaM  and  eEF-­2KCBD  in  the  context  of  the  Ca2+-­
CaM•eEF-­2KCBD  complex  was  achieved  using  standard  backbone-­directed  triple-­resonance  strategies139  
using  the  experiments  shown  in  Table  2.2.  A  variety  of  15N-­  or  13C-­edited  (with  or  without  filtering  on  15N  or  
13C)   NOESY-­HSQC   or   NOESY-­HMQC   experiments   (Table   2.3)   were   used   to   complete   resonance  
assignments  and   to  obtain  distance  constraints   for  structure  determination.  CaM  methionine  ε-­positions  
were  assigned  through  a  13C-­edited  NOESY-­HSQC  using  CaM  13C,  1H-­labeled  at  the  Ile-­δ1  position  and  
13C-­labeled  at  the  Met-­ε  position  in  an  otherwise  U-­[2H,12C,15N]-­labeled  background  (IM-­labeled)  in  complex  
with   unlabeled   eEF-­2KCBD.   IM-­labeling   of   CaM   was   achieved   by   incorporating   labeling   schemes   as  
described  earlier140  within  the  expression  and  purification  protocol  discussed  above.  The  backbone  1H,  13C,  
and  15N  resonances  of  apo-­CaM  in  the  apo-­CaM•eEF-­2KCBD  complex  were  also  assigned  using  standard  
backbone-­directed  triple  resonance  strategies  (Table  2.2).  
Backbone  resonance  assignments  for  apo-­  and  Ca2+-­CaM  were  obtained  by  utilizing  assignments  
obtained  under  conditions  similar  to  ours  (kindly  provided  by  the  Griesinger  laboratory)  and  those  available  
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in   the   literature   141.   Various   backbone-­directed   triple-­resonance   experiments   (Table   2.2)   were   used   to  
resolve  ambiguities  and  confirm  assignments.  
  




Points  are  complex  points,  sweep-­widths  are  in  ppm,  field  is  1H  frequency  in  MHz  
Ca2+-­CaM  in  the  Ca2+-­CaM•eEF-­2KCBD  Complex  
   D1   D2   D2   Field  
Experiment   Points   SW   Nucleus   Points   SW   Nucleus   Points   SW   Nucleus     
HNCO   512   13.3   1H   37   12   13C   37   28   15N   600  
HN(CA)CO   512   13.3   1H   37   12   13C   37   28   15N   600  
CBCA(CO)NH   512   13.3   1H   48   64   13C   32   28   15N   600  
HNCACB   512   14.0   1H   32   27   15N   48   66   13C   600  
H(CC)(CO)NH-­TOCSY   512   15.0   1H   32   30   15N   53   9   1H   500  
(H)CC(CO)NH-­TOCSY   512   13.3   1H   50   70   13C   30   30   15N   600  
CCH-­TOCSY   512   10.0   1H   64   70   13C   40   70   13C   600  
eEF-­2KCBD  in  the  Ca2+-­CaM•eEF-­2KCBD  Complex  
   D1   D2   D3   Field  
Experiment   Points   SW   Nucleus   Points   SW   Nucleus   Points   SW   Nucleus     
HNCO   512   14   1H   24   22   15N   29   9   13C   500  
CBCA(CO)NH   512   12.6   1H   30   22   15N   47   70   13C   800  
HNCACB   512   14.0   1H   27   22   15N   39   56   13C   800  
HNCA   512   14.0   1H   25   22   15N   50   16.4   13C   900  
H(CC)(CO)NH   512   11.0   1H   23   20.5   15N   46   9.8   1H   900  
(H)CC(CO)NH   512   16.0   1H   23   16   15N   47   60   13C   600  
HCCH-­TOCSY   512   12.0   1H   32   60   13C   64   9   1H   600  
Apo-­CaM  in  the  Apo-­CaM•eEF-­2KCBD  Complex  
   D1   D2   D3   Field  
Experiment   Points   SW   Nucleus   Points   SW   Nucleus   Points   SW   Nucleus     
HNCO   512   14.0   1H   37   27   15N   37   11.2   13C   800  
HN(CA)CO   512   13.3   1H   37   12   13C   37   28   15N   600  
CBCA(CO)NH   512   14.0   1H   32   27   15N   26   66   13C   800  
HNCACB   512   14.0   1H   32   27   15N   31   66   13C   800  
HNCA   728   13.3   1H   30   35   13C   30   28   15N   600  
Apo-­CaM  
   D1   D2   D3   Field  
Experiment   Points   SW   Nucleus   Points   SW   Nucleus   Points   SW   Nucleus     
HNCO   512   13.9   1H   32   26   15N   60   12   13C   800  
HN(CA)CO   512   13.9   1H   32   26   15N   33   12   13C   800  
CBCA(CO)NH   512   13.9   1H   32   26   15N   42   65   13C   800  
HNCACB   512   13.9   1H   32   26   15N   60   65   13C   800  
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Table  2.3.  NOESY  parameters  experiments  in  the  Ca2+-­CaM•eEF-­2KCBD  complex  
  
Ca2+-­CaM  in  the  Ca2+-­CaM•eEF-­2KCBD  Complex  
     D1   D2   D3   Field    
Experiment   Points   SW    Nucleus   Points   SW     Nucleus   Points   SW    Nucleus   Mixinga       
15N-­edited  NOESY-­HSQC   512   13.0   1H   48   30   15N   128   13   1H   100   800  
13Caliphatic-­edited  NOESY-­HSQC   512   13.0   1H   65   72   13C   122   13   1H   120   800  
13Caromatic-­edited  NOESY-­HMQC   512   14.0   1H   135   11   1H   24   30   13C   150   800  
13Caliphatic-­filtered  NOESY-­HSQC   512   13.0   1H   49   70   13C   69   13   1H   120   600  
13C  I,  M-­edited  NOESY-­HSQC   512   13.3   1H   64   13.3   1H   20   10   13C   300   600  
eEF-­2KCBD  in  the  Ca2+-­CaM•eEF-­2KCBD  Complex  
   D1   D2   D3   Field    
Experiment   Points   SW    Nucleus   Points   SW     Nucleus   Points   SW    Nucleus   Mixinga       
15N-­edited  NOESY-­HSQC   512   12.6   1H   22   17   15N   85   12.6   1H   120     900  
13Caromatic-­edited  NOESY-­HSQC   512   11.0   1H   32   28   13C   64   13   1H   150     500  
13Caromatic-­edited  NOESY-­HMQC   512   13.0   1H   32   28   13C   90   13   1H   150     800  
13Caliphatic-­filtered  NOESY-­HSQC   512   12.0   1H   30   59   13C   60   10   1H   150     800  
  
aMixing  time  is  in  ms.  
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2.3.5  Chemical  shift  perturbation  analysis  
Chemical  shift  perturbations  for  backbone  amides  between  two  states  1,  2  were  calculated  using  
the  following  equation:  
 












            (1)  
Where  δH1,2  and  δN1,2  are  the  1H  and  15N  chemical  shifts,  respectively,  for  each  state.  
2.3.6  Analysis  of  the  interaction  between  apo-­CaM  and  eEF-­2KCBD  
Given  the  weaker  affinity  of  eEF-­2KCBD  towards  apo-­CaM,  an  estimate  of  the  binding  affinity  of  the  peptide  
was  obtained  using  NMR-­based  titrations.  Starting  with  a  300  µL  sample  containing  80  µM  of  U-­[15N,13C]-­
CaM  and  447  µM  [unlabeled]-­eEF-­2KCBD  in  apo-­NMR  buffer,  eEF-­2KCBD  was  diluted  at  each  titration  point  
by  replacing  the  complex  in  solution  with  aliquots  of  80  µM  U-­[15N,13C]-­apo-­CaM  alone  in  apo-­NMR  buffer.  
Sixteen   different   reverse   titration   points   were   monitored   by   15N,   1H   HSQC   spectra.   After   transferring  
assignments,  representative  residues  from  the  C-­lobe  for  the  eEF-­2KCBD-­saturated  state  (CaM:eEF-­2KCBD  
ratio  of  1:5.6)  were  chosen  and  their  intensity  (I)  as  a  function  of  the  final  eEF-­2KCBD  concentration  (P=0,  
10,  20,  30,  40,  50,  60,  80,  100,  120,  160,  200,  240,  360,  400,  447  µM;;  CaM  concentration  C0=80  µM)  were  
fitted  to  Equation  (2)  to  obtain  an  estimate  of  the  KD.    
2.3.7  Determination  of  the  Ca2+  requirement  of  the  Ca2+-­CaM•eEF-­2KCBD  complex     
A  sample  containing  150  µM  of  U-­[15N,13C]-­apo-­CaM  and  250  µM  of  [unlabeled]-­eEF-­2KCBD  was  
prepared  in  a  buffer  containing  20  mM  Bis-­Tris  at  pH  6.8,  150  mM  KCl,  and  40  µM  EGTA.  Using  a  10  mM  
Ca2+  stock  solution,  Ca2+  was  titrated  into  the  Ca2+-­free  complex  in  19  increments  up  to  a  final  concentration  
of  5.3  molar  equivalents  of  Ca2+.  The  titration  course  was  monitored  using  15N,  1H  HSQC  spectra  (1H  =  512  
points,  SW  =  13  ppm;;  15N  =  128  points,  SW  =  28  ppm).  The  final  peak  positions,  especially  for  the  N-­lobe  
of   CaM,   deviated   from   those   of   the   1:1   Ca2+-­CaM•eEF-­2KCBD   complex.   These   resonances   were   then  
assigned  by  titrating  unlabeled  eEF-­2KCBD  into  the  1:1  complex  of  U-­[15N,13C]-­Ca2+-­CaM•[unlabeled]-­eEF-­
2KCBD.  After  complete  assignment  of  resonances,  the  intensities  for  each  resonance  in  the  spectrum  was  
quantified  at  each  concentration  of  Ca2+  and  subsequently  utilized  to  determine  the  Ca2+  requirement  of  the  
complex.  
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2.3.8  Structure  calculations  
The  structure  of  the  Ca2+-­CaM•eEF-­2KCBD  complex  was  performed  using  ARIA2.3  (CNS2.1.2)142  using  the  
PARALLHDG  force  field  with  PROLSQ  non-­bonded  energy  terms143  and  experimental  distance  and  angular  
restraints.   NOE-­based   distance   restraints   were   extracted   from   several   sets   of   3-­dimensional   NOESY  
experiments  recorded  on  two  distinct  Ca2+-­CaM•eEF-­2KCBD  samples,  where  either  only  the  protein  or  the  
peptide  was  15N-­13C  labeled  (Table  2.3).  Backbone  Ф  and  Ψ  dihedral  restraints  were  derived  from  the  1HN,  
13Cα,   13Cβ,   13C   and   15N   chemical   shifts   using   TALOS+144.   To   ensure   correct   packing   of   the   peptide  
sidechains  with   those   of   the   protein   a   set   of   intermolecular   distance   restraints   based   on   unambiguous  
assignments  were  injected  at  the  beginning  of  the  structure  calculations.  These  intermolecular  restraints  
were  obtained  from  manually  assigned  cross-­peaks  of  the  filtered  NOESY  experiments  (Figure  2.4)  that  
were  converted  into  distances.  After  few  runs  of  structure  calculation,  the  ARIA  protocol  was  able  to  assign  
a  sufficient  number  of  intermolecular  NOEs,  and  the  manual  distance  restraints  were  no  longer  necessary  
to  obtain  correct  packing.  At  that  stage  of  the  calculation  protocol  only  the  assigned  peaklists  (manually  or  
automatically  assigned)  were  used  and  manual  distances  were  no  longer  utilized.  
Structure  calculations  consisted  of  eight  cycles  of  iterative  NOE  assignment.  Assignments  obtained  
in  this  fashion  were  converted  into  distance  restraints  by  the  ambiguous  distance  restraints  (ADR)  protocol  
as   implemented   in   the  ARIA   software   suite.   These  were   combined  with  manually   assigned  NOEs   and  
dihedral  angle  restraints  generated  by  TALOS+  for  the  structure  calculations.  Calculations  were  performed  
using  a  torsion  angle  dynamics  based  simulated  annealing  protocol  where  100  structures  were  generated  
at   every   iteration  with   the   25   lowest   energy   structures  were   used   for   the   next   iteration.   The   simulated  
annealing  protocol  consisted  of  a  high  temperature  torsion  angle  stage  with  10000  steps  at  10000  K  (using  
30  ps  time  steps),  followed  by  a  cooling  phase  to  2000  K  in  8000  steps.  The  next  steps  consisted  of  two  
Cartesian  dynamics  cooling  phases:  (i)  2000  K  to  1000  K  in  10000  steps  (using  3  fs  time  steps)  and  (ii)  
from  1000  K  to  50  K  in  8000  steps  (using  3  fs  time  steps).  Force  constants  of  5,  25  and  200  KCal•mol-­1  
were  used  for  the  dihedral  restraints  and  10,  10,  50  KCal•mol-­1  were  used  for  the  distance  restraints  during  
the  three  temperature  stages  of  the  simulated  annealing  protocol.  Prochiral  proton  and  methyl  groups  from  
Val  and  Leu  were   treated  using   the   floating  chirality  method.  At   the  end   the  eighth   iteration,  25   lowest  
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energy  structures  were  submitted  to  a  final  refinement  step  in  an  explicit  solvent  shell  using  the  OPLS  force-­
field145.    
At   the   final   stages   of   the   structure   calculation  Ca2+   ions  were   added   to   the   complex   using   12  
unambiguous  distance  restraints  (based  on  the  canonical  Ca2+-­  binding  sites  of  the  N-­lobe  of  CaM  and  2  
Ca2+   ions)  and  an  optimized  version  of  the  PARALLHDG  force  field  was  used.  The  simulated  annealing  
protocol  was  the  same  as  that  described  above  except  that  600  structures  (instead  of  100  structures)  were  
generated   for  each   iteration.  At   the   final   step,   the  100   lowest  energy   structures  were  subject   to  a   short  
restrained  molecular  dynamics  simulation  in  explicit  solvent  using  XPLOR-­NIH146.  
After  the  final  run,  the  water-­refined  structures  that  did  not  have  any  distance  or  dihedral  constraint  
violations   >   0.5   Å   and   5°,   respectively,   were   ordered   according   to   the   combined   RMSDs   on   the   C-­
lobe/peptide  residues  (see  legend  to  Table  2.1)  and  the  top  20  structures  were  selected  for  validation  using  
PROCHECK-­NMR  2.0147  and  the  WHATIF  web-­server148.  Individual  structures  of  the  NMR  ensemble  were  
superimposed   using   the   McLachlan   algorithm   as   implemented   in   the   program   PROFIT  
(http://www.bioinf.org.uk/software/profit/)   and   analyzed   using   Molmol149   and   UCSF   Chimera150.  
Experimental  restraints  and  structural  statistics  are  summarized  in  Table  2.1.    
2.3.9  Measurement  and  analysis  of  residual  dipolar  couplings  
Residual  dipolar  couplings  on  the  Ca2+-­CaM•eEF-­2KCBD  complex  were  measured  utilizing  C12E5/n-­
hexanol151  based  partially  aligned  phases.  A  partially  aligned  sample  of  the  Ca2+-­CaM•eEF-­2KCBD  complex  
was  prepared  by  the  direct  addition  of  C12E5/n-­hexanol151  from  a  16%  w/w  stock  (r=0.93).  The  resultant  
NMR  sample  consisted  of  100  µM  of  the  Ca2+-­CaM•eEF-­2KCBD  complex,  5.4%  w/w  C12E5/water  in  Ca2+-­
NMR  buffer.  1H-­15N  residual  dipolar  couplings  (RDCs)  were  measured  at  30  °C  and  800  MHz  using  a  2-­D  
IPAP152  pulse  sequences  (512  and  144  complex  points  for  1H  and  15N  dimensions  respectively  with  sweep-­
widths  of  15  and  30  ppm,  respectively).  The  corresponding  1H-­15N  scalar  couplings  were  measured  on  an  
isotropic  sample  under  otherwise  identical  experimental  conditions.  RDCs  from  partially  overlapped  peaks  
were  excluded  from  the  analysis.    
The  criterion  used  to  select  RDCs  for  further  analysis  was  as  follows:  First  all  residues  having  {1H}-­
15N   NOE   values   below   0.6   were   discarded.   For   the   remaining   residues,   RDCs   were   retained   if   the  
corresponding  {1H}-­15N  NOE  value  was  2  standard  deviations  above  the  mean.  RDC  values  were  fitted  to  
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the  intact  structures  of  the  final  refined  NMR  ensemble  as  well  to  the  corresponding  N-­lobe  (residues  1-­77)  
and  the  C-­lobe  (residues  82-­148)  separately  using  the  software  PALES153.  RDC  values  exhibiting  violations  
above  10  Hz  in  more  than  50%  of  the  structures  were  iteratively  excluded  from  the  calculations.  At  the  end,  
23  and  15  RDCs  from  the  N-­lobe  and  C-­lobe,  respectively,  were  retained.    
Quality  factors154  were  calculated  using  the  following  equation  (note  that  the  Q-­factor  calculated  in  
this  fashion  may  exceed  1);;  
 
Q =
rms Dobs −Dcalc( )
rms Dobs( )
rms Dobs( ) =
2Da
2 4+3R2( )
5             (3)  
where  Dobs  and  Dcalc  are  the  measured  residual  dipolar  couplings  and  those  calculated  from  the  structure,  
respectively.  Da  and  R  represent  the  normalized  axial  and  rhombic  components  of  the  alignment  tensor,  
respectively.  The  generalized  degree  of  order   (θ)155   for   the  data   from   the  N-­  and  C-­lobes  were  used   to  



















            (4)  
where  i  indexes  the  N-­lobe  and  C-­lobe  data.  The  elements  of  the  Saupe  order  matrix  are  defined  in  their  
respective  principal  axis  frames.  
2.3.10  Fluorescence  binding  assays  
Dansylated  CaM  (D-­CaM)  was  prepared  as  previously  described156  and  used  to  measure  its  affinity  
towards  full-­length  wild-­type  eEF-­2K,  the  Trp85Ser  mutant  and  eEF-­2KCBD.  Assays  were  performed  in  384-­
well  plates  (Corning,  black  flat-­bottom)  using  a  Synergy  H4  micro-­plate  reader  at  27  °C  in  a  buffer  containing  
25  mM  HEPES  at  pH  7.5,  2  mM  DTT,  10  µg/mL  BSA,  100  µM  EGTA,  50  mM  KCl,  and  150  µM  CaCl2  
containing  a  final  concentration  100  nM  D-­CaM  (C0).  40  µL  of  1.25X  buffer  was  added  to  each  well  of  the  
plate  followed  by  addition  of  titrant.  An  appropriate  volume  of  25  mM  HEPES  (pH  7.5)  was  added  to  bring  
the  final  volume  to  50  µL/well.  Separate  wells  were  used  for  each  additional  concentration  of  titrant.  Plates  
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were  allowed  to  equilibrate  for  at  least  5  minutes  at  27  °C  before  measurements  were  taken.  D-­CaM  was  
excited  at  340  nm  and  emission  readings  were  taken  at  490  nm.  The  fluorescence  intensity  was  normalized  
according  to  Equation  5  to  determine  the  fraction  of  CaM  bound  (Fb)  at  a  particular  eEF-­2K  concentration  
and  fitted  to  Equation  6  to  obtain  the  apparent  dissociation  constant  (KD).    







                  (5)  
 
Fb =
(C0 + E + KD )− (C0 + E + KD )
2 −4C0E
2C0
         (6)  
2.3.11  Cell-­based  assays  
Knockout  MCF-­10A  (eEF-­2K–/–)  cells  (Sigma-­Aldrich)  were  transfected  with  vectors  encoding  wild-­
type  eEF-­2K  or  the  Trp85Ser  mutant,  and  the  cells  were  lysed  after  48  hours.  Lysates  were  analyzed  by  
Western   blotting   using   eEF-­2K,   eEF-­2   or   pT56-­eEF-­2   specific   antibodies101   with   pan-­Actin   as   loading  
control.  48  hours  post-­transfection,  another  set  of  transfected  cells  were  treated  with  either  25  mM  2-­DOG  
(30  min),   400   µM  H2O2   (1   h),   5   µM   ionomycin   (5  min)   or   starvation   with   DPBS   (6   h),   48   hours   post-­
transfection,  followed  by  lysis  and  Western  blot  analysis  as  before101.  All  experiments  were  performed  in  
triplicate.  
2.3.12  Analysis  of  the  interaction  between  apo-­CaM  and  eEF-­2KCBD  
Given  the  weaker  affinity  of  eEF-­2KCBD  towards  apo-­CaM,  an  estimate  of  the  binding  affinity  of  the  
peptide  was  obtained  using  NMR-­based  titrations  as  described  in  detail  in  the  Supplemental  Materials  and  
Methods.  In  brief,  representative  residues  from  the  C-­lobe  for  the  eEF-­2KCBD-­saturated  state  (CaM:eEF-­
2KCBD  ratio  of  1:5.6)  were  chosen  and  their  intensities  (I)  as  a  function  of  the  final  eEF-­2KCBD  concentration  
(P)  at  a  constant  CaM  concentration  (C0=80  µM)  were  fitted  to  Equation  (2),    
       
I = I∞
KD +C0 + P( )− KD +C0 + P( )
2
−4C0P
2C0             (2)  
where  I¥  is  the  peak  intensity  (in  arbitrary  units)  at  saturation.  
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2.4  Results  
2.4.1  The  Ca2+-­loaded  state  of  CaM  forms  a  tight  complex  with  eEF-­2KCBD    
Isothermal   titration   calorimetry   (ITC)  measurements   suggest   that   eEF-­2KCBD   binds  Ca2+-­loaded  
CaM  with  high  affinity  (KD=153±15  nM;;  average  over  measurements  in  triplicate)  under  conditions  used  in  
our  NMR  experiments  (Figure  2.2A).  Large  chemical  shift  perturbations  (CSPs)  are  seen  upon  comparing  
the  1H,  15N  HSQC  spectrum  of  Ca2+-­CaM  with  that  of  the  1:1  Ca2+-­CaM•eEF-­2KCBD  complex  (Figure  2.3).    
The  C-­lobe  displays   larger  CSPs  (average  over  C-­lobe   residues,  ∆δ=0.17±0.15  ppm)   in  absolute   terms  
compared  to  the  N-­lobe  (average  over  N-­lobe  residues,  ∆δ=0.07±0.07  ppm)  (Figure  2.2B).  This  suggests  
that   in   the   Ca2+-­loaded   state   of   CaM,   eEF-­2KCBD   engages   both   lobes   with   the   C-­lobe   playing   a  more  
significant  role,  perhaps   in  anchoring  eEF-­2KCBD  to  CaM,  while   the   interactions  with   the  N-­lobe  are   less  
robust.  Surprisingly,  addition  of  an  excess  of  the  eEF-­2KCBD  peptide  leads  to  further  perturbations  largely  
in  the  N-­lobe  of  CaM,  while  the  C-­lobe  resonances  display  minimal  further  changes  (Figure  2.4).  This  may  
indicate  that  in  the  1:1  complex  the  N-­lobe  of  CaM  is  still  available  to  participate  in  further  weak,  perhaps  
non-­specific  interactions  with  excess  peptide.    
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Figure  2.2.  Interaction  between  eEF-­2KCBD  with  CaM  in  the  presence  of  Ca2+.  (A)  ITC  trace  representative  
of   three   repeats   is   shown.   For   the   trace   shown,   KD=137.2±18.8   nM,   ∆H=-­16.6   KCal•mol-­1,   ∆S=-­22.5  
Cal•mol-­1•K-­1.  (B)  Backbone  amide  chemical  shift  perturbations  induced  on  Ca2+-­CaM  upon  formation  of  
the  1:1  Ca2+-­CaM•eEF-­2KCBD  complex.  The  locations  of  the  eight  helices  (A,  B,  C,  D  on  the  N-­lobe  and  E,  
F,  G,  H  on   the  C-­lobe)   are   shown.  The  blue  bar   represents   residues   that   are   unassigned   in   the  Ca2+-­
CaM•eEF-­2KCBD  complex.  
  


















































	   52	  
  
  
Figure  2.3.  Overlay  of  1H,  15N  HSQC  spectra  of  the  Ca2+-­CaM•eEF-­2KCBD  complex  (green)  and  Ca2+-­CaM  
alone  (black).  
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Figure  2.4.  Chemical  shift  perturbations  (CSPs)  induced  on  CaM  in  the  Ca2+-­CaM•eEF-­2KCBD  complex  in  
the  presence  of  an  excess  of  eEF-­2KCBD  peptide.  The  CSPs  were  calculated  using  the  chemical  shifts  of  
the  1:1  Ca2+-­CaM•eEF-­2KCBD  complex  as  reference.  
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The  1H,  15N  HSQC  spectrum  of  eEF-­2KCBD  (Figure  2.5)  in  the  context  of  the  1:1  Ca2+-­CaM•eEF-­
2KCBD  complex  is  characterized  by  a  higher  degree  of  spectral  dispersion  compared  with  that  of  free  eEF-­
2KCBD  indicating  the  formation  of  a  well-­defined  structure  upon  complex  formation.  The  F81-­M95  segment  
of  eEF-­2KCBD  displays  {1H}-­15N  steady  state  NOEs  that  are  modest  to  large  (0.58-­0.89,  Figure  2.6)  when  
bound  to  CaM  suggesting  that  this  segment  is  folded  in  the  complex.  A  particularly  illustrative  observation  
is  the  large  chemical  shift  change  seen  for  the  indole  NH  resonance  of  Trp85  upon  binding.  This  residue  
has   been   suggested   to   be   a   key   hydrophobic   anchor   for   the   interaction   between   CaM   and   eEF-­2K97.  
Notably,  the  Trp85  indole  NH  also  displays  a  significant  (for  a  sidechain  position)  steady-­state  NOE  value  
(0.48±0.13)  suggesting  that  it  is  ordered  in  the  complex,  possibly  due  to  a  close  interaction  with  CaM.  This  
contrasts  the  indole  NH  resonance  of  Trp99  that  is  disordered  (NOE=-­0.77±0.17)  in  the  bound  state.  
	  





Figure  2.5.  Overlay  of  1H,  15N  HSQC  spectra  of  eEF-­2KCBD  in  the  free  state  (orange)  and  in  the  1:1  Ca2+-­
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Figure  2.6.  Steady-­state  {1H}-­15N  NOE  for  eEF-­2KCBD  in  the  Ca2+-­CaM•eEF-­2KCBD  complex.  The  NOEs  for  
the  sidechain  indole  NH  positions  for  Trp85  and  Trp99  are  shown  in  red.  The  backbone  amide  resonance  
of  His80  was  not  detected  in  the  spectra  and  is  depicted  by  the  green  ‘*’.  The  locations  of  the  two  prolines  
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2.4.2  The  Full  Complement  of  Ca2+  ions  is  not  Required  for  the  CaM/eEF-­2KCBD  Interaction  
CSPs  measured  in  Ca2+-­free  CaM  in  the  presence  of  eEF-­2KCBD  indicate  an  interaction.  In  contrast  
to  the  Ca2+-­loaded  CaM  discussed  above,  these  CSPs  are  restricted  to  the  C-­lobe  of  CaM  (Figure  2.7A,  
∆δ=0.45±0.32  ppm)  with  minimal  changes  being  seen  in  the  N-­lobe  (∆δ=0.02±0.01  ppm).  As  in  the  case  of  
the  interaction  in  the  presence  of  Ca2+,  the  binding  is  in  the  slow  exchange  regime  on  the  NMR  chemical  
shift   timescale.  Fitting  the  intensities  of  the  bound-­state  peaks  in  the  presence  of   increasing  amounts  of  
eEF-­2KCBD  to  Equation  2  yields  a  KD  value  (averaged  over  20  residues)  of  36±19  µM  suggesting  a  ~240-­
fold  weaker  interaction  in  the  absence  of  Ca2+.  Given  the  affinity,  the  slow-­exchange  behavior  is  somewhat  
surprising  though  not  unprecedented157.  
   Titration  of  Ca2+  into  the  apo-­CaM•eEF-­2KCBD  complex  (~79%  saturated)  has  little  effect  on  the  C-­
lobe   resonances.   In   contrast,   several   N-­lobe   resonances   disappear   and   then   reappear   at   higher  
concentrations   of   Ca2+   at   positions   corresponding   to   those   in   the   1:1   Ca2+-­CaM•eEF-­2KCBD   complex.  
Comparison  of  the  spectra  of  the  Ca2+-­CaM•eEF-­2KCBD  and  apo-­CaM•eEF-­2KCBD  (1:3  mixture  of  apo-­CaM  
and  eEF-­2KCBD)  complexes  suggests  that  the  largest  differences  between  the  two  species  are  in  the  N-­lobe  
(Figure   2.7B,   ∆δ=0.27±0.26   ppm)   with   minimal   differences   in   the   C-­lobe   (∆δ=0.03±0.03ppm).   The  
intensities  of  peaks  corresponding   to   the  Ca2+-­loaded  state  of   the  complex   for   resonances  of   the  Ca2+-­
binding   loops   exhibit   contrasting   behavior   for   the   N-­   and   C-­lobes   during   the   Ca2+   titration.   While   the  
intensities  of  C-­lobe  peaks  are  stable  over  the  Ca2+-­titration  course,  those  of  the  N-­lobe  increase  in  intensity  
(as  the  Ca2+-­loaded  state  becomes  populated)  and  saturate  at  around  2-­equivalents  of  Ca2+  (Figure  2.8).  
Analyses  of  chemical  shift  signatures  known  to  be  diagnostic  for  the  presence/absence  of  Ca2+  in  EF-­hand  
containing  proteins  are  also  very  revealing.  The  amide  1H  of  the  conserved  glycine  at  the  6th  position  (G6)  
of  the  Ca2+-­binding  loop  is  known  to  exhibit  chemical  shift  values  larger  than  10.0  ppm  in  the  Ca2+-­bound  
state158.  In  the  present  case,  the  1H  chemical  shifts  for  C-­lobe  residues,  G98  and  G134,  are  10.60  (10.61)  
and  10.27  (10.26)  ppm  in  the  apo-­CaM•eEF-­2KCBD  complex  (Ca2+-­CaM•eEF-­2KCBD  complex),  respectively.  
This  suggests  that  the  C-­lobe  EF-­hands  locally  attain  a  Ca2+-­bound  like  conformation  in  the  presence  of  
eEF-­2KCBD  even   in   the  absence  of  Ca2+.   In   the  N-­lobe,  G25   is  broadened  out   (10.58  ppm   in   the  Ca2+-­
CaM•eEF-­2KCBD  complex),  but  G61  has  observable  amide  1H  chemical  shifts  of  9.87  ppm  and  10.54  ppm  
in  the  apo-­CaM•eEF-­2KCBD  and  Ca2+-­CaM•eEF-­2KCBD  complexes,  respectively,  showing  the  characteristic  
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Ca2+-­induced  downfield  shift.  Similarly,  the  amide  15N  chemical  shifts  of  the  hydrophobic  residues  at  the  8th  
position  (I27,  I63  for  the  N-­lobe;;  I100,  V136  for  the  C-­lobe)  of  the  Ca2+-­binding  loops  are  known  to  undergo  
significant   downfield   shifts   in   the   presence   of   Ca2+   159.   I63   (I27   is   broadened   out)   shows   a   4.83   ppm  
downfield  shift  in  the  Ca2+-­CaM•eEF-­2KCBD  complex  compared  to  the  apo-­CaM•eEF-­2KCBD  complex,  while  
the  resonance  positions  for  I100  and  V136  are  virtually  identical  presence  and  absence  of  Ca2+.  Finally,  it  
has  been  noted  that  the  orientation  of  a  large  aromatic  group  at  the  -­4  position  of  the  Ca2+-­binding  loop  
leads  to  large  upfield  shifts  of  the  13Cβ  resonance  of  the  first  Ca2+-­loop  aspartate  (D20  for  the  N-­lobe  and  
D93  for  the  C-­lobe)  in  the  presence  of  Ca2+  160.  We  note  that  while  D20  13C   resonance  is  shifted  upfield  
by   1.55   ppm   in   the  Ca2+-­CaM•eEF-­2KCBD   state   compared  with   the   apo-­CaM•eEF-­2KCBD   state,   the  D93  
resonance  is  virtually  identical  in  the  two  states.  We  also  note  that  D58  (at  the  3rd  position  of  the  second  N-­
lobe  EF-­hand)  is  also  upfield  shifted  by  1.45  ppm  in  the  Ca2+-­CaM•eEF-­2KCBD  complex.    
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Figure  2.7.  Structural  differences  in  CaM  in  the  presence  of  eEF-­2KCBD  under  low  and  high  Ca2+  conditions.  
(A)  Chemical  shift  changes  induced  on  apo-­CaM  in  the  presence  of  a  3-­fold  molar  ratio  of  eEF-­2KCBD.  The  
black  and  green  bars  represent  residues  that  are  unassigned  in  the  apo-­CaM•eEF-­2KCBD  complex  and  apo-­
CaM  alone,  respectively.  (B)  Differences   in  chemical  shifts  between  the  apo-­CaM•eEF-­2KCBD  and  Ca2+-­
CaM•eEF-­2KCBD  complexes.  The  blue  and  green  bars  represent  residues  that  are  unassigned  in  the  Ca2+-­
CaM•eEF-­2KCBD  complex  and  the  apo-­CaM•eEF-­2KCBD  complex,  respectively.    
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Figure  2.8.  Build-­up  of  intensities  of  peaks  characteristic  of  the  1:1  Ca2+-­CaM•eEF-­2KCBD  complex  for  the  
EF-­hand  residues  for  the  N-­  and  C-­lobes  by  the  addition  of  increasing  amounts  of  Ca2+  to  the  apo-­CaM•eEF-­
2KCBD  complex.  
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   Based  on  this  multitude  of  data  it  is  apparent  that  the  N-­lobe  Ca2+  sites  are  occupied  in  the  Ca2+-­
CaM•eEF-­2KCBD   complex.   However,   the   minimal   CSPs   for   the   backbone   and   for   diagnostic   sidechain  
positions  for  C-­lobe  resonances  in  the  presence  of  Ca2+  suggest  that  the  C-­lobe  sites  are  not  metal  bound  
in  the  Ca2+-­CaM•eEF-­2KCBD  complex.  A  scenario  where  eEF-­2KCBD  drives  the  conformation  of  the  C-­lobe  
around  the  Ca2+-­sites  to  bound-­like  conformations  even  in  the  absence  of  metal  (this  is  certainly  true  around  
G6,  as  discussed  above)  leading  to  minimal  further  perturbations  upon  metal  binding,  could  be  imagined.  
However,  the  presence  of  Ca2+  would  be  expected  to  produce  local  chemical  shift  perturbations,  at  the  very  
least.  These  are  not  seen  in  the  present  case.  Therefore,  in  the  structure  calculations  described  below,  we  
assume  that  only  the  N-­lobe  Ca2+-­sites  are  occupied  in  the  Ca2+-­CaM•eEF-­2KCBD  complex.  
2.4.3  Solution  structure  of  the  Ca2+-­CaM•eEF-­2KCBD  complex      
In  order  to  obtain  further  insight  into  the  mode  of  interaction  between  CaM  and  eEF-­2KCBD  in  the  
Ca2+-­loaded  state  of  the  former,  we  solved  the  structure  of  the  Ca2+-­CaM•eEF-­2KCBD  complex  using  solution  
NMR  techniques  (see  Table  2.1  for  statistics).  It  is  evident  from  the  structural  ensemble  (Figure  2.9)  that  
there   is   considerable   dynamics   between   the   N-­   and   C-­lobes   of   CaM  when   bound   to   eEF-­2KCBD.   This  
presence  of  this  mobility  is  confirmed  by  a  lack  of  inter-­lobe  NOE  cross-­peaks,  by  the  fact  that  the  linker  
residues  T79  (0.33±0.03)  and  D80  (0.42±0.03)  show  low  steady-­state  {1H}-­15N  NOE  values  (not  shown),  
and  by  an  analysis  of  residual  dipolar  coupling  (RDC)  data  (see  below).    
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Table  2.1.  Refinement  and  structure  statistics  for  the  Ca2+-­CaM•eEF-­2KCBD  complex  
Pairwise  Cartesian  RMS  deviation  (Å)  
   N-­lobe   C-­lobe   C-­lobe/eEF-­2KCBD  
Global  backbone  heavy  atoms   0.89  ±  0.14   0.90  ±  0.14     
Global  heavy  atomsa   1.66  ±  0.14   1.93  ±  0.14     
Ordered  backbone  heavy  atoms   0.80  ±  0.14   0.78  ±  0.14   0.90  ±  0.16  
Ordered  heavy  atomsb   1.72  ±  0.16   1.90  ±  0.16   1.99  ±  0.18  
  
Restraint  information  
NOE  derived  distance  restraints  
Intra-­residue   1079  
Inter-­residue   1015  
Sequential   447  
Medium   382  
Long   286  
Inter-­molecular   140  
Distance  restraints  for  Ca2+c   12  
Dihedral  angle  restraints   293  
  
Energies  (KCal•mol-­1)  
Total   -­8209.4  ±  175.1  
NOE   52.4  ±  7.4  
Cdih   2.1  ±  0.6  
  
Ramachandran  statistics  (%)d  
Most  favored  regions   90.0  ±  1.4  
Additionally  allowed  regions   8.7  ±  1.7  
Generously  allowed  regions   0.5  ±  0.6  
Disallowed  regions   0.7  ±  0.9  
  
Restraint  violations  
Distance  restraints  (>  0.5  Å)   0  
Dihedral  restraints  (>  5°)   0  
  
Average  RMS  deviation  from  experimental  restraints  
Distance  restraints  (Å)   0.0188  ±  0.0014  
Dihedral  angle  restraints  (°)   0.3396  ±  0.0521  
  
Average  RMS  deviation  from  idealized  geometries  
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Distance  restraints  (Å)   0.0141  ±  5.10x10-­4  
Dihedral  angle  restraints  (°)   1.297  ±  0.036  
  
Average  RMS  Z-­scores  for  deviation  from  current  reliable  structurese  
Bond  lengths   0.67  ±  0.02  
Bond  angles   0.73  ±  0.02  
Omega  angle   0.64  ±  0.03  
Side-­chain  planarity   0.86  ±  0.07  
Improper  dihedral  distribution   0.90  ±  0.03  
Inside/Outside  distribution   1.04  ±  0.02  
  
Average  Z-­scores  for  deviation  from  current  reliable  structurese  
1st  generation  packing  quality   -­0.32  ±  0.19  
2nd  generation  packing  quality   -­0.61  ±  0.30  
 1/ 2  rotamer  normality   -­1.61  ±  0.41  
Backbone  conformation   0.75  ±  0.22  
  
Q-­Factors  for  Residual  Dipolar  Couplings  
Individual  Lobes   0.27  ±  0.02  (N-­lobe)   0.24  ±  0.05  (C-­lobe)  
Pearson  correlation  co-­efficient   0.93  ±  0.02  (N-­lobe)   0.86  ±  0.04  (C-­lobe)  
Average  Q-­Factors   0.25  ±  0.03  
  
  
aGlobal  RMSD:  4-­76  for  the  N-­lobe  (1-­77)  and  83-­146  for  the  C-­lobe  (82-­148)  
bSecondary  structure:  6-­19,  26-­39,  45-­55,  65-­76  (N-­lobe);;  82-­92,  103–112,  118–128,  138–146  (C-­lobe).  C-­
lobe/peptide  RMSD:  83-­146  (CaM  C-­lobe);;  82-­92  (eEF-­2KCBD).  
cCa2+-­O  distances  for  the  sidechains  of  D20,  D22,  D24,  E31,  D56,  D58  and  N60,  E67,  and  the  backbone  
carbonyls  of  T26  and  T62  were  set  to  the  range  2.2-­2.6  Å.  
dValues  based  on  PROCHECK147  analysis  (1-­148  for  CaM  and  74-­100  for  eEF-­2KCBD).  
eValues  based  on  WHATIF148.  
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Figure  2.9.  Solution  structure  of   the  Ca2+-­CaM•eEF-­2KCBD  complex.  20  structures  representing  the  final  
NMR  ensemble  have  been  overlaid  using  the  C-­lobe  and  eEF-­2KCBD  (see  Table  2.1).  The  N-­lobe  (1-­77)  
and  C-­lobe  of  CaM  (82-­148)  have  been  colored  green  and  blue  respectively  and  the  linker  (78-­81)  is  colored  
grey.  eEF-­2KCBD  is  colored  dark  orange.  The  N-­lobe  of  CaM,  the  linker,  6  residues  on  the  N-­terminus  and  
7  residues  on  the  C-­terminus  of  eEF-­2KCBD  are  hidden  to  allow  better  visualization  of  the  C-­lobe  eEF-­2KCBD  
interactions  in  the  lower  panel.  The  sidechains  of  the  critical  Trp85  are  shown  and  colored  light  orange.  The  
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Figure  2.10.  Contacts  between  CaM  and  eEF-­2KCBD.   (A)  The  CaM/eEF-­2KCBD   interface   is  stabilized  by  
three  sets  of  interactions:  1-­5-­8  hydrophobic  docking  (residues  labeled  and  outlined  using  blue  rectangles)  
of  eEF-­2KCBD  onto  the  the  CaM  C-­lobe;;  interactions  between  Pro98  (outlined  using  a  green  rectangle)  on  
eEF-­2KCBD  and   the  CaM  N-­lobe;;   two  sets  of  electrostatic   interactions   (outlined  by   red  circles)   involving  
basic  residues  on  eEF-­2KCBD  and  acidic  residues  on  CaM.  Detailed  views  of  the  1-­5-­8  binding  (B)  and  the  
interaction  of  Pro98  (C)  with  the  C-­lobe  and  the  N-­lobe  of  CaM,  respectively,  are  shown.  Locations  of  key  
residues  on  the  CaM  surface  are  colored  (yellow  for  the  C-­lobe  and  magenta  for  the  N-­lobe)  and  labeled  
(in  black).  eEF-­2KCBD  residues  are  labeled  in  orange.  The  dashed  lines  indicate  residues  that  point  out  the  
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eEF-­2KCBD  forms  a  long  single  helix  that  is  well-­defined  from  Phe81  to  Ala92  in  line  with  the  {1H}-­
15N  NOE  discussed  above.  As  suggested  by  the  CSP  data,  a  majority  of  the  stabilizing  contacts  between  
eEF-­2KCBD  and  CaM  involves  the  C-­lobe  of  the  latter  with  few  contacts  involving  the  N-­lobe  (Figure  2.10A).  
Trp85  on  eEF-­2KCBD  inserts  deep  into  a  hydrophobic  pocket  formed  by  the  sidechains  of  F92,  I100,  M124,  
I125,   A128,   V136,   F141   and   M144   (Figure   2.10B).   Significant   contacts   are   also   seen   between   the  
sidechains  of  Ile89  and  those  of  A88,  F92,  F141  and  M145  on  CaM.  Ala92  on  eEF-­2KCBD  makes  multiple  
contacts  with  the  sidechains  of  V91,  F92  and  L112.  Thus  eEF-­2KCBD  interacts  with  CaM  in  an  anti-­parallel  
fashion  in  a  mode  that  largely  conforms  to  a  1-­5-­8  binding  mode  with  Trp85  being  the  key  anchor  residue  
at  the  1-­position  (Figure  2.10A).  Some  contacts  are  also  seen  between  the  C-­terminus  of  eEF-­2KCBD  and  
the  CaM  N-­lobe  (Figures  2.10A,  C).  These  involve  contacts  between  Pro98  with  F19,  I27,  L32,  I63  and  
M71.  Trp99  (position  14  for  a  canonical  1-­5-­8-­14  interaction)26  contacts  F19  and  M71  through  its  backbone  
and  has  few  consistent  ring  contacts  <  5  Å  within  the  NMR  ensemble  suggesting  a  high  degree  of  disorder  
in  this  region  as  expected  from  the  low  {1H}-­15N  NOE  values  for  the  sidechain  indole.  While  most  of  the  
interactions  between  CaM  and  eEF-­2KCBD  involve  hydrophobic  residues,  Lys91  and  Lys93  on  eEF-­2KCBD  
make  electrostatic  contacts  with  CaM  residues  E114  and  E84,  respectively.    These  interactions  stabilize  
opposite  faces  of  eEF-­2KCBD  and  serve  to  anchor  it  to  helices  F  and  E  on  the  C-­lobe  of  CaM  (Figure  2.10A).    
The  angles  between  the  helices  that  form  the  EF  hands  in  the  N-­lobe  and  C-­lobe  of  CaM  (Table  
2.4),  calculated  using  an  in-­house  protocol  based  on  the  algorithm  defined  by  Kuboniwa  et.  al12,  provides  
insight  into  the  differences  in  overall  conformations  of  the  two  lobes.  Based  on  our  Ca2+  titration  data,  the  
N-­lobe  Ca2+  sites  of  CaM  appear  to  be  occupied;;  this  is  borne  out  by  the  fact  that  the  inter-­helical  angles  
for  the  N-­lobe  are  similar  to  the  Ca2+-­bound  state  of  CaM  rather  than  those  in  apo  CaM.  In  contrast,  the  
inter-­helical  angles  in  the  C-­lobe,  especially  those  involving  helix  F,  are  unique.  While  the  E/G,  E/H  and  
G/H  angles  resemble  those  in  Ca2+-­loaded  CaM,  the  E/F  angle  is  significantly  smaller  than  both  Ca2+-­CaM  
and  apo-­CaM,  and  the  F/H  angle   is   larger   than  both  states.  The  F/G  angle   is   intermediate  between  the  
more  closed  conformation  seen  for  apo-­CaM  and  the  more  open  conformation  seen  for  Ca2+-­CaM.  These  
changes  in  inter-­helical  angles  appear  to  be  the  result  of  the  reorientation  of  the  F-­helix  away  from  the  Ca2+-­
bound-­like  state  (Figure  2.11).  Additionally,  the  angle  between  helices  D  and  E,  which  defines  the  inter-­
lobe  angle,  is  larger  than  that  seen  both  for  Ca2+-­loaded  CaM  and  apo-­CaM  suggesting  a  greater  degree  
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of   lobe   closure   than  both   cases.  However,   as   in   the   case  of   apo-­CaM,   there   is   a   significant   degree  of  
variability,   suggesting   that   several   inter-­lobe   orientations   are   sampled   within   the   NMR   ensemble.   A  
conformation  of  CaM  that  is  more  closed  than  the  ligand-­free  state  is  also  borne  out  by  an  analysis  of  the  
hydrodynamic   properties   of   the   Ca2+-­CaM•eEF-­2KCBD   complex   using   15N   relaxation   data.   An   axially-­
symmetric  diffusion  tensor  is  obtained  upon  analysis  for  the  data  for  the  N-­  and  C-­lobes  separately  with  an  





Figure  2.11.  Displacement  of  the  F  helix  in  the  C-­lobe  of  CaM  in  the  Ca2+-­CaM•eEF-­2KCBD  complex  relative  
to  that  in  Ca2+-­CaM  (PDB:  1CLL).  Four  structures  (1,  10,  15  and  20)  that  define  the  extremes  of  the  NMR  
ensemble  are  shown   in  shades  of  blue  and  green.  The  structure  of  Ca2+-­CaM   is  shown   in  orange.  The  
structures  have  been  aligned  using  residues  84-­92,  118-­128  and  138-­146.    
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Table  2.4.  Inter-­helical  angles  of  CaM  in  the  Ca2+-­CaM•eEF-­2KCBD  complex  
  
   Apo-­CaM   Ca2+-­CaM   Ca2+-­CaM•eEF-­2KCBD  Complex   Ca2+-­CaM•SKCBD  Complex  
N-­lobe  
A/B   133±1   87   86±3   96  
A/C   93±2   160   155±4   151  
A/D   123±1   107   119±3   116  
B/C   125±2   111   113±3   111  
B/D   49±2   40   48±3   43  
C/D   128±1   87   82±4   89  
C-­lobe  
E/F   134±1   104   93±2   99  
E/G   77±1   142   137±4   116  
E/H   142±2   118   122±5   145  
F/G   141±1   112   123±2   140  
F/H   31±3   36   53±5   60  
G/H   134±2   94   95±5   92  
Inter-­lobe     
D/E   32±16   20   79±13   83  
  
For  consistency  with  Kuboniwa  et.  al12  the  helices  of  CaM  have  been  defined  here  as  A  (6-­18),  B  (29-­38),  
C  (45-­54),  D  (65-­74),  E  (83-­91),  F  (102-­111),  G  (118-­127)  and  (139-­145).  The  mean  and  standard  deviation  
of  inter-­helical  angles  are  reported  for  apo  (25  structures,  PDB:1CFC),  Ca2+-­CaM  (PDB:1CLL)  and  from  the  
20-­structure  ensemble  of  the  Ca2+-­CaM•eEF-­2KCBD  complex  determined  here.  Also  shown  are  the  values  
calculated  for  the  Ca2+-­CaM•SKCBD  complex  (PDB:1G4Y)60.  The  angles  that  define  the  intra-­hand  and  inter-­
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2.4.4  Inter-­lobe  dynamics  in  the  Ca2+-­CaM•eEF-­2KCBD  complex  
The  Ca2+-­CaM•eEF-­2KCBD  structural  ensemble   is  characterized  by  an   inability   to  simultaneously  
align  the  N-­  and  C-­lobes  of  CaM,  and  the  low  {1H}-­15N  NOE  values  for  linker  residues  point  to  significant  
inter-­lobe  dynamics.  We  used  a  set  of  1H-­15N  RDCs  to  validate  the  structural  dynamics  of  the  ensemble.  
Using   intact   structures   i.e.   data   for   the   N-­lobe   and   C-­lobe   simultaneously   from   the   NMR   ensemble   to  
analyze   the   RDCs   resulted   in   very   poor   Q   factors   (1.10±0.39,   correlation   co-­efficient=0.47±0.14).   In  
contrast,  use  of  data  for  the  N-­lobe  and  C-­lobe  separately  produced  far  better  Q  factors  (N-­lobe:  0.27±0.04,  
C-­lobe:  0.24±0.05),  and  correlation  co-­efficients  (N-­lobe:  0.93±0.02,  C-­lobe:  0.86±0.04)  suggesting  that  the  
RDC  data  could  not  be  explained  by  a  single  relative  orientation  of  the  N-­  and  C-­lobes  of  CaM.  We  also  
noted  that  the  absolute  values  of  the  RDCs  measured  for  the  N-­lobe  residues  were  roughly  12%  smaller  
than  those  of  the  C-­lobe.  We  used  the  ratio  of  the  generalized  degree  of  order  (θ)  values155  for  the  N-­  and  
C-­lobes   to   define   an   order   parameter   (S2)   for   inter-­lobe   dynamics   using   Equation   3.   A   value   of   S2  
=0.68±0.17  is  indicative  of  significant  inter-­lobe  dynamics.  
2.4.5  Trp85  plays  a  critical  role  in  the  Ca2+-­CaM-­mediated  activation  of  eEF-­2K  
Based  on  the  structural  results  it   is  evident  that  Trp85  plays  a  critical  role  in  docking  eEF-­2KCBD  
onto  CaM.  In  order   to  ascertain  whether   the   importance  of  hydrophobic   interactions   involving  Trp85  are  
maintained   in   full-­length  eEF-­2K,  we  compared   the  ability  of  wild-­type  and  Trp85Ser   (in  which  Trp85   is  
replaced  by  a  polar  residue)  eEF-­2K  to  interact  with,  and  be  activated  by  Ca2+/CaM.  Full-­length  eEF-­2K  
(KD=16.7±2.8   nM,   Figure   2.12A)   binds   Ca2+-­CaM   roughly   15-­fold   more   tightly   than   eEF-­2KCBD  
(KD=245.0±25.8  nM)  under  similar  conditions;;  the  latter  is  consistent  with  the  value  of  153  nM  determined  
by  ITC  under  NMR  conditions.  This  confirms  that  the  largest  contribution  to  the  interaction  between  Ca2+-­
CaM  and  eEF-­2K  results  from  the  sequence  encoded  by  eEF-­2KCBD  though  additional  weak  interactions  
outside  this  segment  cannot  be  ruled  out.  In  contrast,  the  Trp85Ser  mutation  leads  to  an  ~80-­fold  reduction  
in  binding  affinity  (KD=1.4±0.1  µM)  (Figure  2.12A)  compared  to  full-­length  wild-­type  eEF-­2K.  The  decreased  
association  of  a  GST-­tagged  eEF-­2K  Trp85Gly  and  Trp85Ala  mutants  with  CaM  has  been  demonstrated  
before97,99.    
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Figure  2.12.  Influence  of  the  Trp85Ser  mutation  on  full-­length  eEF-­2K.  (A)  Fluorescence  binding  assays  
measuring   interaction   between   wild-­type   full-­length   eEF-­2K   (blue),   eEF-­2KCBD   (black)   or   the   Trp85Ser  
mutant  (red)  and  dansyl-­CaM  in  the  presence  of  Ca2+.  The  points  (errors  from  duplicate  measurements)  
represent  the  fraction  of  CaM  in  the  bound  state  (calculated  using  Equation  5)  at  various  concentrations  of  
titrant  and  the  solid  curves  represent  the  fits  to  Equation  6.  (B)  Results  of  the  Western  blot  analysis  for  eEF-­
2  phosphorylated  on  Thr56  after  transfection  of  knockout  MCF-­10A  (eEF-­2K–/–)  cells  with  vectors  encoding  
wild-­type  eEF-­2K  or  the  Trp85Ser  mutant  along  with  appropriate  controls.  Also  shown  is  the  level  of  eEF-­2  
phosphorylated  on  Thr56  upon  stimulation  with  25  mM  2-­DOG  (30  min)  (C),  400  µM  H2O2  (1  h)  (D),  5  µM  
ionomycin  (5  min)  or  starvation  with  DPBS  (6  h)  (E),  along  with  the  appropriate  controls.    Note  that  the  blots  
shown  in  (B)  have  been  cropped  from  those  shown  in  (D)  for  untreated  samples.  
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We  tested  the  effect  of  the  Trp85Ser  mutation  on  the  ability  of  eEF-­2K  to  phosphorylate  eEF-­2  on  
T56  in  cells.  Wild-­type  eEF-­2K  and  the  Trp85Ser  mutant  were  transiently  expressed  in  an  eEF-­2K-­/-­  MCF-­
10A  cell-­line  (in  which  both  eEF-­2K  alleles  are  knocked-­out)  by  transfection  with  vectors  encoding  either  
wild-­type  eEF-­2K  or  the  Trp85Ser  mutant.  When  cell  lysates  are  probed  for  phosphorylation  of  eEF-­2  on  
T56  by  Western  blot,  no  eEF-­2  significant  phosphorylation  is  seen  for  the  Trp85Ser  mutant  in  contrast  to  
wild-­type  control  (Figure  2.12B).  Additionally,  cells  were  subjected  to  a  variety  of  stimuli  known  to  result  in  
enhanced  eEF-­2  phosphorylation  through  eEF-­2K  activation.  These  include  treatment  with  2-­DOG  to  inhibit  
glycolysis,  treatment  with  H2O2  to  increase  oxidative  stress,  starvation  (Dulbecco’s  PBS),  and  enhanced  
Ca2+  efflux  (ionomycin)  (Figures  2.12C-­E).  In  all  cases  cells  expressing  wild-­type  eEF-­2K  show  enhanced  
eEF-­2  phosphorylation,  while  those  expressing  the  Trp85Ser  mutant  show  no  significant   increase  in  the  
levels  of  phosphorylated  eEF-­2.  
2.5  Discussion  
Our  results  suggest  that  the  most  critical  interactions  between  eEF-­2KCBD  and  CaM  occurs  through  
the  C-­lobe  of  the  latter,  both  in  the  Ca2+-­loaded  and  Ca2+-­free  states.  In  the  absence  of  Ca2+,  the  significantly  
weaker  interaction  (KD  ~36  µM)  involves  only  the  C-­lobe,  leaving  the  N-­lobe  largely  free.  The  N-­lobe  of  CaM  
becomes  engaged  in  the  presence  of  Ca2+,  taking  part  in  interactions  that  in  isolation  are  extremely  weak  
(estimated   to   be   ~4  mM   if   the   free   energies   of   the   interactions   involving   the  CaM  N-­   and  C-­lobes   are  
considered   to   be   additive).   However,   the   N-­lobe   interactions   in   combination   with   the   already   present  
interactions  involving  the  C-­lobe  leads  to  a  high  affinity  (KD  ~  0.15  µM)  engagement  of  eEF-­2KCBD  in  the  
Ca2+-­loaded  state.  This  is  a  possible  mechanism  by  which  eEF-­2K  may  sense  Ca2+  levels  and  modulate  its  
affinity  towards  CaM  perhaps  in  combination  with  other  factors  such  as  pH  that  are  known  to  alter  the  Ca2+-­
requirement  of  CaM  to  attain  Ca2+-­bound  like  conformations162.  Our  recent  results  (Tavares  et.  al  2016,  in  
preparation)  suggest  that  the  primary  role  of  Ca2+  appears  to  be  to  promote  the  binding  of  CaM  to  eEF-­2K  
rather  than  to  induce  an  active  conformation  of  the  enzyme.  
A  unique  feature  of  the  Ca2+-­CaM•eEF-­2KCBD  complex  is  the  absence  of  Ca2+  in  the  C-­lobe  sites.  
In  spite  of  the  fact  that  the  overall  affinity  of  the  C-­lobe  sites  for  Ca2+  has  been  determined  to  be  higher  than  
those  of  the  N-­lobe  sites55,  engagement  of  eEF-­2KCBD  appears  to  reduce  the  Ca2+  affinity  of  the  C-­lobe  sites.  
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The   ability   of   interaction   partners   of   CaM   to   modulate   its   Ca2+-­binding   affinity   has   been   discussed  
before163,21.    
An   inspection   of   the   structure   of   the   Ca2+-­CaM•eEF-­2KCBD   complex   provides   some   clues   into  
factors  that  could  modulate  the  Ca2+  binding  ability  of  the  CaM  C-­lobe.  A  notable  feature  is  a  shift  in  the  
backbone  for  each  of  the  two  C-­lobe  Ca2+-­coordinating  EF  hands  (EF-­3  and  EF-­4,  Figure  2.13)  compared  
to  Ca2+-­CaM   alone.   For   EF-­4,   the   significant   inward   shift   of  Q135   (which   coordinates  Ca2+   through   its  
backbone  carbonyl)  would  result  in  a  clash  with  the  metal  ion  if  this  site  were  occupied.  This  shift  is  likely  
the  result  of  the  interaction  of  the  neighboring  V135  with  Trp85  on  eEF-­2KCBD.  While  less  drastic  than  in  the  
case  of  EF-­4,   the  backbone  of  Y99   (which  also   coordinates  Ca2+   through   its   carbonyl   oxygen)   in  EF-­3  
undergoes  an  outward  shift  placing  it  a  position  too  distant  to  optimally  coordinate  Ca2+.  The  adjoining  I100  
also  makes  key  contacts  with  Trp85  in  eEF-­2KCBD.  Key  sidechains  involved  in  metal  co-­ordination  are  also  
in  sub-­optimal  conformations,  though  we  hesitate  to  interpret  this  given  the  lower  precision  in  determining  
the  sidechain  orientations.  Additionally,  as  previously  described,  the  inter-­hand  angle  (F/G,  Table  2.4)  also  
has  a  value  that  is  intermediate  between  the  Ca2+-­loaded  and  the  Ca2+-­free  forms.  It  has  been  noted  that  
Ca2+  binding  in  the  C-­lobe  is  highly  co-­operative164.  Thus,  subtle  changes  in  the  Ca2+  affinities  of  individual  
C-­lobe  EF  hands  could  be  amplified  to  a  large  extent.    
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Figure  2.13.  A  comparison  of   the   two  Ca2+-­binding  EF-­hands   from   the  C-­lobe  of  CaM  using   the   same  
structures  as  in  Figure  2.11.  The  shifts  of  the  backbone  away  from  and  into  the  metal  site  for  EF-­3  and  EF-­
4,  respectively,  are  evident.  Key  residues  that  contribute  to  metal  coordination  are  shown  and  labeled.  D93  
for  EF-­3   and  D129   for  EF-­4   that   lie   above   the   plane   of   the   paper   and   form  one   of   the   vertices   of   the  
pentagonal  bi-­pyramid,  are  not  shown,  for  better  visualization.  The  clash  between  the  backbone  carbonyl  
oxygen  of  Q135  in  the  NMR  structures  with  the  Ca2+  ion  from  the  crystal  structure  of  Ca2+-­CaM  is  indicated  
by  the  orange  arrow.  
	  






Figure  2.14.  Comparison  of  the  structures  of  the  1:1  Ca2+-­CaM•eEF-­2KCBD  complex  (CaM  C-­lobe  in  dark  
blue  and  eEF-­2KCBD  in  light  blue)  with  the  Ca2+-­CaM•SKCBD  complex  (PDB:  1G4Y)60.  Only  the  relevant  parts  
of   the   structure   are   shown.   Ile89   on   eEF-­2KCBD   that   has   different   spatial   orientation   compared   to   the  
corresponding   L428   on   SKCBD   is   labeled   in   red.   Trp85/W432   and   A92/A425   that   have   similar   spatial  
orientations  in  the  two  complexes  are  labeled  in  black.  
  
  
Though  the  C-­lobe  of  CaM  does  not  appear  to  contain  Ca2+  when  bound  to  eEF-­2KCBD,    its  binding  
mode  is  distinct  from  IQ-­motif-­based  interactions  that  define  the  binding  of  peptides  to  apo-­CaM23.  Some  
similarities   exist   between   the   structure   of   the   Ca2+-­CaM•eEF-­2KCBD   complex   and   that   of   the   small-­
conductance  Ca2+-­activated  K+  channel   (SK)  complexed   to  CaM60.   In   the   latter   structure,   that   is   rather  
unique,  the  dimeric  CaM-­binding  domain  (SKCBD)  has  a  CaM  molecule  bound  to  each  end  forming  a  2:2  
complex;;   binding  also  occurs   in   a   1-­5-­8  mode  but   in   reversed   fashion.  As   in   the  Ca2+-­CaM•eEF-­2KCBD  
complex,  Ca2+  is  also  absent  from  the  C-­lobe  sites  while  the  N-­lobe  sites  are  occupied.  Comparison  of  the  
recognition  motifs   in   the   two   cases   suggest   some   similarities   (Figure   2.14)   but   also   several   points   of  
divergence.  In  the  Ca2+-­CaM•SKCBD  complex,  a  Trp432  occupies  a  similar  spatial  position  as  Trp85  in  eEF-­
2KCBD,  though  unlike  the  latter,   the  former  simply  sits  on  a  hydrophobic  surface  formed  by  M124,  E127,  
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prongs  that  define  the  Ca2+-­free  interactions  in  the  Ca2+-­CaM•SKCBD  structure,  the  completely  buried  I428  
occupies  a  different  physical  orientation  than  Ile89  in  eEF-­2KCBD.  The  final  prong  of  the  trident,  A425,  is  in  
a  roughly  similar  spatial  orientation  as  Ala92  in  eEF-­2KCBD.  However  electrostatic  interactions  (between  the  
sidechains  of  Lys91  and  E114,  Lys93  and  E84)  similar  to  those  that  further  stabilize  the  interaction  of  eEF-­
2KCBD  with  the  C-­lobe  of  CaM  are  missing  in  the  Ca2+-­CaM•SKCBD  complex.    
The  structure  of  the  Ca2+-­CaM•eEF-­2KCBD  complex  provides  insight  into  the  critical  nature  of  the  
hydrophobic  interactions  involving  Trp85  on  eEF-­2K.  This  residue  is  fully  conserved  in  metazoans  (Phe  in  
mollusca,  Figure  2.15).  Mutation  of  this  residue  to  glycine  or  alanine  has  been  previously  shown  to  disrupt  
Ca2+-­CaM  binding   to  GST-­tagged  eEF-­2K99.  Here  we  demonstrate   that  a  Trp85Ser  mutation  causes  an  
~80-­fold  reduction  in  binding  to  a  full-­length  tag-­free  eEF-­2K.  Additionally,  the  Trp85Ser  mutant  is  severely  
compromised  in  its  ability  to  phosphorylate  eEF-­2  in  cells.  Recent  studies  have  shown  that  hydroxylation  
on  Pro98  (also  fully  conserved,  Figure  2.15)  by  hydroxylases,  that  are  inactivated  during  hypoxic  conditions,  
lead  to  activation  of  eEF-­2K  and  impaired  protein  translation165.  We  have  shown  that  Pro98  contributes  to  
the  engagement  of  the  N-­lobe  and  based  on  our  structure  it  is  conceivable  that  the  introduction  of  a  polar  
group  on  Pro98  would  reduce  its  hydrophobic  interactions  with  the  N-­lobe  of  CaM.  Given  that  N-­lobe  based  
interactions  are  weaker  with  respect   to   those   involving  the  C-­lobe,  and  themselves  do  not  appear   to  be  
critical,  hydroxylation  of  Pro98  should  have  a  relatively  small  effect  on  CaM  binding,  in  agreement  with  the  
data  of  Moore  et.  al165.  In  the  same  study  it  was  also  shown  that  mutation  of  Trp99  (Trp99Ala,  Trp99Leu)  
does   not   lead   to   a   significant   reduction   in  CaM  binding,   as   expected   from  our   structure.  However,   the  








Figure  2.15.  Alignment  of  metazoan  eEF-­2K  sequences.  Only  the  sequence  corresponding  to  the  CBD  are  
shown.  The  human  sequence  corresponds  to  eEF-­2KCBD.  The  hydrophobic  residues  at  positions  1,  5  and  8  
that  contact  the  CaM  C-­lobe  are  shaded  red;;  the  major  point  of  contact  with  the  N-­lobe  is  a  Pro  (at  position  
13),  that  is  shaded  blue.  
  
Our  present  studies  provide  a  clear  structural  basis  for   the  recognition  of  Ca2+-­CaM  by  eEF-­2K.  
They  do  not  however,  provide  insight  into  how  this  interaction  serves  to  facilitate  the  two-­step  activation  of  
the  enzymatic  activity  of  eEF-­2K.  Such  insight  can  be  only  obtained  upon  the  availability  of  the  structure  of  
a  construct  of  eEF-­2K  that  encompasses  the  CBD  in  addition  to  the  catalytic  domain  and  part  of  the  R-­loop  
that  includes  Thr348.  Also  intriguing  is  the  observation  that  a  phospho-­mimetic  R-­loop  mutant  Ser500Asp  
makes  the  activity  of  eEF-­2K  Ca2+  but  not  CaM-­independent66.  Perhaps  the  interactions  involving  the  C-­
lobe   under   Ca2+-­free   conditions   favor   additional   N-­lobe   mediated   interactions   outside   the   region  
encompassed  by  eEF-­2KCBD.  We  expect  our  present  studies  to  lay  the  groundwork  for  deciphering  the  inner  
workings  of  this  unique  enzyme.  
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Chapter  3  –  Functional  Interactions  Between  Calmodulin  and  Eukaryotic  Elongation  Factor  2  Kinase  
*3-­letter  amino  acid  code  for  eEF-­2K  and  1-­letter  amino  acid  code  for  CaM  were  used  
  
3.1  Introduction  
To  fine-­tune  the  eukaryotic  protein  synthesis  machinery  translating  at  the  average  rate  ~2  amino  
acids  per  second,166-­169  eukaryotic  cells  employ  regulatory  protein  kinases,  such  as  cyclin-­dependent  kinase  
1   (CDK1),   eukaryotic   elongation   factor   2-­kinase   (eEF-­2K),   mammalian   target   of   rapamycin   complex   1  
(mTORC1),   mitogen-­activated   protein   kinase   1   (MAPK1),   ribosomal   protein   S6   kinase   beta-­1   (S6K),  
etc.170,93  These  kinases  phosphorylate  the  downstream  substrates  involved  in  protein  translation  initiation  
and   elongation   to   modulate   the   rate   of   overall   protein   synthesis   to   maintain   proteostasis   –   adequate  
regulation   of   protein   synthesis,   protein   folding,   and   protein   degradation170,   combined   with   additional  
regulations   such   as   phosphatase-­dependent   protein   dephosphorylation   and   ubiquitin   ligase-­dependent  
protein   degradation,   chaperone-­mediated   protein   folding,   etc.   Among   the   protein   kinases,   eEF-­2K,   a  
ubiquitously  expressed  protein  kinase  in  eukaryotes94,101,  regulates  the  rate  of  protein  translation  elongation  
by  phosphorylating  of  its  only  known  physiological  substrate,  eEF-­2.  Phosphorylated  eEF-­2  loses  its  affinity  
toward  the  ribosome93  and  thus  impedes  the  translation  elongation  rate.  For  adequate  proteostasis,  cells  
tightly  control  the  activity  of  eEF-­2K  as  a  post-­transcriptional  control  regulator  to  produce  proteins  of  their  
needs   in   the   right   place   at   the   right   time.   To   efficiently   phosphorylate   eEF-­2,   eEF-­2K   first   undergoes  
activation   via   auto-­phosphorylation   of   its   Thr348.   Binding   of   calcium-­loaded   calmodulin   (Ca2+-­CaM),   a  
cofactor  of  this  enzyme,  boosts  up  the  auto-­phosphorylation  rate  by  a  104-­fold  and  increases  the  substrate  
phosphorylation   rate  by  a  103-­fold101,  which  are   further   regulated  by   the  post-­translational  modifications  
(phosphorylation,  hydroxylation,  etc.),  pH,  or  redox66,165.  
Even  though  eEF-­2K  was  initially  named  Ca2+/CaM-­dependent  protein  kinase  III  (CaMKIII),  it  was  
soon  called  eEF-­2K  as  it  did  not  share  much  sequence  homology  with  other  Ca2+/CaM-­dependent  protein  
kinases   (CaMK).   In   addition,   eEF-­2K   did   not   undergo   “release   of   inhibition”   steps   (Figure   1.5)   that   all  
CaMKs  adopt,  which  made  the  name  eEF-­2K  more  common.  Later,  it  was  categorized  as  a  member  of  the  
alpha  kinase  family,  comprising  only  six  protein  kinases  in  the  human  kinome,  where  eEF-­2K  is  the  only  
known  member  to  be  regulated  by  CaM.  Two  alpha  kinase  domain  structures  have  been  solved  (myosin  
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heavy  chain  kinase  A  (MHCKA)  and  transient  receptor  potential  cation  channel  member  7  (TRPM7))171-­174,  
where   its   structural   homology  with   other   kinase   families   and   its   critical   residues   for   activity   have   been  
highlighted.    However,  how  eEF-­2K  gets  activated  by  CaM  remained  elusive.  
Recent   structural   studies   performed   in   our   lab   using   hydrogen   deuterium   exchange   mass  
spectrometry  (HXMS),  cross-­linking  mass  spectrometry  (XLMS),  SAXS,  and  computational  &  homology-­
modelling  combined  with  our  previously  solved  structure  of  Ca2+-­CaM  in  complex  with  a  peptide  derived  
from  the  CaM-­binding  region  of  eEF-­2K  (eEF-­2KCBD)69  allowed  us  to  generate  a  model  based  on  a  truncated  
construct  of  eEF-­2K  (TR)  in  complex  with  Ca2+-­CaM70.  The  model  provides  insight  into  the  first  step  of  the  
two-­step   eEF-­2K   activation   where   (Ca2+)2-­CaM   recognizes   the   CaM-­binding   region   of   eEF-­2K   (CBD),  
tightened  by  further  interactions  between  the  N-­terminal  lobe  of  CaM  (N-­lobeCaM)  and  the  N-­terminal  lobe  
of  the  kinase  domain  (N-­lobeKD)  (Figure  3.1).    
This   interaction   causes   significant   changes   of   the   surface   exposure   of   eEF-­2K,   including   the  
phosphate  binding  pocket  (PBP)  where  phospho-­Thr348  docks   into,  catalytic  center,  and  the  C-­terminal  
region  (CTR)  of  eEF-­2K,  allowing  eEF-­2K  to  adopt  an  optimal  conformation  to  efficiently  auto-­phosphorylate  
Thr348  for  activation.    
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Figure  3.1.  The  molecular  envelope  of  the  CaM•TR  complex  generated  from  the  SAXS  data  showing  the  
approximate  dimensions  with  the  spatial  locations  of  CaM  (light  blue),  CBD  (orange),  KD  (dark  blue)  and  
truncated  CTR   (CTR496–725)   (purple)   in   the  context  of   the  KD•CTR496–725  complex.   In   this  hatchet-­
shaped  complex,  N-­lobeCaM  makes  close  contacts  with  the  N-­lobeKD,  confirmed  by  the  XLMS  data.  Figure  
3.1  was  reprinted  and  modified,  with  permission  from  Ref70.  Copyright  2018  by  Elsevier.  
  
While  the  structural  data  provided  a  clear  view  of  the  CaM-­mediated  structural  impact  on  various  
regions  of  TR  en  route   to  full  activation,  how  the  bound  CaM  molecule  triggers  the  activation  of  eEF-­2K  
remains  elusive.  It  has  been  demonstrated  that  the  conformation  of  CaM  bound  to  a  peptide  derived  from  
the  CaM-­binding  region  (CBD)  of  the  target  could  be  different  from  that  of  the  CBD-­containing  domain  or  
full-­length  enzyme-­bound  form.  In  case  of  death-­associated  protein  kinase  1  (DAPK1),  the  N-­lobeCaM  adopts  
a  significantly  different  orientation  upon  engaging  the  kinase  domain  of  DAPK1  (PDB:2X0G)  opposed  to  
the  DAPK1CBD  peptide-­bound   form   (PDB:  1YR5)   (Figure  3.2)71,  which   facilitates   the  dissociation  of   the  
auto-­inhibitory   segment.  We   reasoned   that   characterization  of   the   conformation  of   TR-­bound  CaM  and  
identification   of   the   key   residues   for   activation   will   help   us   understand   more   deeply   about   how   CaM  
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Figure  3.2.  Crystal  structure  of  Ca2+-­CaM  in  complex  with  (A)  a  peptide  derived  from  DAPK1  containing  
CaM-­binding  region  (DAPK1CBD)  (orange)  (PDB:1YR5)  and  (B)  the  kinase  domain  of  DAPK1  (DAPK1KD)  
(orange)  (PDB:  2X0G).  When  the  two  structures  are  aligned  along  the  CaM-­binding  region,  the  C-­lobesCaM  
in  both  states  (gray  and  coral  blue)  adopt  a  similar  conformation.  While  the  bulky  hydrophobic  anchors  dock  
into  each  lobe  CaM  in  a  1-­14  binding  mode  in  both  cases  (Trp305  into  the  C-­lobeCaM  and  Leu318  into  the  
N-­lobeCaM),   the   N-­lobeCaM   (pink   in   the   DAPK1CBD-­bound   state   and   green   in   the   DAPK1KD-­bound   state)  
adopts   a   significantly   different   orientation.   When   bound   to   DAPK1KD,   the   N-­lobeCaM   makes   additional  
electrostatic   contacts   with   the   DAPK   family-­specific   basic   loop   and   the   catalytic   domain   that   exert  
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3.2  Motivation  
3.2.1  Development  of  the  molecular  probes  of  TR  
To  characterize  the  role  of  CaM  upon  activation  of  eEF-­2K,  we  first  decided  to  obtain  the  molecular  
probes  of  eEF-­2K  from  various  regions  of  the  protein  that  provides  useful  structural  information  about  the  
CaM-­mediated  conformational  changes  for  activation.  This  approach  will  allow  us  to  test  the  conformational  
requirement  of  CaM  to  trigger  activation  of  eEF-­2K.  The  molecular  probes  would  help  us  categorize  which  
states  of  CaM  induce  conformational  changes  of  eEF-­2K  toward  activation  (such  as  Ca2+-­bound  versus  
apo  or  the  wild-­type  versus  mutant).  To  overcome  the  sample  stability  issue  of  full-­length  eEF-­2K  (FL),  a  
truncated  construct  of  eEF-­2K  (TR)  was  generated  where   the  disordered  N-­terminal   loop  (from  Met1   to  
Ser70)  was  deleted  and  the  regulatory  loop  (from  S359  to  Leu489)  was  replaced  by  a  short  linker  containing  





Figure  3.3.  Domain  outline  of  full-­length  eEF-­2K  (FL;;  82.2  kDa)  and  truncated  eEF-­2K  (TR;;  60.2  kDa).  In  
FL  (top),  the  CaM-­binding  region  (CBD)  is  located  next  to  the  N-­terminal  disordered  region,  followed  by  the  
kinase  domain   (KD)   containing   the  allosteric   phosphate   binding  pocket   (PBP),   regulatory   loop   (R-­loop)  
containing  the  auto-­phosphorylatable  Thr348,  and  the  C-­terminal  region  (CTR).  In  TR  (bottom),  disordered  
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Figure  3.4.  TR  remains  as  active  as  the  wild  type.  (A)  TR  displays  a  CaM-­mediated  activity  (picomoles  of  
product  per  picomole  of  enzyme)  to  phosphorylate  pep-­S,  a  substrate-­mimetic  peptide,  in  the  presence  of  
Ca2+  (red).  TR  cannot  phosphorylate  pep-­S  in  the  absence  of  CaM  (green).  (B)  Activity  of  TR  (blue)  toward  
pep-­S  remains  comparable  to  that  of  FL  (red)  in  the  presence  of  Ca2+-­CaM.  kobs  values  were  determined  
using  the  initial  rate  regime.  (C)  TR  remains  as  active  as  the  wild  type  toward  eEF-­2  in  MCF-­10A  (eEF-­
2K−/−)   cells   following   transient   transfection,   despite   the   lower   level   of   expression   (all   measurements   in  
duplicate).  Relative   activities   of   TR  and  FL   toward   eEF-­2   are   shown   in   the   right   panel   (averaged  over  
duplicate  measurements)  normalized  to  the  cellular  levels  of  each  construct.  Figure  3.4  was  reprinted  and  
modified,  with  permission  from  Ref70.  Copyright  2018  by  Elsevier.  
  



































































	   83	  
   TR  retained  its  CaM-­dependent  activity  as  efficient  as  FL70  (Figure  3.4),  so  we  decided  to  build  
molecular  probes  of  TR  as  we  reasoned   that   the  CaM-­mediated  structural   impact  onto  activation  of  TR  
should  remain  the  same  as  FL.  Human  TR  well  expressed  in  E.  coli,  and  remained  soluble  up  to  ~40  µM  at  
our  experimental  condition  (25   C,  20  mM  BisTris  6.8,  150  mM  KCl,  10  mM  CaCl2,  5mM  β-­mercaptoethanol,  
and   0.1%   NaN3).   Given   that   the   critical   intermolecular   contacts   between   CaM   and   TR   occur   through  
hydrophobic  interactions  and  the  changes  in  the  chemical  environment  of  the  hydrophobic  sidechains  in  
the  core  and  at  the  interaction  surface  are  often  great  indicators  of  the  structural  changes,  we  decided  to  
utilize  methyl  groups  of  the  hydrophobic  sidechains  as  molecular  probes  of  the  CaM•TR  complex  (60.2  KDa  
TR  and  16.7  kDa  CaM).  We  employed  methyl-­TROSY  (transverse  relaxation  optimized  spectroscopy)  NMR  
strategies  to  monitor  the  methyl  probes  of  the  complex  in  various  conditions.  This  method  allowed  us  to  
observe  the  correlation  between  1H  and  13C  of  the  hydrophobic  methyl  groups  of  the  complex  despite  the  
large  system,  thanks  to  slow  nuclear  spin  relaxation  rate  from  their  dipolar  interactions  in  the  13C1H3  spin  
system  that  contributes  to  improved  resolution  and  a  signal  to  noise  ratio175.  Among  the  commonly  used  
Ile/Leu/Val/Met/Ala/Thr  methyl  probes,  we  chose  Ile  residues  of  TR  as  the  main  probes,  given  that  15  out  
of  20  Ile  residues  of  TR  are  located  in  the  kinase  domain  (KD)  and  the  other  5  Ile  residues  in  the  C-­terminal  
region  (CTR).  To  assign  each  Ile-­δ1  resonance  from  each  Ile  residue,  mutational  approach  was  assessed.    
3.3  Materials  and  methods  
3.3.1  Production  of  13C,1H-­Ile-­δ1,2H-­labeled  TR  
Plasmids  encoding  His6-­SUMO-­TR  and  corresponding  point  mutants  were  transformed  into  E.  coli  
C41  (DE3)  cells.  Each  Ile  residue  in  TR  was  mutated  one  at  a  time  to  Leu  (except  for  Ile232,  which  was  
mutated   to  Ala,  and   Ile522,  which  was  mutated   to  Ser)  by  site-­directed  mutagenesis  using   the  Phusion  
Master  Mix  with  HF  Buffer  and  Q5  High-­Fidelity  2X  Master  Mix  (New  England  BioLabs).  Fresh  C41  (DE3)  
colonies  were  inoculated  into  starter  LB  cultures  supplemented  with  ampicillin  (100  mg/L),  grown  at  37  °C  
until  the  A600  reached  0.6,  centrifuged  (4000  g  for  15  min  at  4  °C).  The  cell  pellet  was  re-­suspended  in  a  
starter  M9  medium  prepared  in  D2O  and  grown  overnight.  The  overnight  culture  was  inoculated  into  a  0.5-­
L  D2O-­based  M9  medium  supplemented  with  1  g/L  14NH4Cl  and  2  g/L  2H-­glucose  and  grown  at  37  °C.  When  
the  A600   reached  0.5,  50  mg/L  (methyl-­13C,  3,3-­d2)  α-­ketobutyric  acid   (Cambridge   Isotope  Laboratories)  
was  added  to  the  growth  that  was  incubated  for  1  h,  followed  by  induction  with  0.5  mM  IPTG  at  18  °C  for  
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22  h.  Cells  were  harvested  by  centrifugation  (2820g  for  30  min  at  4  °C)  and  re  suspended  in  lysis  buffer  (50  
mM  Tris  at  pH  7.8,  500  mM  NaCl,  150  mM  KCl,  5  mM  β-­mercaptoethanol,  20  mM  imidazole  and  1  mM  
CaCl2).  After  lysis  by  sonication,  the  lysate  was  centrifuged  (15,000g  for  30  min  at  4  °C).  The  supernatant  
was  extracted  and  incubated  with  Ni  NTA  beads  (Qiagen)  for  1  hour  at  4  °C.  The  beads  were  poured  into  
an  Econo-­Column  (Bio-­Rad),  washed  with  10  column  volumes  of  lysis  buffer  and  eluted  with  elution  buffer  
(lysis   buffer   containing   250  mM   imidazole).   ULP1   protease   (1:1000  ULP1   to   fusion  mass   ratio)   and  λ  
phosphatase  (0.25  nmol)  were  added  into  the  eluate,  which  was  then  dialyzed  against  4  L  dialysis  buffer  
(20  mM  Tris  at  pH  7.5,  150  mM  NaCl,  5mM  β-­mercaptoethanol  and  1mM  MnCl2)  at  4  °C  for  16  h,  using  
12-­  to  14-­kDa  MWCO  dialysis  bag  (Spectra/Por).  Dialyzed  samples  were  centrifuged  (15,000  g  for  30  min  
at  4  °C),  filtered  (0.22  μm),  and  purified  over  a  5  mL  HiTrap  Q  HP  (GE  Healthcare  Biosciences)  column  
using  a  linear  gradient  of  0.2–0.8  M  NaCl  (20  mM  Tris  at  pH  7.5,  5  mM  β-­mercaptoethanol).  The  TR  sample  
was  further  purified  using  a  gel  filtration  column  Superdex  200  10/300  GL,  GE  Heathlcare  Biosciences)  pre-­
equilibrated  with  the  NMR  buffer  containing  20  mM  BisTris  at  pH  6.8,  150  mM  KCl,  10  mM  CaCl2,  5  mM  β-­
mercaptoethanol  and  0.1  %  NaN3.  
3.3.2  Production  of  unlabeled  and  U-­[15N,2H]-­labeled  CaM  
CaM  was  cloned,  expressed,  and  purified  as  described   in  Chapter  2   (specify   the  section),  with  
some  modifications  in  the  protocol.  Plasmid  encoding  His10-­SUMO-­CaM  was  transformed  into  E.  coli  BL21  
(DE3)  cells.  Fresh  colonies  were  inoculated  into  a  5  mL  starter  Luria-­Bertani  (LB)  media  supplemented  with  
kanamycin  (50  mg/L),  grown  overnight  at  37  ˚C,  and  centrifuged  (4000  g  for  15  min  at  4  ˚C).  The  cell  pellet  
was  re-­suspended  in  20  mL  LB  or  D2O-­based  M9  media  supplemented  with  2  g/L  2H-­glucose  and  grown  at  
37  ˚C.  When  the  A600  reached  0.6,  the  starter  cultures  were  inoculated  into  a  culture  containing  a  larger  
volume  of  the  same  media  and  was  grown  to  A600  of  0.6,  followed  by  induction  with  0.5  mM  IPTG  at  18  ˚C  
for  20  hours.  Cells  were  harvested  by  centrifugation  (2820  g  for  30  min  at  4  ˚C)  and  re-­suspended  in  lysis  
buffer  (25  mM  Tris  at  pH  7.8,  300  mM  NaCl,  and  1.5  M  Guanidine-­HCl).  After  lysis  by  sonication,  the  lysate  
was  centrifuged  (15,000  g  for  30  min  at  4  ˚C).  The  supernatant  was  extracted  and  incubated  with  Ni-­NTA  
beads  (Qiagen)  for  1  hour  at  4  ˚C.  The  beads  were  poured  into  an  Econo-­Column  (Bio-­Rad),  washed  with  
3   column  volumes  of   denaturation  buffer   (lysis   buffer  with  6  M  Guanidine-­HCl),   followed  by  10   column  
volumes  of  lysis  buffer.  Then,  His10-­SUMO-­CaM  was  eluted  with  elution  buffer  (lysis  buffer  containing  250  
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mM  imidazole).  ULP1  protease  (1:1000  ULP1  to  fusion  mass  ratio)  was  added  into  the  eluate,  which  was  
then  dialyzed  against  4  L  dialysis  buffer  (20  mM  Tris  at  pH  7.5,  100  mM  NaCl,  and  5  mM  β-­mercaptoethanol)  
using  3.5  kDa  MWCO  dialysis  bag  (Spectra/Por).  Cleaved  CaM  was  passed  over  a  Ni-­NTA  column  and  
washed   with   2   column   volumes   of   the   dialysis   buffer.   The   flow-­through   and   the   wash   samples   were  
combined  and  4  mM  CaCl2  was  added.  Ca2+-­CaM  was  further  purified  over  a  phenyl  sepharose  column  
(HiTrap  Phenyl  Sepharose  5  mL  FF,  GE  Healthcare  Biosciences)  using  10  column  volumes  of  wash  buffer  
(20  mM  Tris  at  pH  7.5  and  4  mM  CaCl2)  and  4  column  volumes  of  elution  buffer  (20  mM  Tris  at  pH  7.5  and  
4  mM  EDTA).  The  eluate  was  finally  purified  over  a  size  exclusion  column  (Superdex  75  10/300  GL,  GE  
Healthcare  Biosciences)  with  the  NMR  buffer  containing  20  mM  BisTris  at  pH  6.8,  150  mM  KCl,  10  mM  
CaCl2,  5  mM  β-­mercaptoethanol  and  0.1  %  NaN3.  
3.3.3  NMR  Titrations  for  Ile-­δ1  assignment  
All  NMR  experiments  were  performed  at  25  °C  on  a  Bruker  Avance  spectrometer  operating  at  800  
MHz  equipped  with  a  cryogenic  probe  capable  of  applying  pulsed  field  gradients  along  the  z-­axis.  A  30  μM  
sample   of   13C,1H-­Ile-­δ1,2H-­labeled   TR   in   NMR   buffer   prepared   in   D2O   was   used   in   the   CaM   titration  
experiments   using   13C,   1H  HMQC   spectra   (64   and   512   complex   points   in   the   13C   and   1H   dimensions,  
respectively,   with   corresponding   sweep   widths   of   7   and   12.5   ppm).   In   addition   to   apo   TR,   data   were  
obtained   in   the  presence  of  0.25,  0.5,  1,  2  and  4  molar  equivalents  of  U-­[15N,2H]-­CaM.  All  spectra  were  
processed  using  NMRPipe137  and  analyzed  using  NMRViewJ138.  Assignment  of  the  Ile-­δ1  resonances  was  
obtained  using  13C,1H  SOFAST-­HQMC176  spectra  of  13C,1H-­Ile-­δ1,2H-­TR  mutants  at  700  MHz  (64  or  96  or  
128  and  512  complex  points  in  the  13C  and  1H  dimensions,  respectively,  with  corresponding  sweep-­widths  
of  7  and  13.3  ppm)  in  the  absence/presence  of  various  molar  ratios  of  unlabeled  CaM.  The  concentrations  
of   the  various   Ile  mutants  of  TR   in   the  NMR  samples  varied   from  11.4   to  46  μM.  The  SOFAST-­HMQC  
experiments  ensured  the  rapid  collection  of  correlation  spectra  for  the  mutants  which  had  varying  degrees  
of  stability  in  solution.    
3.3.4  Production  of  the  CaM•TR  complex  
13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  CaM,  U-­[15N,2H]-­labeled  CaM,  unlabeled  TR,  and  13C,1H-­Ile-­δ1,2H-­
labeled  TR  were  prepared  under  the  same  purification  steps  as  described  in  sections  3.3.1  and  3.3.2.  To  
express  13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  CaM,  [methyl-­13C]  methionine  was  added  in  addition  to  (methyl-­13C,  
	  
	   86	  
3,3-­d2)  α-­ketobutyric  acid  (Cambridge  Isotope  Laboratories)  upon  induction  into  the  culture  grown  in  D2O  
M9  media.  Purified  TR  and  CaM  were  mixed  at  a  1  to  3  molar  ratio  (TR  to  CaM)  and  purified  over  a  size  
exclusion  column  (Superdex  200  16/60  HiLoad)  equilibrated  with  buffer  containing  20  mM  BisTris  at  pH  
6.8,  2  mM  CaCl2,  150  mM  KCl,  5  mM  β-­mercaptoethanol,  and  0.1%  NaN3.  Fractions  containing  the  complex  
were  combined  (Figure  3.8)  and  further  buffer-­exchanged  using  a  3  kDa  MWCO  centrifugal  concentrator  
(EMD  Milipore).  When  the  complex  was  concentrated  down  to  ~  300  µL  in  the  concentrator,  the  sample  
was  transferred  to  a  new  concentrator  equilibrated  with  the  apo-­buffer  containing  20  mM  BisTris  at  pH  6.8,  
4  mM  EGTA,  150  mM  KCl,  5  mM  β-­mercaptoethanol,  and  0.1%  NaN3.  After  buffer-­exchanging  twice  in  the  
apo-­buffer  (~  280-­fold  dilution),  a  D2O-­based  NMR  buffer  (20  mM  BisTris  at  pH*  6.8,  150  mM  KCl,  5  mM  β-­
mercaptoethanol,  and  0.1%  NaN3;;  pH*  =  observed  pH)  was  used  to  buffer-­exchange  further  by  four  times  
(~  77,000-­fold  dilution).  The  buffer-­exchange  process  was  performed  at  10  ˚C  to  ensure  the  quality  of  the  
complex  at  a  1  to  1  molar  ratio.    
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Figure  3.8.  Gel  filtration  traces  of  TR  alone  (red)  and  in  complex  with  Ca2+-­CaM  (excess  in  a  1  to  3  TR  to  
CaM  ratio)  (blue)  using  a  Superdex  200  HiLoad  16/60  (GE  HealthCare  Biosciences)  pre-­equilibrated  with  
buffer  containing  20  mM  BisTris  at  pH  6.8,  2  mM  CaCl2,  150  mM  KCl,  5  mM  β-­mercaptoethanol,  and  0.1%  
NaN3.  Fractions  from  each  peak  was  analyzed  via  SDS  PAGE  using  a  12  %  SDS  gel.  Peak  #1  contained  
both  TR  and  CaM,  indicating  that  they  form  a  high-­affinity  complex.  Peak  #2  contained  free  Ca2+-­CaM.    
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3.3.5  Production  of  U-­[15N,2H]-­labeled  eEF-­2KCBD  
U-­[15N,2H]-­labeled  eEF-­2KCBD  sample  was  also  prepared  for  the  reference  experiments.  Plasmids  
encoding  His6   -­SUMO-­eEF-­2KCBD  were   transformed   into  E.   coli  BL21   (DE3)   cells.  Fresh  colonies  were  
inoculated   into  a  5  mL  starter  Luria-­Bertani  (LB)  media  supplemented  with  kanamycin  (50  mg/L),  grown  
overnight  at  37  ˚C,  and  centrifuged  (4000  g  for  15  min  at  4  ˚C).  The  cell  pellet  was  re-­suspended  in  20  mL  
D2O-­based  M9  media  supplemented  with  1  g/L  15NH4Cl  and  2  g/L  2H-­glucose  and  grown  at  37  ˚C.  When  
the  A600  reached  0.6,  the  starter  cultures  were  inoculated  into  a  culture  containing  a  larger  volume  of  the  
same  media  and  was  grown  to  A600  of  0.6,  followed  by  induction  with  0.5  mM  IPTG  at  18  ˚C  for  20  hours.  
Cells  were  harvested  by  centrifugation  (2820  g  for  30  min  at  4  ˚C)  and  re-­suspended  in  lysis  buffer  (25  mM  
Tris  at  pH  7.8,  300  mM  NaCl,  and  6  M  Guanidine-­HCl).  After  lysis  by  sonication,  the  lysate  was  centrifuged  
(15,000  g  for  30  min  at  4  ˚C).  The  supernatant  was  extracted  and  incubated  with  Ni-­NTA  beads  (Qiagen)  
for  1  hour  at  4   C.  The  beads  were  poured  into  an  Econo-­Column  (Bio-­Rad),  washed  with  3  column  volumes  
of  lysis  buffer,  followed  by  10  column  volumes  of  wash  buffer  (25  mM  Tris  at  pH  7.5,  300  mM  NaCl,  and  
1.5  M  Guanidine-­HCl).  Then,  His6-­SUMO-­eEF-­2KCBD  was  eluted  with  elution  buffer  (wash  buffer  containing  
250  mM  imidazole)  and  dialyzed  against  4  L  dialysis  buffer  (20  mM  Tris  at  pH  7.5,  100  mM  NaCl,  and  5  
mM  β-­mercaptoethanol)  overnight  at  4  ˚C.  ULP1  protease  (1:1000  ULP1  to  fusion  mass  ratio)  was  added  
into  the  dialyzed  sample  and  incubated  at  30  ˚C  for  2  hours.  The  cleaved  sample  was  syringe-­filtered  (22  
µm)   then  passed   through  a  Q-­sepharose  column   (HiTrap  Q  5mL  HP,  GE  Healthcare  Biosciences)  and  
washed  with  buffer  A  (20  mM  Tris  at  pH  7.5).  Fractions  in  the  flow-­through  and  the  wash  were  combined  
and  further  injected  into  a  SP-­sepharase  column  (HiTrap  SP  5mL  HP,  GE  Healthcare  Biosciences).  After  
washing  the  column  with  10  column  volumes  of  buffer  B  (buffer  A  +  200  mM  NaCl),  the  sample  was  eluted  
with  the  original  NMR  buffer  containing  20  mM  BisTris  pH  6.8,  10  mM  KCl,  150  mM  KCl,  0.1%  NaN3.  After  
checking  the  peptide  quality  via  mass  spectrometry  (MALDI-­TOF),  eEF-­2KCBD  was  further  buffer-­exchanged  
into  the  apo-­buffer  and  the  D2O-­based  NMR  buffer  in  the  same  buffer-­exchange  steps  described  above.    
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3.3.6  Ca2+-­titrations  
Ca2+-­titration   NMR   experiments   were   performed   at   25   °C   on   a   Bruker   Avance   spectrometer  
operating  at  800  MHz  equipped  with  a  cryogenic  probe  capable  of  applying  pulsed  field  gradients  along  the  
z-­axis.  A  30  μM  complex  of  13C,1H-­Ile-­δ1,2H-­labeled  TR•U-­[15N,2H]-­labeled  CaM  or  unlabeled  TR•  13C,1H-­
Ile-­δ1/Met-­ε,2H-­labeled  CaM  prepared  in  D2O  NMR  buffer  was  used  in  the  Ca2+-­titration  experiments  using  
13C,   1H   HMQC   spectra   (64   and   512   complex   points   in   the   13C   and   1H   dimensions,   respectively,   with  
corresponding  sweep  widths  of  7  and  12.5  ppm).  Data  were  obtained  in  the  presence  of  0,  0.5,  1,  2,  3,  4,  
8,   16.7,  33.3,  and  333.3  molar  equivalents  of  Ca2+.  All   spectra  were  processed  using  NMRPipe137  and  
analyzed  using  NMRViewJ138.    
3.3.7  Production  of  13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  CaM  H107K  
13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled   CaM   H107K   was   prepared   under   the   same   expression   and  
purification  steps  as  the  wild  type  described  in  sections  3.3.2  and  3.3.4.  
3.3.8  Production  of  the  CaM  H107K•TR  complex  
   The  complex  of  13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  CaM  H107K  and  unlabeled  TR  was  prepared  under  
the  same  purification  steps  as  described  in  section  3.3.4.  
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3.4  Result  
3.4.1  CaM-­mediated  chemical  shift  perturbation    
Using   the   mutational   approach   coupled   with   the   Ca2+-­CaM-­titration   method,   15/20   Ile-­δ1  
resonances  were   unambiguously   assigned   (Figure   3.5).  Resonances   of   Ile89   and   Ile349   could   not   be  
uniquely  identified  but  found  a  single  cluster  along  with  Ile237.  Ile131,  Ile214,  and  Ile215  are  close  in  space  
on  the  N-­lobeKD  and  mutation  of  one  caused  chemical  shift  perturbation  of  the  other  two,  and  this  exercise  





Figure  3.5.  Assignment  of   the  TR   Ile-­δ1   resonances.   13C,1H-­HMQC  spectrum   (800  MHZ)  of   13C,1H-­Ile-­
δ1,2H-­TR   is   shown.   The   resonances   corresponding   to   Ile131   and   Ile215   in   the   blue   box   could   not   be  
assigned  uniquely  from  the  mutational  strategies.  Ile89,  Ile349,  and  Ile237  are  expected  to  be  in  the  central  
resonance  cluster,  as  no  noticeable  chemical  shift  perturbation  was  observed  upon  mutation70.  
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As  expected,  most  of  the  Ile  resonances  in  the  KD  showed  significant  perturbations  in  the  presence  
of  Ca2+-­CaM  (Figure  3.6A).  These  include  Ile131  and  Ile215,  located  on  the  N-­lobeKD,  as  well  as  Ile251,  
Ile271,  Ile275  and  Ile287,  all  of  which  lie  at  or  near  the  PBP  and  the  glycine-­rich  loop  (G-­loop).  Resonances  
corresponding   to   residue   Ile275  near   the  catalytic   loop/G-­loop  and   Ile209  on   the   inter-­lobe   linker  of   the  
kinase  domain  (KD)  are  not  identifiable  in  the  bound  state  spectra,  likely  due  to  extremely  large  chemical  
shift  changes.  Ile232,  a  conserved  hydrophobic  residue  in  alpha  kinase  that  stabilizes  the  adenine  group  
of   ATP,   undergoes   a   large   chemical   shift   perturbation,   acting   as   a   signature   resonance   for   the   CaM-­
mediated  conformational   changes.  These  changes   indicate   large  conformational   rearrangements  at   the  
catalytic   center.   Homology   model   of   the   eEF-­2K   KD   (Figure   3.6B)   shows   that   the   Ile   residues   are  
distributed  throughout  the  KD,  from  the  N-­lobeKD  to  the  phosphate  binding  pocket  (PBP).  This  indicates  a  
potential  allosteric  network  that  transduces  the  engagement  of  the  N-­lobeKD  by  Ca2+-­CaM  to  remote  sites  
including  the  PBP  and  the  G-­loop.  On  the  other  hand,  most  of  the  Ile  residues  on  the  CTR  do  not  show  
significant  chemical  shift  perturbation70  (Figure  3.6B).  
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Figure  3.6.  Binding  of  Ca2+-­CaM   induces   large  conformational   changes  of   the  eEF-­2K  KD.   (A)   13C,1H-­
HMQC  spectra  (800  MHZ)  of  13C,1H-­Ile-­δ1,2H-­TR  alone  (dark  green)  and  in  complex  with  U-­[15N,2H]-­labeled  
Ca2+-­CaM  (pink)  at  a  1  to  1  molar  ratio  in  the  presence  of  1  mM  CaCl2  are  shown.  Resonance  assignments  
	  
	   93	  
of   the   free   and   the   CaM-­bound   states   were   achieved   via   mutational   strategies   combined   with   CaM-­
titrations.  Ile  residues  uniquely  assigned  in  green  (except  for  Ile131/Ile215  and  Ile317)  are  indicated  in  the  
(B)  kinase  domain  homology  model  (from  Ala108  to  Asp327)  based  on  the  catalytic  domains  of  the  atypical  
kinases  MHCKA  and  TRPM7,  generated  in  the  previous  study101.  Ile131/Ile215  were  assigned  as  a  pair  in  
light   blue  and   Ile317   (in   the  Zn2+-­binding  motif)   could  not   be  assigned.  Upon  binding  of  Ca2+-­CaM,  TR  
undergoes   significant   conformational   changes   indicated  by   the   chemical   shift   perturbation  of   the   Ile-­δ1  
resonances.  Noticeably,  Ile89  in  CBD  get  repositioned  from  the  central  cluster  in  the  apo  all  the  down  to  
the  left  bottom  corner  of  the  spectra  when  bound  to  Ca2+-­CaM.  Ile232  that  directly  stabilizes  the  adenine  
group  of  ATP  also  gets  repositioned  (center).  Ile251  in  the  PBP  and  Ile213/214/15  in  the  N-­lobeKD  show  
noticeable  resonance  shift.  Ile173  nearby  the  P-­loop  (red)  shows  noticeable  peak-­broadening  while  I275  in  
the   catalytic   loop   (red)   gets   repositioned   elsewhere.   Meanwhile,   Ile-­δ1   resonances   of   the   CTR   (Ile  
518/522/567/581/614;;  not  shown  in  B)  do  not  show  noticeable  chemical  shift  perturbation.  Overall,  every  
Ile-­δ1   resonances   show   noticeable   CaM-­induced   changes,   indicating   that   CaM   causes   substantial  
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3.4.2  Roles  of  CaM  
Our  methyl-­TROSY  spectra  of  13C,1H-­Ile-­δ1,2H-­labeled  TR  in  the  presence  and  absence  of  Ca2+-­
CaM   confirmed   the   large   structural   impact   throughout   the   KD   induced   by   the   binding   of   Ca2+-­CaM,  
consistent  with  the  HXMS  studies70.  Now  that  we  have  powerful  molecular  probes  that  report  changes  in  
various  regions  of  the  KD  that  respond  to  any  variable  introduced  to  the  system,  we  decided  to  use  these  
as  probes  to  further  investigate  what  is  causing  the  conformational  changes  of  TR  upon  binding  of  Ca2+-­
CaM.  Since  the  removal  of  CBD  did  not  make  eEF-­2K  constitutively  active98,  CaM-­mediated  activation  of  
eEF-­2K  was  not  expected   to  undergo  a  simple   “release  of   inhibition,”  where  CBD  that  acts  as  an  auto-­
inhibitory  domain  and   is   removed   from   the  active   site  upon  binding  of  CaM   (Figure  1.5).  Therefore,   to  
understand   how   the   CBD-­bound   CaM   molecule   activates   eEF-­2K,   we   first   decided   to   investigate   the  
conformational  states  of  CaM   in   the  TR-­bound  state  and  compare   it  with   the  eEF-­2KCBD-­bound  state   to  
deduce  the  functional  role  of  the  region  that  show  differences  between  the  two  states.    
First,  to  monitor  the  conformational  states  of  CaM  upon  binding  of  TR,  we  decided  to  obtain  the  
molecular  probes  for  CaM.  This   time,  we  decided  to  use  9  Met-­ε  methyl  groups  (M36,  M51,  M71,  M72,  
M76,  M109,  M124,  M144,  and  M145)  and  8  Ile-­δ1  methyl  groups  (I9,  I27,  I52,  I63,  I85,  I100,  I125,  and  I130)  
(Figure  3.7)  as  the  probes  to  monitor  the  conformation  of  TR-­bound  CaM  by  employing  the  same  NMR  
methyl-­TROSY  strategy177.  Assignments  of  the  free  Ca2+-­CaM  Ile-­δ1/Met-­ε  resonances  were  obtained  from  
Dr.  Chistian  Griesinger  and  Dr.  Fernando  Rodriguez-­Castañeda.  Assignments  of  Ca2+-­CaM  Ile-­δ1/Met-­ε  
resonances   in   the   eEF-­2KCBD-­bound   state   was   obtained   from   previous   our   work69,   deposited   in   the  
Biological   Magnetic   Resonance   Bank   (BMRB:   30063).   Assignments   of   free   apo-­CaM   Met-­ε   methyl  
resonances  were   obtained   from   the   previously   published  work178.   Assignments   of   free   apo-­CaM   Ile-­δ1  
methyl  resonances  were  obtained  by  running  H(CC)(CO)NH-­TOCSY,  (H)CC(CO)NH-­TOCSY,  and  CCH-­
TOCSY  experiments  performed  at  25  °C  on  Bruker  Avance  spectrometers  operating  at  800  MHz  and  600  
MHz  equipped  with  cryogenic  probes  capable  of  applying  pulsed  field  gradients  along  the  z-­axis.  Finally,  
the  Ile-­δ1  and  Met-­ε  methyl  resonances  of  the  C-­lobe  of  eEF-­2KCBD-­bound  apo-­CaM  (U-­[15N,13C]-­labeled)  
were   transferred   from   the   C-­lobe   assignments   of   eEF-­2KCBD-­bound   Ca2+-­CaM.   To   confirm   the   C-­lobe  
assignments,  13C  I,  M-­edited  NOESY-­HSQC  experiment  (500  ms  mixing  time)  was  run  at  at  35  ˚C  using  
13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  CaM   (105  µM)   in   complex  with   unlabeled   eEF-­2KCBD   (1  mM)   in   a   buffer  
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containing  20  mM  BisTris  at  pH  6.5,  150  mM  KCl,  20  mM  EGTA,  and  5%  D2O.  The  Ile-­δ1  and  Met-­ε  methyl  
resonances   of   the   N-­lobe   of   eEF-­2KCBD-­bound   apo-­CaM   were   directly   transferred   from   the   N-­lobe  
assignments  of  free  apo-­CaM.  Intra-­  and  inter-­molecular  NOEs  originating  from  the  apo-­CaM  Ile-­δ1  and  
Met-­ε  methyl  resonances  were  well  matching  with  the  C-­lobe  structure  of  Ca2+-­CaM  in  complex  with  eEF-­
2KCBD  (PDB:  5J8H).  Additional  13C,1H-­HMQC  spectra  were  collected  at  25  ˚C  to  complete  the  assignment  
transfer.    
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Ile  residues  in  CaM  are  located  at  various  regions,  including  the  Ca2+-­binding  loops  (I27,  I63,  I100,  
and  I130),  the  solvent-­exposed  face  of  the  helices  (I9  and  I52),  and  the  hydrophobic  patch  (I85  and  I125).  
I100  and  I125  in  the  C-­lobeCaM  frequently  supplement  the  formation  of  the  C-­lobeCaM  hydrophobic  patch  by  
interacting  with  the  target  hydrophobic  anchors.  In  the  meanwhile,  most  of  the  Met  residues  play  critical  
roles   in   forming   the  hydrophobic  patches   (except   for  M76   located  at   the   inter-­lobe   linker)   to  attract   the  
nonpolar   groups   of   the   target   proteins,   assisted   by   the   long  Met   sidechain   that   grants   conformational  
flexibility179,178,180.  We  reasoned  that  the  CaM  Ile-­δ1  and  Met-­ε  methyl  probes  work  together  synergistically  
to  monitor  the  hydrophobic  moiety,  surface-­exposed  face  of  the  helices,  Ca2+-­binding  loops,  as  well  as  the  
inter-­lobe  linker.  Therefore,  we  decided  to  employ  NMR  to  monitor  these  molecular  probes  from  the  CaM-­
side  to  inspect  conformational  state  as  CaM  associates  with  TR  to  gain  insight  into  roles  of  each  CaM  lobe  
when  bound  to  TR,  and  to  pin-­point  critical  residues  to  understand  how  the  binding  of  Ca2+-­CaM  leads  to  
activation  of  eEF-­2K.  Thus,  we  initially  planned  to  titrate  unlabeled  TR  into  13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  




















Figure  3.7.  Structure  of  Ca2+-­CaM  in  a  
target-­bound   state   (bound   to  
skMLCKCBD,   adopted   from   PDB:  
2BBM).  8  out  of  9  methionine  residues  
(gold)  directly  participate  in  forming  the  
common  hydrophobic  pockets  of  each  
lobe  (except  for  M76,  positioned  in  the  
inter-­lobe   linker)   and   2   out   of   9   Ile  
residues  (coral  blue)  directly  participate  
in   forming   the   common   hydrophobic  
pockets  while  other  Ile  residues  are  in  
various   areas,   including   the   Ca2+-­
binding  loops  and  the  surface-­exposed  
face  of  the  helices.    
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3.4.3  Roles  of  Ca2+  -­  Rationale  
To  overcome  the  issue  of  TR  aggregation/precipitation  when  used  in  excess,  we  decided  to  use  
Ca2+  as  a  titrant  into  a  1  to  1  apo-­CaM•TR  complex  at  30  µM.  Without  Ca2+,  it  was  expected  that  free  apo-­
CaM  population  would  be  the  majority.  As  Ca2+  is  titrated,  we  anticipated  that  the  N-­lobeCaM  will  immediately  
sense  Ca2+,  which  enhances  the  overall  affinity  of  the  complex,  by  engaging  Pro98  while  the  apo-­C-­lobeCaM  
the  helical  region  of  CBD.  As  more  Ca2+  is  titrated  that  allow  CaM  and  TR  to  form  a  high  affinity  complex,  
we  would  be  able  clearly  monitor  the  conformational  states  of  CaM  upon  formation  of  the  complex  with  TR.  
Therefore,  Ca2+-­titration  NMR  method  was   employed   to   surveil   the   conformational   states   of   13C,1H-­Ile-­
δ1/Met-­ε,2H-­labeled  CaM  as  it  tightly  engages  TR  induced  by  Ca2+.  This  strategy  would  also  allow  us  to  
monitor  the  conformational  states  from  the  TR  side  upon  formation  of  a  tight  complex  with  CaM  induced  by  
Ca2+   to   understand   how   the  Ca2+-­dependent   complex   formation  would   impact   the   structure   of   TR   that  
provide  insight  into  the  function  of  each  lobe  of  CaM.  Detailed  protocol  is  mentioned  in  section  3.3.4  and  
Figure  3.8.  
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Figure  3.9.  eEF-­2KCBD  weakly   interacts  with  apo-­CaM  at  pH  6.8   in  a  D2O-­based  buffer.      13C,1H-­HMQC  
spectra  (800  MHZ)  of  13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  apo-­CaM  alone  (black)  and  in  complex  with  U-­[15N,2H]-­
labeled  eEF-­2KCBD  in  a  1  to  1.5  molar  ratio  (purple)  are  shown.  In  the  absence  of  Ca2+,  addition  of  eEF-­
2KCBD  in  a  1  to  1.5  CaM:eEF-­2KCBD  molar  ratio  was  not  enough  to  saturate  apo-­CaM  in  the  bound-­state.  
Slight  chemical  shift  perturbation  in  M109,  M124,  and  M145  are  observed,  which  are  involved  in  making  
specific  interactions  with  eEF-­2KCBD.    
  
3.4.4  CaM•TR  1  to  1  complex  in  the  absence  of  Ca2+  
Given   that   the   affinity   of   apo-­CaM   toward   eEF-­2KCBD   at   pH   6.8   is   not   tight   (KD   ~36   µM)69,   we   initially  
anticipated   to  observe  a  major  population  of   free  apo-­CaM   in   the   13C,1H-­HMQC  spectrum  of   13C,1H-­Ile-­
δ1/Met-­ε,2H-­labeled  CaM  in  a  1  to  1  complex  (30  µM)  with  unlabeled  TR,  just  like  our  reference  spectra  of  
13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  CaM  in  complex  with  U-­[15N,2H]-­labeled  eEF-­2KCBD  at  a  1  to  1.5  CaM:eEF-­
2KCBD  molar  ratio  (Figure  3.9).  Surprisingly,  majority  of  CaM  (>  90%)  adopted  the  eEF-­2KCBD-­bound  form,  
mimetic  to  our  reference  spectra  of  13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  CaM  in  complex  with  U-­[15N,2H]-­labeled  
eEF-­2KCBD  at  a  1  to  20  CaM:eEF-­2KCBD  molar  ratio  (Figure  3.10).  In  the  bound  form,  apo-­C-­lobeCaM  acts  
as  a  main  docking  module,  showing  large  chemical  shift  perturbations  for  Ile-­δ1  of  I85,  I100,  I125,  I130  and  
Met-­ε  of  M109  and  M145.  Two  Met-­ε  (M124  and  M144)  resonances  were  broadened  out  upon  binding.  In  
the  meanwhile,  the  apo-­N-­lobeCaM  Ile-­δ1/Met-­ε  resonances  remained  the  same  as  those  of  free  apo-­CaM.  
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The  chemical  shifts  of  all  the  probes  remained  nearly  identical  to  the  eEF-­2KCBD-­bound  state,  indicating  that  
the  conformation  of  apo-­CaM  bound  to  TR  remains  nearly  same  as  the  eEF-­2KCBD-­bound  form  albeit  with  
the  significantly  enhanced  affinity  as  the  spectrum  of  apo-­CaM  in  the  1  to  1  complex  with  TR  in  the  absence  




Figure  3.10.  Tight  interaction  between  CaM  and  TR  in  the  absence  of  Ca2+.  13C,1H-­HMQC  spectra  (800  
MHZ)  of   13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  apo-­CaM  alone   (black),   in  complex  with  U-­[15N,2H]-­labeled  eEF-­
2KCBD  in  a  1  to  20  CaM:eEF-­2KCBD  molar  ratio  (emerald),  and  in  a  1  to  1  complex  with  unlabeled  TR  (red)  
are  shown.  Formation  of  a  1   to  1  complex  of  CaM  and  TR  in   the  absence  of  Ca2+  was  enough  to  drive  
majority  of  the  apo-­CaM  population  in  the  TR-­bound  state,  indicated  by  the  signature  C-­lobeCaM  resonances  
in  the  eEF-­2KCBD-­bound  form  (labeled  in  red).  In  both  eEF-­2KCBD-­bound  and  TR-­bound  states,  the  N-­lobeCaM  
Ile-­δ1/Met-­ε  resonances  remain  identical  to  those  of  free  apo-­CaM  (labeled  in  black),  indicating  that  the  N-­
lobe  is  unlikely  to  participate  in  making  specific  interactions  with  TR.    
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Figure  3.11.  Ca2+-­dependent  binding  affinity  enhancement  of  CaM  toward  TR.  13C,1H-­HMQC  spectra  (800  
MHZ)  of  13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  apo-­CaM  in  complex  with  unlabeled  TR  in  a  1  to  1  molar  ratio  (red)  
and  the  same  complex  with  Ca2+   in  a  1:0.5  CaM:Ca2+  (pink)  are  shown.  Resonances  of  TR-­bound  apo-­
CaM  are  labeled  in  red,  while  resonances  of  apo-­C-­lobeCaM  in  the  unbound  population  are  labeled  in  black.  
When  Ca2+  is  added,  free  apo-­C-­lobeCaM  resonances  (labeled  in  black)  immediately  disappear,  indicative  
of  binding  affinity  enhancement.    
  
  
3.4.5  Ca2+-­titration  into  the  CaM•TR  complex  –  observation  from  the  CaM  side     
Based  on  our  observation  of  a  high-­affinity  interaction  between  apo-­CaM  and  TR,  we  hypothesized  
that  the  C-­lobeCaM  acts  as  a  recognition  module  that  attaches  CaM  onto  eEF-­2K,  while  the  N-­lobeCaM  acts  
as   a   Ca2+-­sensor   that   makes   eEF-­2K   functional   by   enhancing   the   binding   affinity   of   the   complex   and  
inducing  conformational  changes  of  TR.  To  test  our  hypothesis,  Ca2+  was  titrated  into  the  13C,1H-­Ile-­δ1/Met-­
ε,2H-­labeled  CaM  in  a  1  to  1  complex  (30  µM)  with  unlabeled  TR  at  1  to  0.5,  1,  2,  3,  4,  8,  16.7,  33.3,  and  
333.3  CaM:Ca2+  molar  ratios.  As  expected,   immediately  after  adding  Ca2+  at  a  1  to  0.5  CaM:Ca2+  molar  
ratio,  free  apo-­CaM  resonances  vanished  caused  by  the  affinity  enhancement  (Figure  3.11).  As  more  Ca2+  
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was   titrated,   only   the   N-­lobeCaM   Ile-­δ1/Met-­ε   resonances   showed   Ca2+-­dependent   chemical   shift  
perturbation  (Figure  3.12).  Ile-­δ1/Met-­ε  resonances  of  the  C-­lobeCaM  did  not  change,  consistent  with  the  
native  mass  spectrometry  data   that  confirmed  requirement  of   two  Ca2+   ions   for   the  CaM•TR  complex70.  
Interestingly,  the  Ile-­δ1/Met-­ε  resonances  of  the  N-­lobeCaM  during  the  Ca2+-­titration  were  different  from  the  
eEF-­2KCBD-­bound  state.  Most  of   the  Ca2+-­bound  N-­lobeCaM   Ile-­δ1/Met-­ε   resonances  resembled   those  of  
free  (Ca2+)4-­CaM,  except  for  I27,  I52,  and  M72  (Figure  3.13)  that  responded  to  Ca2+  uniquely.  I27  is  located  
at  the  Ca2+-­binding  loop  in  the  EF-­hand  motif  1  (EF1)  of  CaM  and  I52  is  located  at  helix  C  of  EF2  at  the  
hydrophilic  surface.  M72  is  located  at  helix  D  of  EF2,  pointing  toward  the  hydrophobic  pocket  (Figure  3.14).    
  
  
Figure  3.12.  Ca2+-­dependent  chemical  shift  perturbation  of  TR-­bound  CaM.  13C,1H-­HMQC  spectra   (800  
MHZ)   of   13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled   CaM   in   a   1   to   1   complex   with   unlabeled   TR   at   different  
concentrations  of  Ca2+  are  shown.  Starting  from  the  apo-­state  (red),  Ca2+   is  added  to  CaM  at  CaM:Ca2+  
molar  ratios  of  1  to  1  (orange),  2  (yellow),  and  4  (green).  The  N-­lobeCaM  resonances  undergo  noticeable  
chemical  shift  perturbation  during  Ca2+-­titration,  while  the  C-­lobeCaM  resonances  do  not  undergo  chemical  
shift  perturbation.      
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Figure  3.13.  Fully  Ca2+-­saturated  state  of  TR-­bound  CaM.  13C,1H-­HMQC  spectra  (800  MHZ)  of  13C,1H-­Ile-­
δ1/Met-­ε,2H-­labeled  (Ca2+)4-­CaM  alone  (dark  magenta)  and  13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  CaM  in  a  1  to  1  
complex  with  unlabeled  TR  at  a  1  to  8  CaM:Ca2+  molar  ratio  (light  blue)  are  shown.  Assignments  of  the  free  
(Ca2+)4-­CaM  resonances  are  labeled  in  purple  and  assignments  exclusive  to  Ca2+-­CaM  bound  to  TR  are  
labeled  light  blue.  While  most  of  the  N-­lobe  resonances  of  Ca2+-­CaM  bound  to  TR  remains  near  identical  
to  the  N-­lobe  resonances  of  free  (Ca2+)4-­CaM,  I27,  I52,  and  M72  resonances  show  subtle  chemical  shift  
perturbation,   indicating   that   the   N-­lobe   may   be   involved   in   making   weak   contacts   with   TR   that   could  
significantly  enhance  the  binding  affinity  of  the  complex.  The  C-­lobe  resonances  of  Ca2+-­CaM  bound  to  TR  
show  noticeable  chemical  shift  perturbation,  indicating  that  the  C-­lobeCaM  makes  specific  interactions  with  
TR.      
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Overall,   methyl   resonances   of   the   TR-­bound   N-­lobeCaM   indicate   that   it   may   not   be   involved   in  
making  specific  hydrophobic  contacts  with  TR,  as  the  methyl  resonances  of  the  N-­lobeCaM  remain  nearly  
identical  to  those  of  the  N-­lobeCaM  of  free  (Ca2+)4-­CaM.  However,  the  subtle  resonance  differences  for  I27,  
I52,  and  M72  indicate  that  the  N-­lobeCaM  could  be  involved  in  making  weak  interactions  with  the  TR,  utilizing  
the  surface  hydrophilic  residues  of  helix  C  and  D  of  CaM  without  causing  dramatic  chemical  environemtnal  
changes   of   the   N-­lobeCaM   hydrophobic   pocket.   Unlike   binding   of   eEF-­2KCBD,   where   it   takes   ~   2  molar  
equivalents  of  Ca2+  to  completely  saturate  the  population  of  the  N-­lobeCaM  in  the  eEF-­2KCBD-­bound  state69,  
the   population   saturation   of   TR-­bound  N-­lobeCaM  was  observed  when  8  molar   equivalents   of  Ca2+  was  
added,  with  respect  to  CaM.  This  indicates  that  one  out  of  two  Ca2+-­binding  sites  in  the  N-­lobeCaM  may  have  







Figure   3.14.   Conformation   of   CaM   bound   to   eEF-­
2KCBD   (PDB:  5J8H).  eEF-­2KCBD   is   removed   from   the  
structure.   Positions   of   I27,   I52,   and   M72   in   the   N-­
lobeCaM  are  indicated  in  coral  blue  (for  Ile)  and  orange  
(for  Met).   I52  and  M72  are  located  in  helix  C  and  D,  
respectively.  I27  is  located  in  the  Ca2+-­binding  loop  of  
EF1.   These   residues’   unique   resonances   upon  
binding  TR  in  the  presence  of  Ca2+-­CaM  are  indicated  
in  the  13C,1H-­HMQC  spectra  from  Figure  3.13.    
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Figure  3.15.  Potential  conformational  heterogeneity  of  TR-­bound  Ca2+-­CaM.  13C,1H-­HMQC  spectrum  (800  
MHZ)  of  13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  CaM  in  a  1  to  1  complex  with  unlabeled  TR  at  a  1  to  33.3  CaM:Ca2+  
molar   ratio  are  shown.  As   the  concentration  of  Ca2+   increases   that   causes   the  chemical   shift  of   the  N-­
lobeCaM,  a  new  set  of   resonances  (labeled   in  purple)  show  up   in  addition   to   the  primary  TR-­bound  form  
(labeled   in  blue),   indicated  by   the   labels   in  dark  magenta.  The  second  set  of   resonances   resemble   the  
resonances  of  free  (Ca2+)4-­CaM  primarily  on  the  C-­lobeCaM.  Interestingly,  resonances  of  I27,  I52,  and  M72  
in  the  free  (Ca2+)4-­CaM  form  also  emerge.    
  
Strangely,  upon  Ca2+-­saturation,  we  started  observing  a  second  set  of  the  Ile-­δ1/Met-­ε  resonances  
resembling  the  resonances  of  free  (Ca2+)4-­CaM  (Figure  3.15).  We  initially  guessed  that  this  originated  from  
the  increased  population  of  free  (Ca2+)4-­CaM  where  excess  Ca2+  binds  to  the  C-­lobeCaM,  outcompeting  TR.  
To  confirm  if  they  were  in  the  free  and  TR-­unbound  form,  we  first  buffer-­exchanged  the  NMR  sample  into  
a   H2O-­based   NMR   buffer   containing   20   mM   BisTris   at   pH   6.8,10   mM   CaCl2,   150   mM   KCl,   5   mM   β-­
mercaptoethanol,  0.1%  NaN3,  5%  D2O,  and  50  µM  DSS.  Then,  we  ran  13C,1H-­HSQC  experiments  to  favor  
observation  of  free  (Ca2+)4-­CaM  as  the  TROSY  effect  is  lost  in  the  HSQC  experiments,  which  would  cause  
broadening  of  the  resonances  in  the  TR-­bound  form.  However,  majority  of  these  Ile-­δ1/Met-­ε  resonances  
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that  resemble  free  (Ca2+)4-­CaM  were  not  observed  in  the  13C,1H-­HSQC  spectra  (Figure  3.16),  indicating  
that  these  resonances  represent  the  TR-­bound  state.  Thus,  possible  conformational  heterogeneity  seemed  
to  arise  as  the  concentration  of   free  Ca2+  elevated.  Overall,  our  experiments  clarified  that   the  C-­lobeCaM  
maintains  the  eEF-­2KCBD-­bound  form  as  it  engages  TR,  whereas  the  N-­lobeCaM  adopts  a  conformation  like  
that  of   free  CaM  both   in   the  absence  and  presence  of  Ca2+  (Figure  3.17)  with   the  possibility  of  making  
weak  interactions  with  TR  using  solvent-­exposed  residues  in  helix  C  and/or  D.  Thus,  up  to  this  point,  we  
speculated  that  binding  of  Ca2+  in  the  N-­lobe  allows  making  additional  interactions  with  the  N-­lobeKD  that  
causes  activation  of  eEF-­2K.    
  
  
Figure  3.16.  Comparison  of  the  HSQC  and  HMQC  spectra  of  TR-­bound  Ca2+-­CaM.  13C,1H-­HMQC  (black)  
and   HSQC   (red)   spectra   (800   MHZ)   of   13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled   CaM   in   a   1   to   1   complex   with  
unlabeled  TR   in  10  mM  CaCl2   (at   a  1   to  333.3  CaM:Ca2+  molar   ratio)   are   shown.   In   the   13C,1H-­HSQC  
spectrum,  significant  broadening  of  the  methyl  resonances  is  observed  due  to  the  loss  of  the  TROSY  effect.  
Resonances  of  I9,  I130,  M51,  M71,  and  M76  are  observed,  indicating  that  they  are  not  in  the  interaction  
surface  surround  by  nearby  protons  from  TR  that  could  cause  peak-­broadening.  Noticeably,  the  second  set  
of  methyl  resonances  that  resemble  free  (Ca2+)4-­CaM  are  also  broadened  out  in  the  13C,1H-­HSQC  spectrum,  
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Figure  3.17.  Proposed  conformation  of  TR-­bound  CaM  in  the  presence  and  absence  of  Ca2+  based  on  the  
13C,1H-­HMQC  spectra  of  CaM  in  various  states.  The  C-­lobeCaM  (gray)  adopts  the  eEF-­2KCBD  (orange)-­bound  
state,  staying  Ca2+-­free.  The  N-­lobeCaM  acts  as  a  Ca2+-­sensor/binding-­affinity  enhancer,  adopting   the  N-­
lobeCaM  conformation  of  free  apo-­CaM  (pink)  and  Ca2+-­CaM  (dark  magenta)  in  the  absence  and  presence  
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Figure   3.18.   Binding   effect   of   apo-­CaM  onto  TR.   13C,1H-­HMQC  spectra   of   13C,1H-­Ile-­δ1,2H-­labeled  TR  
alone  (dark  green)  and  in  complex  with  U-­[15N,2H]-­labeled  apo-­CaM  (blue)  at  a  1  to  1  molar  ratio  are  shown.  
Significant  chemical  shift  perturbation  of  the  Ile  resonances  in  the  kinase  domain  is  observed,  including  a  
slight  peak-­broadening  of  Ile567  in  the  CTR.    
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Figure   3.19.   Conformational   similarities   between   apo-­CaM   and   Ca2+-­CaM-­bound   TR.   13C,1H-­HMQC  
spectra   of   13C,1H-­Ile-­δ1,2H-­TR   in   complex   with   U-­[15N,2H]-­labeled   CaM   at   a   1   to   1   molar   ratio   in   the  
presence  and  absence  of  Ca2+  are  shown.  The  CaM-­mediated  chemical  shift  perturbation  remains  nearly  
identical   in   the   absence   (blue)   and   presence   (pink)   of   Ca2+.   In   both   cases,   Ile89   in   CBD,   Ile232   that  
stabilizes  adenine  group  of  ATP,  Ile251  in  PBP,  Ile213/214/15  in  the  N-­lobeKD,  and  Ile173  nearby  the  P-­
loop  all  show  very  similar  resonances  with  subtle  shifts.  The  Ca2+-­induced  subtle  peak  shifts  are  presumably  
caused  by  the  interaction  between  the  N-­lobeCaM  and  the  N-­lobeKD.  Overall,  Ile-­δ1  resonances  show  nearly  
identical  CaM-­mediated  conformational  rearrangement  of  the  kinase  domain  of  eEF-­2K  at  pH  6.8  in  a  D2O-­
based  buffer,  suggesting  a  possibility  that  the  binding  of  CaM  via  C-­lobeCaM  is  sufficient  to  trigger  activation  
of  eEF-­2K  by  rearranging  the  catalytic  center.  
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3.4.6  Ca2+-­titration  into  the  CaM•TR  complex  –  observation  from  the  TR  side  
To  test  our  initial  hypothesis  about  the  roles  of  each  lobe  when  bound  to  TR,  13C,1H-­HMQC-­based  
Ca2+-­titration  experiments  of  the  reversely  labeled  complex  (13C,1H-­Ile-­δ1,2H-­labeled  TR  in  complex  with  U-­
[15N,2H]-­labeled   CaM)   were   performed.   Our   first   spectra   of   apo-­CaM-­bound   TR   provided   a   completely  
different  answer  to  our  hypothesis:  binding  of  apo-­CaM  causes  large  spectral  changes  of  TR  (Figure  3.18),  
reminiscent  of  the  Ca2+-­CaM-­bound  state  (Figure  3.19).    
This   suggests   that   strong   binding   affinity   between   apo-­CaM   and   TR   can   induce   large  
conformational  changes  of  TR  without  the  binding  of  Ca2+  at  pH*  6.8  (pD  ~7.24).  Specifically,  the  interaction  
between  C-­lobeCaM  and  TR  is  sufficient  to  cause  these  changes.  It  has  been  demonstrated  that  the  activity  
of  eEF-­2K  is  pH-­dependent,  where  the  activity  of  eEF-­2K  is  enhanced  as  the  pH  becomes  acidic.  181,182,  
and  the  binding  affinity  between  Ca2+-­CaM  and  eEF-­2KCBD  is  enhanced  as  the  pH  drops  99.  When  Ca2+  was  
titrated   into   the   complex   of   13C,1H-­Ile-­δ1,2H-­labeled   TR   and   U-­[15N,2H]-­labeled   CaM,   Ile-­δ1   methyl  
resonances  of  Ile89,  Ile232,  Ile131/215,  and  Ile214  in  the  CaM-­bound  form  progressively  shifted  (Figure  
3.20),  while  Ile251  in  the  PBP  and  I173  nearby  the  P-­loop  remain  unchanged.  Consistent  with  the  previously  
observed  Ca2+-­dependent  N-­lobeCaM  chemical  shift  perturbation,   these  Ca2+-­dependent   resonance  shifts  
are   likely   to   be   affected   by   the   interaction   between   the   N-­lobeCaM   and   the   N-­lobeKD,   which   provides  
additional  binding  energetics.  In  summary,  NMR  Ca2+-­titration  data  for  the  CaM•TR  complex  indicate  that  
most  of  the  interactions  between  CaM  and  TR  are  localized  between  apo-­C-­lobeCaM  and  CBD,  which  could  
be  sufficient  to  help  eEF-­2K  attain  conformation  necessary  for  activation.  Binding  of  Ca2+  in  the  N-­lobeCaM  
further  promotes  the  interaction  between  the  N-­lobeCaM  and  the  N-­lobeKD  that  enhances  the  binding  affinity  
of  the  complex.    
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Figure   3.20.   Titration   of   Ca2+   into   the   apo-­CaM•TR   complex.   (A)   13C,1H-­HMQC   spectra   (800  MHZ)   of  
13C,1H-­Ile-­δ1,2H-­labeled  TR  in  a  1  to  1  complex  with  U-­[15N,2H]-­labeled  CaM  at  various  concentration  of  
Ca2+  are  shown.  Starting  from  the  apo-­state  (blue),  Ca2+  is  added  into  the  TR•CaM  complex  at  CaM:Ca2+  
molar  ratios  of  1  to  1  (yellow),  4  (red),  and  33.3  (pink).  Ile89,  Ile131,  Ile214,  Ile215,  and  Ile232  show  subtle  
yet  progressive  chemical  shift  perturbation  as  Ca2+  is  titrated.    These  Ile  residues  are  localized  in  the  N-­
lobeKD   (B),   indicating   that   the   interaction  between   the  Ca2+-­bound  N-­lobeCaM   and   the  N-­lobeKD   seem   to  
further  enhance  the  binding  affinity  of  the  complex.    
  
3.4.7  pH  effect  on  the  binding  affinity  of  CaM  toward  eEF-­2K  
How   did   CaM   tightly   bind   to   TR   and   cause   substantial   chemical   perturbation   of   the   TR   NMR  
spectra,  despite  the  expected  weak  affinity  in  the  absence  of  Ca2+?  We  speculate  that  the  binding  affinity  
of  CaM  toward  eEF-­2K  could  change  in  a  pH-­dependent  manner  in  the  absence  of  Ca2+.  Since  the  principal  
interaction  site  between  CaM  and  eEF-­2K   is   localized  between   the  C-­lobeCaM  and  CBD,  we  decided   to  
obtain   NMR   spectra   of   CaM   in   complex   with   eEF-­2KCBD   at   various   pH.   We   prepared   NMR   samples  
containing  13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  CaM  in  complex  with  U-­[15N,2H]-­labeled  eEF-­2KCBD  at  a  1  to  17  
CaM:eEF-­2KCBD  molar  ratio  in  a  H2O-­based  buffer  containing  20mM  BisTris,  4  mM  EGTA,  150  mM  KCl,  50  
µM  DSS,  5%  D2O,  and  0.1%  NaN3,  and  acquired  13C,1H-­SOFAST-­HMQC  spectra  at  various  pH:  5.31,  6.17,  
6.83,  and  7.50.  Indeed,  the  population  of  apo-­CaM  in  free  and  and  in  the  eEF-­2KCBD-­bound  form  drastically  
shifted  in  a  pH-­dependent  manner.  While  Ile-­δ1/Met-­ε  resonances  of  apo-­CaM  indicated  that  majority  of  
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apo-­CaM  were  in  the  eEF-­2KCBD-­bound  state  at  pH  5.31  and  pH  6.17,  they  indicated  that  majority  of  apo-­





Figure  3.21.  Effect  of  pH  on  the  apo-­CaM  affinity  toward  eEF-­2KCBD.  13C,1H-­HMQC  spectra  (800  MHZ)  of  
13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  CaM   in  a  1   to  17  complex  with  U-­[15N,2H]-­labeled  eEF-­2KCBD  at  pH  5.31  
(blue),  6.17  (yellow),  6.83  (pink),  and  7.50  (dark  green)  are  shown.  At  pH  5.31  and  6.17,  majority  of  the  
apo-­CaM  population  adopts  the  eEF-­2KCBD-­bound  form,  indicated  by  the  unique  methyl  resonances  of  the  
C-­lobeCaM,  labeled  in  red.  The  N-­lobeCaM  resonances  that  remain  nearly  identical  to  those  of  free  apo-­CaM  
(labeled  in  black)  undergo  subtle  chemical  shift  perturbation  as  pH  increases.  At  pH  6.83,  the  eEF-­2KCBD-­
unbound  population  becomes  the  majority,  indicating  that  the  pKa  of  the  interaction  between  apo-­CaM  and  
eEF-­2KCBD  is  somewhere  between  6.17  and  6.83.  At  pH  7.50,  only  free  apo-­CaM  methyl  resonances  are  
observed  despite  the  presence  of  eEF-­2KCBD  in  a  1  to  17  CaM:eEF-­2KCBD  molar  ratio,  indicating  that  the  
binding  affinity  between  CaM  and  eEF-­2KCBD  is  significantly  weakened.    
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3.4.8  Potential  function  of  H107  in  the  activation  of  eEF-­2K  
If  the  major  contributor  to  the  interaction  between  CaM  and  eEF-­2K  is  the  apo-­C-­lobeCaM  and  CBD,  
and  the  conformation  of  CaM  bound  to  TR  resembles  the  eEF-­2KCBD-­bound  form  while  the  site  of  interaction  
is  localized  near  the  N-­lobeKD,  then  how  exactly  does  CaM  trigger  activation  of  eEF-­2K?  One  CaM  mutant  
could  provide  a  possible  explanation  for  the  mode  of  activation.  In  2015,  Xie  et  al.  reported  that  that  CaM  
H107K  abolishes  the  activity  of  eEF-­2K182.  This  mutant  was  initially  designed  to  test  if  the  mutation  of  His107  
to  Lys  could  mimic  the  protonated  His  at  acidic  pH  to  check  if  His107  was  playing  a  critical  role  for  the  pH-­
dependent  activity  of  eEF-­2K.  Interestingly,  while  the  CaM  mutant  abolished  the  activity  of  eEF-­2K  at  pH  
6.8  and  7.2,  it  maintained  tight  interactions  with  eEF-­2KCBD  in  the  presence  of  Ca2+  (KD  ~38  nM  for  the  CaM  
WT  and  KD  ~122  nM  for  the  H107K  mutant)182.  H107  did  not  act  as  a  pH-­sensor,  but  we  speculated  that  
H107  of  CaM  could  play  a  critical  role  in  activation  of  eEF-­2K  by  making  functional   interactions  with  the  
“switch”  regions  of  eEF-­2K  that  can  initiate  the  allosteric  networks  throughout  the  KD  from  the  binding  of  
CaM.  Therefore,  we  decided  to  employ  NMR  to  further  investigate  the  role  of  H107  of  CaM.      
3.4.9  CaM  H107K  is  well  folded  and  can  recognize  eEF-­2KCBD  in  the  presence  and  absence  of  Ca2+  
To  rule  out  the  possibility  of  conformational  difference  of  CaM  H107K  from  the  WT  as  a  culprit  for  
the  abolished  activity  of  eEF-­2K,  we  first  collected  reference  13C,1H-­HMQC  spectrum  of  13C,1H-­Ile-­δ1/Met-­
ε,2H-­labeled  CaM  H107K  in  the  presence  and  absence  of  Ca2+.  The  C-­lobe  of  CaM  H107K  (C-­lobeH107K)  
showed  slight  chemical  shift  perturbations  of  Ile-­δ1/Met-­ε  methyl  resonances  in  the  absence  of  Ca2+  (Figure  
3.22).  Met-­ε  resonances  of  M124  and  M144  that  represent  the  C-­lobeCaM  hydrophobic  pocket  showed  ~0.04  
ppm  shift   in  the  1H  dimension,  while  I125  also  forming  the  hydrophobic  pocket  showed  decreased  peak  
intensity,   indicative   of   subtle   differences   in   conformation   and/or   dynamics   in   the   C-­lobeH107K.   The   N-­
lobeH107K   methyl   resonances   were   unaffected   by   the   mutation.   13C,1H-­HMQC   spectrum   of   13C,1H-­Ile-­
δ1/Met-­ε,2H-­labeled  CaM  H107K  in  the  presence  of  Ca2+  matched  nearly  identical  to  that  of  WT,  indicative  
of  nearly  identical  conformation  (Figure  3.23).          
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Figure  3.22.  apo-­CaM  H107K  displays  subtle  structural  difference  in  the  C-­lobeH107K  compared  to  the  wild  
type.   (A)   13C,1H-­HMQC  spectra   (800  MHZ)  of   13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  apo-­CaM  WT  (dark  green)  
and   H107K   (pink)   are   shown.   Subtle   resonance   differences   of   M124   and   M144   are   observed.   These  
methionine   residues,   critical   for   target-­binding,   are   located   in   the   C-­lobeCaM,   indicated   in   (B).   Marginal  
resonance  differences  are  also  observed  for  I100,  I125,  and  M145.  Overall,  mutation  of  H107  causes  subtle  
chemical  environment  changes  in  the  C-­lobeCaM.    
	  
	   114	  
  
  
Figure  3.23.  Ca2+-­CaM  H107K  maintains  a  similar  structure  to  the  wild  type.  13C,1H-­HMQC  spectra  (800  
MHZ)  of  13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  Ca2+-­CaM  WT  (dark  green)  and  H107K  (pink)  are  shown.  Unlike  
the  apo-­state  (Figure  3.22),  Ca2+-­CaM  WT  and  H107K  adopt  a  nearly  identical  conformation,  except  for  
I100  where  a  very  slight  chemical  shift  perturbation   is  observed.  This  suggests   that  CaM  H107K  is  well  
folded  and  can  form  hydrophobic  patches  same  as  CaM  WT.    
  
Next,  we  tested  if  CaM  H107K  could  recognize  eEF-­2KCBD  in  the  absence  of  Ca2+  using  13C,1H-­Ile-­
δ1/Met-­ε,2H-­labeled  CaM  H107K  and  U-­[15N,2H]-­labeled  eEF-­2KCBD.  As  expected,  when  excess  eEF-­2KCBD  
(1  to  20  CaM:eEF-­2KCBD  molar  ratio)  was  added,  13C,1H-­HMQC  spectra  of  13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  
CaM  H107K  remained  the  same  as  the  WT  in  complex  with  eEF-­2KCBD  (Figure  3.25).  When  slight  excess  
of  eEF-­2KCBD  was  added   into   13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  CaM  H107K  at  a  1   to  1.5  CaM:eEF-­2KCBD  
molar   ratio   in   the   absence   of  Ca2+,   noticeable   population   of   the   eEF-­2KCBD-­bound   state  was   observed  
(Figure  3.24),  indicating  that  the  interaction  between  CaM  H107K  and  eEF-­2KCBD  could  be  slightly  stronger  
than  the  WT.  In  summary,  our  spectral  data  suggest  that  CaM  H107K  recognizes  eEF-­2KCBD  in  a  nearly  
identical  conformation  to  the  WT  in  the  presence  and  absence  of  Ca2+.    
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Figure  3.24.  apo-­CaM  H107K  shows  enhanced  binding  affinity  toward  eEF-­2KCBD.  13C,1H-­HMQC  spectra  
(800  MHZ)  of  13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  apo-­CaM  WT  (purpule)  and  H107K  (yellow)  in  complex  with  
U-­[15N,2H]-­labeled  eEF-­2KCBD  in  a  1  to  1.5  CaM:eEF-­2KCBD  molar  ratio  are  shown.  While  apo-­CaM  WT  in  a  
slight  excess  of  eEF-­2KCBD  shows  most  the  methyl  resonances  reminiscent  of  free  apo-­CaM  WT  (labeled  
in  black),  apo-­CaM  H107K  in  a  slight  excess  of  eEF-­2KCBD  shows  a  significantly  increased  population  of  
apo-­CaM  in   the  eEF-­2KCBD-­bound  state  (unique  bound-­resonances   labeled   in  yellow).  This   indicates  an  
enhanced  binding  affinity   of   the  apo-­CaM•eEF-­2KCBD   complex,   and   further   highlights   a   possible   role   of  
H107  in  modulating  the  exposure  of  the  C-­lobeCaM  hydrophobic  patch.    
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Figure  3.25.  When  fully  bound  to  eEF-­2KCBD,  apo-­CaM  H107K  adopts  a  similar  conformation  to  that  of  the  
eEF-­2KCBD  apo-­CaM  WT.  13C,1H-­HMQC  spectra  (800  MHZ)  of  13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  apo-­CaM  WT  
(emerald)  and  H107K  (blue)  in  complex  with  excess  U-­[15N,2H]-­labeled  eEF-­2KCBD  in  a  1  to  20  molar  ratio.  




3.4.10  CaM  H107K  forms  a  high  affinity  complex  with  TR  in  the  presence  of  Ca2+  
Consistent  with  the  previously  reported  strong  interaction  between  CaM  H107K  and  eEF-­2KCBD  in  
the   presence   of   Ca2+   182,   we   managed   to   co-­purify   the   13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled   CaM  
H107K•unlabeled   TR   complex   using   the   size   exclusion   column   strategy   mentioned   in   section   3.3.4.  
Undergoing  the  same  buffer-­exchange  thereafter,  a  1  to  1  complex  of  13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  CaM  
H107K•unlabeled  TR  was  obtained  in  the  absence  of  Ca2+  (Figure  3.26).  
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Figure  3.26.  Gel  filtration  traces  of  TR  alone  (red)  and  in  complex  with  Ca2+-­CaM  H107K  (excess  in  a  1  to  
3  TR:CaM  ratio)  (blue)  using  a  Superdex  200  HiLoad  16/60  (GE  HealthCare  Biosciences)  pre-­equilibrated  
with  buffer  containing  20  mM  BisTris  at  pH  6.8,  2  mM  CaCl2,  150  mM  KCl,  5  mM  β-­mercaptoethanol,  and  
0.1%  NaN3.   Fractions   from  each   peak  was   analyzed   via  SDS  PAGE  using   a   12  %  SDS  gel.   Peak   #1  
contained  both  TR  and  CaM  H107K,  indicating  that  they  form  a  high-­affinity  complex.  Peak  #2  contained  
free  Ca2+-­CaM  H107K.    
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3.4.11  Ca2+-­titration  analysis  of  the  CaM  H107K•TR  complex  –  from  the  CaM  side  
13C,1H-­HMQC  spectrum  of  13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  CaM  H107K  in  complex  with  unlabeled  
TR  show  several  differences  from  the  spectra  of  CaM  WT  in  complex  with  TR.  First,  significantly  increased  
population  of  free  apo-­CaM  H107K  is  observed  indicated  by  the  intense  peaks  of  the  free  apo-­C-­lobeH107K  
Ile-­δ1/Met-­ε  resonances  (Figure  3.27).  This  spectral  pattern  is  comparable  to  that  the  eEF-­2KCBD-­bound  
state   of   apo-­CaM   H107K   at   a   1   to   1.5   CaM:eEF-­2KCBD   molar   ratio   mentioned   in   Figure   3.24.   I125  
resonance   splits   into   a   doublet   while   M109   and   M105   resonances   show   significant   peak-­broadening,  
indicative  of  possible  changes  in  dynamics  in  the  C-­lobeH107K  hydrophobic  pocket.  Overall,  these  changes  
indicate  possible  binding  affinity  reduction,  speculated  by  the  spectrum  of  CaM  H107K  bound  to  TR  in  the  
absence  of  Ca2+.  
  
Figure  3.27.  Decreased  binding  affinity  of  apo-­caM  H107K  toward  TR.  13C,1H-­HMQC  spectra  (800  MHZ)  
of  13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  apo-­CaM  WT  (red)  and  H107K  (blue)   in  a  1   to  1  complex  with  TR  are  
shown.  Compared  with  the  resonances  of  apo-­CaM  WT  in  complex  with  TR,  significant  population  increase  
in   the  TR-­unbound  form  is  observed  for  apo-­CaM  H107K  in  a  1   to  1  complex  with  TR,   indicated  by   the  
intense  free  apo-­C-­lobeH107K  resonances  (labeled  in  black).  These  resonances  resemble  those  of  apo-­CaM  
	  
	   119	  
H107K  in  complex  with  slight  excess  of  eEF-­2KCBD  at  a  1  to  1.5  molar  ratio  (yellow).  This  suggests  that  apo-­
CaM  H107K  cannot  make  additional  interactions  with  TR  after  engaging  CBD,  having  a  comparable  binding  
affinity  toward  eEF-­2KCBD.      
  
As  Ca2+-­was  titrated  at  1  to  1,2,3,4,16.7,  and  333.3  CaM  H107K:Ca2+  molar  ratios,  the  population  
of  free  apo-­CaM  H107K  immediately  diminished,  replaced  by  the  TR-­bound  state  along  with  the  signature  




Figure  3.28.  Titration  of  Ca2+  into  the  CaM  H107K•TR  complex.  13C,1H-­HMQC  spectra  (800  MHZ)  of  13C,1H-­
Ile-­δ1/Met-­ε,2H-­labeled  CaM  H107K  in  a  1   to  1  complex  with  unlabeled  TR  at  various  concentrations  of  
Ca2+  are  shown.  Starting  from  the  apo-­state  (blue),  Ca2+  is  added  to  CaM  at  CaM:Ca2+  molar  ratios  of  1  to  
1  (light  blue),  2  (pink),  4  (green),  and  16.7  (dark  orange).  The  N-­lobeCaM  resonances  undergo  noticeable  
chemical   shift   perturbation   during  Ca2+-­titration,   while   the  C-­lobeCaM   resonances   do   not   undergo  much  
chemical  shift  perturbation.  M109  and  M145  resonances  are  broadened  out  leaving  no  Met-­ε  probes  for  
the  C-­lobeH107K.    
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Interestingly,  the  three  unique  N-­lobeCaM  Ile-­δ1  resonances  of  the  WT  (I27,  I52,  and  M72)  are  not  
observed   in   the   CaM   H107K•TR   complex.   Instead,   free   Ca2+-­N-­lobeH107K   Ile-­δ1/Met-­ε   resonances   are  
observed,  indicating  that  the  N-­lobeH107K  may  not  attain  heterogeneous  conformations  upon  Ca2+-­saturation  
due   to   the   differences   in   binding   (Figure   3.29).   In   summary,   CaM   H107K   tightly   interacts   with   TR  
comparable  to  CaM  WT,  but  with  subtle  differences  in  conformation  were  speculated  for  the  C-­lobeCaM  that  




Figure  3.29.  Structural  difference  between  CaM  H107K  and  WT  when  bound  to  TR  in  the  presence  of  Ca2+.  
13C,1H-­HMQC  spectra  (800  MHZ)  of  13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  Ca2+-­CaM  WT  (dark  blue)  and  Ca2+-­
CaM  H107K   (yellow)   in   a   1   to   1   complex  with   unlabeled  TR   in   10  mM  CaCl2   are   shown.  Resonances  
resembling  the  unique  TR-­bound  state  are  labeled  in  blue,  whereas  the  resonances  resembling  free  (Ca2+)4-­
CaM  state  are  labeled  in  purple.  I27,  I52,  and  M72  methyl  resonances  unique  to  TR-­bound  CaM  WT  (in  
dashed  circle)  mimic  the  resonances  of  free  (Ca2+)4-­CaM  in  the  spectrum  of  TR-­bound  Ca2+-­CaM  H107K.  
In   addition,   the   peak   intensities   of   the   resonances   that  mimic   those   of   the  C-­lobe   of   free   (Ca2+)4-­CaM  
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decreased  significantly  in  the  spectrum  of  TR-­bound  Ca2+-­CaM  H107K,  suggesting  lack  of  conformational  
heterogeneity  that  is  present  in  TR-­bound  Ca2+-­CaM.  
  
3.4.12  TR  does  not  attain  conformation  required  for  activation  upon  binding  of  Ca2+-­CaM  H107K    
To   establish   correlation   between   the   tight   affinity   complex   of   Ca2+-­CaM   H107K•TR   and   the  
compromised  activity   eEF-­2K   in   the  bound   state182,  NMR  experiments  were  performed.      13C,1H-­HMQC  
spectrum  of  13C,1H-­Ile-­δ1,2H-­labeled  TR  in  complex  with  excess  U-­[15N,2H]-­labeled  CaM  H107K  at  a  1  to  3  
TR:CaM   H107K   molar   ratio   was   collected   under   10   mM   CaCl2.   As   expected,   only   marginal   spectral  
difference  was  observed  between  TR  alone  and  TR  bound   to  CaM  H107K  (Figure  3.30).   Ile-­δ1  methyl  
resonances  of   Ile131/215  at   the  N-­lobeKD  noticeably  shifted,  while   the   resonance  of   Ile232   in   the  ATP-­
binding  loop  was  shifted  slightly.  Peak  intensity  attenuation  of  Ile209  in  the  inter-­lobe  linker  and  Ile275  in  
the  catalytic  loop  was  observed.  Most  of  the  Ile-­δ1  methyl  resonances  remained  unchanged,  indicating  that  
the  tight  binding  of  Ca2+-­CaM  H107K  failed  to  trigger  CaM-­induced  activation  of  eEF-­2K,  consistent  with  
the  biochemical   data182.   This   suggests   that  H107  of  CaM   is   a   functionally   important   residue   that   could  
facilitate  activation  by  directly  interacting  with  the  “switch”  regions  or  by  affecting  nearby  CaM  residues  to  
promote  intermolecular  interactions  with  the  “switch”  regions  (Figure  3.31).    
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Figure  3.30.  Binding  of  Ca2+-­CaM  H107K  does  not  induce  conformational  changes  of  TR.  (A)  13C,1H-­HMQC  
spectra  (700  MHZ)  of  13C,1H-­Ile-­δ1,2H-­TR  alone  (dark  green)  and  in  complex  with  U-­[15N,2H]-­labeled  CaM  
H107K  at  a  1  to  3  molar  ratio  (red)  in  10  mM  CaCl2.  Despite  the  addition  of  saturating  amount  of  Ca2+-­CaM  
H107K,   TR   failed   to   attain   a   conformation   required   for   activation.   Subtle   chemical   shift   perturbation   of  
Ile131/214/215  in  the  N-­lobeKD,  I232  in  the  ATP-­binding  loop,  and  Ile209  at  the  inter-­lobe  linker  as  well  as  
the  peak  broadening  of  Ile275  in  the  catalytic  loop  are  observed  in  the  spectra.  The  locations  of  these  Ile  
residues  are  illustrated  in  the  homology  model  of  the  kinase  domain  in  (B).    
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Figure  3.31.  Position  of  H107  in  the  fused  CaM•eEF-­2KCBD  model  in  the  TR-­bound  state,  generated  based  
on  the  chemical  shift  perturbation  data  (Figure  3.17).  H107  is  located  at  the  hydrophilic  face  of  helix  F  in  
the  C-­lobeCaM  (gray)  and  does  not  directly  interact  with  eEF-­2KCBD  (orange).  Conformation  of  the  N-­lobeCaM  




Our  Ca2+  titration  experiments  suggest  that  two  main  events  trigger  activation  of  eEF-­2K:  (1)  binding  
of   the  C-­lobeCaM  with  CBD   in  a  Ca2+-­independent  manner  and   (2)   functional   interaction  between   the  C-­
lobeCaM  with  the  “switch”  regions,  where  H107  plays  a  critical  role.  Ca2+-­N-­lobeCaM  facilitates  this  process  
by  acting  as  a  Ca2+-­sensor  that  enhances  the  binding  affinity  by  interacting  with  the  N-­lobeKD.  In  addition,  
pH   plays   a   critical   role   in   controlling   the   binding   affinity   of   the   CaM•TR   complex   via   pH-­dependent  
interaction  between  C-­lobeCaM  and  CBD.  13C,1H-­HMQC  spectra  of  13C,1H-­Ile-­δ1/Met-­ε,2H-­labeled  CaM  in  
complex  with  U-­[15N,2H]-­labeled  eEF-­2KCBD  showed  drastic  fluctuation  of  the  population  of  free  and  eEF-­
2KCBD-­bound  CaM  in  a  pH-­dependent  manner  in  the  absence  of  Ca2+  (Figure  3.21).  
How  could  H107  play  a  critical   role   in  mediating   functional   interactions  with  eEF-­2K?  Since   the  
H107K  mutant   nearly   abolished   the   activity   at   pH   6.9   and   7.4182,   a   simple   charge-­based   electrostatic  
interaction  role  of  H107  could  be  ruled  out.  H107  is  required  for  the  activity  of  eEF-­2K  regardless  of  the  pH  
or  availability  of  Ca2+.  One  possibility  is  that  H107K  directly  makes  intermolecular  interactions,  such  as:  (1)  
cation-­π  interactions  where  His107  can  act  as  a  π  motif  or  the  cation,  (2)  π-­π  stacking  interactions  involving  
His107  and  eEF-­2K  aromatic  amino  acids,  and  (3)  hydrogen-­π  interactions  between  His107  and  eEF-­2K  
aromatic  amino  acids,  where  specific  charges  and  orientations  of  H107  is  required183.  Alternatively,  H107  
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can  promote  polar  interaction  network  among  the  sidechains  of  helix  F  where  H107  resides:  our  structure  
of  the  Ca2+-­CaM•eEF-­2KCBD  complex  shows  that  H107  makes  close  contacts  with  K94,  E104,  R106,  and  
N111   in   our   20-­structure   ensemble   (PDB:   5J8H)69   where   H107   could   affect   these   residues’   sidechain  
accessibility,  orientation,  or  even  H2O-­coordination  to  make  functional  interactions  with  the  eEF-­2K  residues  





Figure  3.32.  Network  of  polar  residues  nearby  H107.  Sidechain  orientations  of  K94,  E104,  R106,  H107,  
and   N111   in   the   C-­lobeCaM   from   the   solution   structure   of   CaM•eEF-­2KCBD   complex   (PDB:   5J8H)   are  
illustrated.  H107   stays  <   3  Å  distance  with   at   least   one  of   the   four   surrounding   residues.     While  H107  
participating  in  a  direct  intermolecular  interaction  between  CaM  and  eEF-­2K  is  viable,  H107  could  indirectly  
influence  the  functional  interaction  between  CaM  and  eEF-­2K  by  controlling  this  network  of  polar  residues  
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One  question  about  the  pH  and  Ca2+-­dependence  of  eEF-­2K  activity  arises  –  if  the  reduced  binding  
affinity  of  apo-­CaM  toward  eEF-­2K  at  pH  7.5  could  be  enhanced  by  the  binding  of  Ca2+  (KD  ~  16.7  nM  for  
Ca2+-­CaM•eEF-­2K)  69,  then  why  does  the  activity  remain  much  lower  at  pH  7.5  than  the  activity  at  pH  6.5  
in   the  presence  of  Ca2+  where   the  affinities  are  comparable?  One  possible  explanation  could  be  a  pH-­
dependent   conformational   changes   of   CaM   and/or   eEF-­2K   that   interferes   direct   or   indirect   functional  
interactions  between  H107  and  the  “switch”  regions.    
While  the  exact  nature  of  this  ‘functional  interaction’  remains  elusive,  one  CaM-­dependent  enzyme  
relies  on  the  functional  interaction  to  induce  allosteric  reorganization  of  the  active  site  after  forming  a  high-­
affinity  complex  with  CaM:  Edema  Factor,  a  calmodulin-­activated  adenylyl  cyclase  from  B.  anthracis.  As  
Edema  Factor  gets  translocated  into  the  eukaryotic  host,  it  hijacks  the  host  CaM  for  activation,  and  rapidly  
produces  lethal  quantity  of  cyclic  AMP  (cAMP)184.  Binding  of  CaM  onto  Switch  A  in  the  helical  region  of  
Edema  Factor  causes  movement  and  rotation  of  the  helical  domain.  This  liberates  Switch  B  and  changes  
its  secondary  structure  to  promote  interaction  with  the  C-­lobeCaM.  Liberated  and  CaM-­bound  Switch  B  then  
stabilizes  Switch  C,  which  facilitates  binding  and  hydrolysis  of  ATP  (Figure  3.33).  Mutational  studies  have  
shown  that  CaM  makes  functional  interaction  between  Asp  647  of  Switch  B  and  R90  of  CaM  which  does  
not  contribute  much  to  the  overall  binding  affinity,  yet  remains  necessary  for  activity.  This  CaM-­mediated  
active  site  rearrangement  of  Edema  Factor  could  be  a  possible  mode  of  activation  employed  by  eEF-­2K.    
We   think   that   eEF-­2K  may   possess   a   group   of   these   switches   that   control   allosteric   cascade  
throughout   the  kinase  domain   to   reorganize   the  active  site   in  a  CaM-­dependent  manner.  Based  on  our  
structural  modelling70,  the  location  of  these  switches  may  residue  at  the  N-­lobeKD  and/or  nearby  CTR.  As  
the   C-­lobeCaM   is   recruited   by   the   CBD,   the   switch   loops   may   undergo   large   conformational/positional  
changes  to  initiate  the  transformation  of  the  active  site  of  eEF-­2K  via  auto-­phosphorylation  of  Thr348.    
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Figure  3.33.  CaM-­mediated  activation  of  Anthrax  Edema  Factor.  (A)  In  the  inactivate-­state  (PDB:  1K8T),  
“switch”  regions  of  Edema  Factor  are  separated  in  space  (Switch  A  and  C)  and  remain  disordered  (Switch  
B).    (B)  In  the  active-­state  (PDB:  1K90)  (Ca2+)2-­CaM  recognizes  Switch  A  in  the  helical  region,  liberating  
Switch  C,  which  makes  Switch  B  ordered.  Together,   these  switches   reshape   the  active  site   to   facilitate  
hydrolysis  of  ATP   to  produce  cAMP.  CaM  R90  makes   “functional   interaction”  with  Asp647  of  Switch  C.  












Edema Factor apo (PDB: 1K8T)
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Chapter  4  –  Future  Directions  
  
4.1  Overview  
Our   recent   preliminary   NMR   data   suggests   that   the   kinase   domain   of   eEF-­2K   undergoes  
conformational  changes  upon  auto-­phosphorylation  of  Thr348  (Figure  4.1),  which  enhances  the  activity  of  
eEF-­2K  toward  the  substrate  by  103-­fold101.  While  how  these  conformational  changes  affect  the  utilization  
of  bound  CaM  to  phosphorylate  the  substrate  raises  many  questions,  our  fundamental  understanding  about  
the  CaM-­dependence  of  eEF-­2K  in  the  ground  state  will  provide  insight  into  the  regulatory  mechanisms  of  
eEF-­2K.  To  achieve  this,  we  seek  to  further  investigate  (1)  pH-­dependent  binding  affinity/activity  between  
CaM  and  eEF-­2K  in  the  presence  and  absence  of  Ca2+  and  (2)  exact  nature  of  the  functional  interactions  
between  CaM  and  eEF-­2K.    
  
  
Figure  4.1.  Effect  of  auto-­phosphorylation  on  the  conformation  of  the  kinase  domain.  13C,1H-­HMQC  spectra  
(700  MHZ)  of   13C,1H-­Ile-­δ1,2H-­TR   in  complex  with  excess  U-­[14N,2H]-­labeled  Ca2+-­CaM  (1   to  4  TR:CaM  
molar   ratio)   in  a  dephosphorylated  state      (pink)  and   in  an  auto-­phosphorylated  state   (blue)  are   shown.    
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Significant   peak   disappearance   in   the   central   resonance   cluster   and   noticeable   appearance   of   new  
resonances  are  observed,  suggesting  that   the  kinase  domain  undergoes  a   large  conformational  change  
upon  activation.  The  resonances  of  CTR  remain  nearly  identical  after  activation,  suggesting  that  the  activity  
enhancement  upon  activation  is  mainly  caused  by  the  conformational  changes  of  the  kinase  domain.    
  
4.2  pH  dependent  binding  affinity  modulation  
As  acidic  pH  enhances  the  binding  affinity  between  CaM  and  eEF-­2KCBD,  mainly  through  the  mode  
of  recognition  between  apo-­C-­lobeCaM  and  eEF-­2KCBD,  clarification  of  the  pH-­dependence  on  the  CaM-­
mediated  eEF-­2K  activation  is  necessary  in  the  presence  and  absence  of  Ca2+.  ITC  experiments  do  not  
provide  reliable  measurements  for  data  analysis  due  to  the  lack  of  heat  release.  Thus,  direct  fluorescence  
or   fluorescence   anisotropy   measurements   could   be   employed.   To   minimize   the   fluorophore-­induced  
measurement   errors,   recent   chemical   modification   methods   could   be   used   to   attach   fluorophores  
specifically  and  irreversibly  compatible  at  a  wide  range  of  pH.  N-­terminal  attachment  of  the  fluorophore185  
on  CaM  will  minimize  fluorophore-­induced  measurement  errors  by  avoiding  the  fluorophore  being  situated  
at   the  main   interaction   site.  Methyl-­TROSY  NMR  experiments   can   be   coupled  with   the   binding   affinity  
measure   at   various   pH   to   provide   structural   information.   These   data   will   supplement   the   biochemical  
experiments  our  collaborator  lab  (Dr.  Kevin  Dalby,  UT  Austin)  is  working  on.  Thermodynamic,  structural,  
and  biochemical  data  on  the  pH-­dependent  activity  changes  of  eEF-­2K  will  not  help  us  better  understand  
fundamental  mechanism  of  CaM-­mediated  activation,  but  also  help  elucidate  how  various  regulations  of  
eEF-­2K  control  the  activity  of  the  enzyme,  including  a  well-­known  post-­translationally  modified  form  of  eEF-­
2K  –  phsopho-­Ser500  eEF-­2K  that  can  be  activated  by  apo-­CaM  even  at  pH  7.5.    
4.3  Characterization  of  the  CaM-­induced  “switch-­on”  mechanism    
Our  “functional   interaction”  hypothesis   to  explain   the  CaM-­mediated  activation  of  eEF-­2K  stems  
from  our  observations  from  the  NMR  experiments.  To  test  this  hypothesis,  we  need  to  well  characterize  the  
CaM-­eEF-­2K  interaction  surface  and  identify  key  residues  for  the  functional  interaction.  Traditional  15N,1H-­
TROSY-­HSQC   experiments   using   the   backbone   amide   groups   as   the  molecular   probes   could   provide  
useful  information  to  characterize  the  functional  interactions  via  chemical  shift  perturbation  and  dynamics  
experiments.  However,  due  to  the  limited  TR  solubility  (only  up  to  40  µM  at  our  current  NMR  condition),  
complete  backbone  assignments  of  eEF-­2K  and  CaM  in  the  bound  state  do  not  seem  plausible.  While  our  
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primary  plan  aims  to  solve  a  structure  of  the  CaM•eEF-­2K  complex  by  X-­ray  crystallography  or  Cryo-­EM,  a  
backup  plan  using  alternative  chimera  protein  approach  should  be  implemented.  Since  the  apo-­C-­lobeCaM  
plays  a  critical  role  in  making  “functional  interactions”  once  bound  to  eEF-­2K,  substitution  of  CBD  with  the  
C-­lobeCaM,  connected  by  a  short  linker  could  potentially  make  eEF-­2K  constitutively  active.  If  this  is  true,  we  
will  take  an  advantage  of  a  native  chemical  approach186,187  by  connecting  U-­[15N,13C,1H]-­labeled  C-­lobeCaM  
with   13C,1H-­Ile-­δ1,2H-­labeled   TR   that   lacks   CBD   (TR∆CBD)   in   trans   to   perform   NOESY   or   Saturation  
transfer-­based  NMR  experiments   to   identify   the   residues   located  at   the   function   interaction   interface   to  
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Appendix  
  
Table  A.1.  Structures  of  CaM  Complexes  













Method   Mode   FLMM  Tetrad  Engagement   Notes   Ref  
1   2BBM   1994-­01-­31  












2   2BBN   1994-­01-­31  







cuniculus   2   2   NMR   C   1-­14      25  
3   1CDL   1994-­08-­31  
Calcium/calmodulin
-­dependent  protein  
kinase  2  alpha  
(CaMK2a)  
Homo  
sapiens   Gallus  gallus   2   2   X-­ray   C   1-­10-­14      188  
4   1CDM   1994-­08-­31  
Calcium/calmodulin
-­dependent  protein  
kinase  2  alpha  
(CaMK2a)  
Rattus  
norvegicus   Bos  taurus   2   2   X-­ray   C   1-­5-­10      189  
5   1CM1   1998-­03-­04  
Calcium/calmodulin
-­dependent  protein  
kinase  2  alpha  
(CaMK2a)  
Bos  taurus   Rattus  norvegicus   2   2   X-­ray   C   1-­5-­10  
Single   conformer  
refinement   190  
6   1CM4   1998-­03-­04  
Calcium/calmodulin
-­dependent  protein  
kinase  2  alpha  
(CaMK2a)  
Bos  taurus   Rattus  norvegicus   2   2   X-­ray   C   1-­5-­10  
Four  conformer  
refinement   190  
7   1VRK   1999-­04-­27  




sapiens   Gallus  gallus   2   2   X-­ray   C   1-­(10)-­14   CaM  E84K   191  
8   1CKK   1999-­09-­10  
Calcium/calmodulin
-­dependent  protein  





norvegicus   2   2   NMR   C   1-­10-­16      192  









sapiens   2   2   NMR   NC     
Ca2+-­bound  C-­
lobe  engages  the  
target,  Ca2+-­
bound  N-­lobe  free  
193  













the  target  from  a  
different  subunit,  
forms  a  dimeric  
complex  
60  







conserved   2   2   X-­ray   C   1-­(10)-­16      194  









anthracis   2   0   X-­ray   NC     
Ca2+-­bound  C-­















anthracis   2   0   X-­ray   NC     
Ca2+-­bound  C-­
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Method   Mode   FLMM  Tetrad  Engagement   Notes   Ref  








anthracis   2   0   X-­ray   NC     
Ca2+-­bound  C-­






15   1MXE   2002-­12-­04  
Calcium/calmodulin
-­dependent  protein  





norvegicus   2   2   X-­ray   C   1-­10-­14      196  








sapiens   2   2   X-­ray   C   1-­14      197  


























hybrida   2   2   NMR   NC     
One  Ca2+-­CaM  
wraps  around  two  
identical  peptides  
199  
19   1QS7   2003-­06-­24  





vulgare   Gallus  gallus   2   2   X-­ray   C   1-­(10)-­14  
1.80  Å  
   NP  
20   1QTX   2003-­06-­24  





vulgare   Gallus  gallus   2   2   X-­ray   C   1-­(10)-­14  
1.65  Å  
   NP  








anthracis   2   0   X-­ray   NC     
Ca2+-­bound  C-­














anthracis   2   0   X-­ray   NC     
Ca2+-­bound  C-­














anthracis   2   0   X-­ray   NC     
Ca2+-­bound  C-­





























laevis   Bos  taurus   2   2   NMR   C   1-­14      203  








anthracis   2   1   X-­ray   NC     
Ca2+-­bound  C-­
lobe  engages  the  
target;;  N-­lobe  
bound  to  1  Ca2+  





	   132	  













Method   Mode   FLMM  Tetrad  Engagement   Notes   Ref  








anthracis   2   1   X-­ray   NC     
Ca2+-­bound  C-­
lobe  engages  the  
target;;  N-­lobe  
bound  to  1  Ca2+  













anthracis   2   1   X-­ray   NC     
Ca2+-­bound  C-­
lobe  engages  the  
target;;  N-­lobe  
bound  to  1  Ca2+  












anthracis   2   2   X-­ray   NC     
Ca2+-­bound  C-­





Mg2+  (10  mM  
CaCl2)  
68  








anthracis   2   1   X-­ray   NC     
Ca2+-­bound  C-­
lobe  engages,  N-­
lobe  bound  to  1  
Ca2+  does  not  
make  many  
specific  contacts,  
Mg2+  (1  mM  
CaCl2)  
68  








anthracis   2   0   X-­ray   NC     
Ca2+-­bound  C-­
lobe  engages  the  
target;;  Ca2+-­free  
N-­lobe  makes  a  
few  polar  
contacts;;  Mg2+  (1  
µM  CaCl2)  
68  








anthracis   2   1   X-­ray   NC     
Ca2+-­bound  C-­
lobe  engages  the  
target;;  N-­lobe  
bound  to  1  Ca2+  
makes  a  couple  




33   2BKH   2005-­06-­07   Unconventional  myosin-­VI  (Myo6)  
Drosophila  
melanogaster   Sus  scrofa   2   2   X-­ray   C   1-­14      204  
34   2BKI   2005-­06-­07   Unconventional  myosin-­VI  (Myo6)   Gallus  gallus   Sus  scrofa   2   2   X-­ray   C   1-­14      204  
35   1ZOT   2005-­08-­09  
Bifunctional  
hemolysin/adenylat




pertussis   2   N/A   X-­ray   U     
Ca2+-­bound  C-­
lobe  engages  the  
target;;  no  N-­lobe;;  
PMEApp,  Mg2+  
205  
36   1YRU   2005-­09-­27  
Bifunctional  
hemolysin/adenylat




pertussis   2   N/A   X-­ray   U     
Ca2+-­bound  C-­
lobe  engages  the  
target;;  no  N-­lobe  
205  










sapiens   2   2   X-­ray   C   1-­10;;  
Contains  IQ  motif;;  
Tyr  at  the  10-­
position  
206  










sapiens   2   2   X-­ray   C   1-­10  
Contains  IQ  motif;;  
Mg2+;;  
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Method   Mode   FLMM  Tetrad  Engagement   Notes   Ref  










sapiens   2   2   X-­ray   C   1-­10  
Contains  IQ  motif;;  
Tyr  at  the  10-­
position  
207  
40   1YRT   2006-­01-­17  
Bifunctional  
hemolysin/adenylat




pertussis   2   N/A   X-­ray   U     
Ca2+-­bound  C-­
lobe  engages  the  
target;;  no  N-­lobe  
205  
41   2COL   2006-­01-­24  
Bifunctional  
hemolysin/adenylat




pertussis   2   N/A   X-­ray   U     
Ca2+-­bound  C-­
lobe  engages  the  




42   2F2O   2006-­02-­21  
Calcineurin  CaMBD  
fused  to  CaM  
(PPP3CA)  




engage  the  target  
from  a  different  
subunit;;  forming  a  
dimeric  complex;;    
2.17  Å  
208  
43   2F2P   2006-­02-­21  
Calcineurin  CaMBD  
fused  to  CaM  
(PPP3CA)  




engage  the  target  
from  a  different  
subunit,  forming  a  
dimeric  complex;;    
2.6  Å  
208  
44   1WRZ   2006-­03-­21  
Death-­associated  





sapiens   2   2   X-­ray   C   1-­(10)-­14      NP  
45   2DFS   2006-­04-­25   Unconventional  myosin-­Va  (Myo5a)  
Mus  
musculus   Gallus  gallus   0   0   EM     C-­IQ           209  
46   1YR5   2006-­07-­04  
Death-­associated  





sapiens   2   2   X-­ray   C   1-­(10)-­14      NP  






Bos  taurus   Homo  sapiens   2   2   X-­ray   C   1-­14      210  
48   2BCX   2006-­10-­31   Ryanodine  receptor  1  (RYR1)   Gallus  gallus  
Oryctolagus  
cuniculus   2   2   X-­ray   C   1-­(13)-­17      211  
49   1ZUZ   2006-­11-­14  
Death-­associated  





sapiens   2   2   X-­ray   C   1-­(10)-­14      NP  




musculus   0   0   X-­ray   C-­IQ           48  
51   2HQW   2007-­11-­13  
Glutamate  receptor  





sapiens   2   2   X-­ray   C   1-­7  
Shallow  
hydrophobic  
pocket  in  the  
Ca2+-­bound  N-­
lobe;;  
Thr  at  the  7  
position  
28  
52   2VAS   2007-­12-­11   Unconventional  myosin-­VI  (Myo6)  
Drosophila  
melanogaster   Sus  scrofa   2   2   X-­ray   C   1-­14   Mg
2+,  ADP,  BeF3-­   212  
53   2VB6   2007-­12-­11   Unconventional  myosin-­VI  (Myo6)   Gallus  gallus   Sus  scrofa   2   2   X-­ray   C   1-­14   Mg
2+,  ADP,  BeF3-­   212  
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Method   Mode   FLMM  Tetrad  Engagement   Notes   Ref  
54   2O5G   2007-­12-­25  
Myosin  light  chain  
kinase,  smooth  
muscle  (Mylk)  
Gallus  gallus   Gallus  gallus   2   2   X-­ray   C   1-­(10)-­14      NP  




Gallus  gallus   Mus  musculus   2   2   X-­ray   C   1-­10-­14      NP  










sapiens   2   2   X-­ray   C   1-­(5)-­10      NP  










sapiens   2   2   X-­ray   C   1-­(5)-­10      NP  




musculus   0   N/A   NMR   NC     
IQ  motif  directly  
interacts  with  the  
C-­lobe  Ca2+-­
binding  loops;;  no  
N-­lobe  
49  
59   2K0F   2008-­06-­10  






sapiens   2   2   NMR   C   1-­(10)-­14      213  










sapiens   2   2   X-­ray   NC   1-­11  
Dimeric  
CaM/CBD  
complex;;  N-­  and  
C-­lobes  of  two  
different  CaM  
molcules  
















sapiens   2   2   X-­ray   C   1-­10  
Contains  IQ  motif;;  
His  at  the  10-­
position  
215  










cuniculus   2   2   X-­ray   C   1-­(5)-­7  














cuniculus   2   2   X-­ray   C   1-­7  















norvegicus   2   2   X-­ray   C   1-­4-­10  
Contains  IQ  motif  
   216  










cuniculus   2   2   X-­ray   C   1-­4-­9-­10  
Contains  IQ  motif  
   216  
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Method   Mode   FLMM  Tetrad  Engagement   Notes   Ref  










sapiens   2   2   NMR   C   1-­5-­(8)-­18        NP  
67   3BYA   2009-­01-­20  
Glutamate  receptor  





sapiens   2   2   X-­ray   C   1-­7  
Ca2+-­bound  N-­




Thr  at  the  7-­
position  
NP  










sapiens   2   2   X-­ray  
NC  










69   2WEL   2009-­04-­14  
Calcium/calmodulin
-­dependent  protein  






sapiens   2   2   X-­ray   C   1-­5-­10        40  










sapiens   2   2   X-­ray   NC   1-­11  
Dimeric  
CaM/CBD  
complex;;  N  and  
C-­lobes  of  two  
different  CaM  
molecules  











Glycine  max   Nicotiana  tabacum   2   N/A   NMR   U     
Ca2+-­bound  C-­
lobe  engages  the  
target;;  no  N-­lobe  
in  the  structure  
219  







sapiens   2   2   X-­ray   C   1-­(5)-­10-­14      220  
73   3GN4   2009-­09-­08   Unconventional  myosin-­VI  (Myo6)  
Drosophila  




2   X-­ray  
C  and  






complex  in  the  
IQ-­motif;;  the  Ile  is  
replaced  by  Met  
221  








sapiens   2   2   X-­ray   C   1-­7-­10  
2.4  Å  
   NP  








sapiens   2   2   X-­ray   C   1-­(4)-­5-­11  
2.6  Å  
   NP  








sapiens   2   2   NMR   C   1-­(14)-­18      222  
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Method   Mode   FLMM  Tetrad  Engagement   Notes   Ref  








norvegicus   2   2   NMR   NC   1-­5-­26  
Each  Ca2+-­bound  
lobe  binds  a  helix  
separated  by  a  





78   2X0G   2010-­01-­26  
Death-­associated  









Leu  at  the  14  
position  
71  




Gallus  gallus   Mus  musculus   2   2   X-­ray   C   1-­(4)-­(5)-­10      NP  
80   3GP2   2010-­04-­07  
Calcium/calmodulin
-­dependent  protein  
kinase  type  II  
subunit  delta  
(CaMKIId)  
Gallus  gallus   Homo  sapiens   2   2   X-­ray   C   1-­5-­10      NP  
81   2L1W   2010-­09-­29   Vacuolar  calcium  ATPase  BCA1   Glycine  max  
Brassica  
oleracea   2   2   NMR   C   1-­18      223  












2   2   X-­ray  
NC  





binding  loop  not  
well-­resolved;;  
canonical  CaM  




83   3L9I   2010-­12-­08   Unconventional  myosin-­VI  (Myo6)  
Drosophila  
melanogaster   Sus  scrofa   2   2   X-­ray   C   1-­(4)-­14      NP  
84   2L53   2011-­01-­05  
Sodium  channel  






sapiens   0   0   NMR   C-­IQ           47  
85   2X51   2011-­01-­26   Unconventional  myosin-­VI  (Myo6)  
Drosophila  
melanogaster   Sus  scrofa   2   1   X-­ray   C   1-­14  
Structurally  
canonical;;  only  3  
Ca2+  ions-­bound  
225  
86   2KXW   2011-­04-­13  
Sodium  channel  






norvegicus   0   N/A   NMR   C-­IQ     
No  N-­lobe  in  the  
structure   58  
87   2L7L   2011-­05-­18  
Calcium/calmodulin
-­dependent  protein  





norvegicus   2   2   NMR   C   1-­(10)-­14      180  

















89   2Y4V   2011-­12-­28  
Death-­associated  





sapiens   2   2   X-­ray   C   1-­(5)-­(10)-­14      NP  
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Method   Mode   FLMM  Tetrad  Engagement   Notes   Ref  




sapiens   N/A   2   NMR   U     
FLMMN  contacts  




contacts  with  E11  
and  E14  of  CaM;;  
promotes  








sapiens   2   N/A   NMR   U     
FLMMC  contacts  




contacts  with  E83  
and  E84  of  CaM;;  
promotes  




92   4DJC   2012-­02-­22  
Sodium  channel  






sapiens   2   2   X-­ray   NC     
Ca2+-­bound  C-­
lobe  engages  the  
target  while  the  
Ca2+-­bound  N-­
lobe  remains  free  
228  
93   4DS7   2012-­03-­07  






es  cerevisiae   0   0   X-­ray   NC     
Dimeric  complex;;  
2  strontium  ions  
used  instead  of  
Ca2+;;  K.  lactis  
CaM  can  only  
bind  2  Ca2+  ions  
229  







sapiens   2?   2?   NMR   C  
1-­(4)-­(5)-­(10)-­
14  
Ca2+  ions  not  
included  in  the  
structure;;  sample  












sapiens   2?   2?   NMR   C  
1-­(4)-­(5)-­(10)-­
14  
Ca2+  ions  not  
included  in  the  
structure;;  sample  

















engage  the  target  
from  a  different  
subunit,  forming  a  
dimeric  complex;;  
C-­lobe  shows  a  
polarity  change  
upon  binding  of  
Ca2+  
6  









sapiens   N/A   2   NMR   U     
FLMMN-­lobe  
contacts  Trp52  
and  Ala55  of  CBD  
in  a  1-­(4)  mode;;;;  
no  C-­lobe  in  the  
structure  
230  
98   2LGF   2012-­06-­13   L-­selectin  (SELL)   Homo  sapiens  
Homo  
sapiens   2   2   NMR   C   1-­3-­7  
very  shallow  
docking   231  
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Method   Mode   FLMM  Tetrad  Engagement   Notes   Ref  
99   4DCK   2012-­06-­27  
Sodium  channel  









sapiens   0   0   X-­ray   C-­IQ     
C-­lobe  is  Mg2+-­
bound   232  









es  cerevisiae   1   2   NMR   C   1-­(4)-­7-­10  
Ca2+-­bound  EF3  
and  Ca2+-­free  
EF4  still  allows  a  
canonical  mode  
of  binding;;  S.  
cerevisiae  CaM  













norvegicus   2   2   X-­ray   C   1-­(5)-­10      234  














engage  the  target  
from  a  different  


















engage  the  target  
from  a  different  














2   1   X-­ray   C   1-­14  
Ca2+  is  missing  
from  EF1  in  the  
structure  –  likely  




105   4AQR   2012-­10-­17  
Calcium-­
transporting  






thaliana   2   2   X-­ray   C   1-­14  
Forms  a  2  CaM  to  
1  target  complex  
both  CaM  
molecules  wrap  
around  the  target  
237  
106   4EHQ   2012-­11-­07  
Calcium  release-­
activated  calcium  





sapiens   2   2   X-­ray   NC     
Ca2+-­bound  C-­
lobe  engages  the  
target  while  the  
Ca2+-­bound  N-­
lobe  remains  free  
238  








sapiens   2   2   X-­ray   C   1-­14      239  
108   4DBP   2013-­01-­30   Unconventional  myosin-­VI  (Myo6)  
Drosophila  
melanogaster   Sus  scrofa   2   2   X-­ray   C   1-­14      NP  
109   4DBQ   2013-­01-­30   Unconventional  myosin-­VI  (Myo6)  
Drosophila  
melanogaster   Sus  scrofa   2   2   X-­ray   C   1-­14  
ADP-­Mg2+    
   NP  
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Method   Mode   FLMM  Tetrad  Engagement   Notes   Ref  
110   2LV6   2013-­02-­20  











C   1-­(11)-­14      240  




musculus   0   0   X-­ray   C-­IQ           241  




musculus   0   0   X-­ray   C-­IQ         241  


































engage  the  target  
from  a  different  






115   2M55   2013-­05-­08   a-­synuclein  (SNCA)   Homo  sapiens  
Homo  
sapiens   2   2   NMR   NC     
C-­lobe  
interactions  with  
the  target  are  
through  polar  
contacts  of  the  
Lys  residues  of  
the  target  and  
Glu/Asp  residues  
of  CaM    
243  
116   3J41   2013-­07-­31  




sapiens   Ovis  aries   2   2   EM   NC     
Ca2+-­CaM  wraps  
around  helical  
regions  of  two  
different  subunits  
244  
117   3WFN   2013-­08-­28  
Sodium  channel  






musculus   0   0   X-­ray   C-­IQ           245  










norvegicus   2   2   X-­ray   NC   1-­14  
Both  Ca2+-­bound  
lobes  engage  the  
target  on  the  
same  face  of  a  
helix    
246  







norvegicus   2   2   NMR   C   1-­14      247  




norvegicus   0   0   X-­ray   C-­IQ           248  
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Method   Mode   FLMM  Tetrad  Engagement   Notes   Ref  
121   2MGU   2014-­02-­12  
Gag  polyprotein  
(GAG;;  MA8-­43  HIV-­





ency  virus  1  





helical  regions  of  
the  target  
249  








sapiens   2?   2?   NMR   C   1-­(4)-­10-­14  
Ca2+  ions  not  




contained  at  least  
1  mM  CaCl2  
  
73  




sapiens   0   0   X-­ray   C-­IQ           250  
124   4JPZ   2014-­04-­16  
Sodium  channel  









sapiens   2?   2   X-­ray   U     
2  Ca2+  ions  in  the  




clear;;  N-­lobe  is  
Ca2+saturated;;  
contains  IQ  motif  
56  
125   4LZX   2014-­05-­07  
Dynein  regulatory  





sapiens   0   0   X-­ray   C-­IQ           251  
126   4M1L   2014-­05-­07  
Dynein  regulatory  





sapiens   2   2   X-­ray   C   1-­7-­10  
Contains  IQ  motif  
   251  
127   4JQ0   2014-­05-­21  
Sodium  channel  









sapiens   2?   2   X-­ray   U     
2  Ca2+  ions  in  the  







128   2M5E   2014-­07-­23  
Sodium  channel  






norvegicus   2   N/A   NMR   U     
Contains  IQ  motif;;  
FLMMC  engages  
Ile1912  of  CBD;;  
no  N-­lobe  in  the  
structure  
54  
129   4Q57   2014-­07-­23   Plectin  (Plec)   Homo  sapiens  
Mus  
musculus   N/A   2   X-­ray   U     
FLMMN  engages  
Leu25  and  Val29  
of  CBD  in  a  1-­4  
binding  mode;;  no  
C-­lobe  in  the  
structure  
NP  














engage  the  target  
from  a  different  
subunit,  forming  a  
dimeric  complex  
252  
131   4UPU   2014-­08-­20  
Inositol-­
trisphosphate  3-­




sapiens   2   2   X-­ray   C   1-­4-­13-­(16)      253  










sapiens   2   2   X-­ray   C   1-­7      254  
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Method   Mode   FLMM  Tetrad  Engagement   Notes   Ref  








sapiens   0   2   X-­ray   C-­IQ     
K+;;  Ca2+-­bound  





complex  but  the  
IQ  interaction  is  
canonical;;  K+  
255  








sapiens   0   2   X-­ray   C-­IQ      Same  as  4UMO   255  
135   4OVN   2014-­12-­03  
Sodium  channel  






sapiens   0   0   X-­ray   C-­IQ     
C-­lobe  is  Mg2+-­
bound   256  




musculus   0   0   X-­ray   C-­IQ         NP  




sapiens   2   2   NMR   C   1-­10  
Cys  at  the  1-­
position,  Tyr  at  
the  10-­position  
257  
138   4PJJ   2015-­04-­29   Unconventional  myosin-­VI  (Myo6)  
Drosophila  
melanogaster   Sus  scrofa   2   0   X-­ray   C   1-­14  
Structurally  
canonical;;  only  2  
Ca2+  ions;;  no  
Ca2+  ion  in  the  N-­
lobe  
258  
139   2N6A   2015-­08-­26  
Gap  junction  delta-­





sapiens   2   2   NMR   NC     
Trp156  deeply  







part  of  the  target  
NP  




musculus   2   2   X-­ray   C   1-­5-­15  
Contains  IQ;;  motif  
   24  





























subunits  of  a  
tetramer  
260  
143   5K8Q   2016-­08-­24  




sapiens   Danio  rerio   2   2   X-­ray   NC     
Ca2+-­bound  C-­
lobe  principally  
interacts  with  the  
target,  while  the  
Ca2+-­bound  N-­
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Method   Mode   FLMM  Tetrad  Engagement   Notes   Ref  
144   5SY1   2016-­08-­24  




sapiens   Danio  rerio   2   2   EM   NC     
Same  as  5K8Q;;  
cholesterol   261  




sapiens   0   0   X-­ray   C-­IQ           262  




member  2  (KCNQ2)  
and  member  3  









regions  of  the  
target  
263  
147   5J8H   2016-­09-­07  
Eukaryotic  





sapiens   0   2   NMR   NC   1-­5-­14  
Ca2+-­free  C-­lobe  
engages  a  helical  
region  while  the  
Ca2+-­bound  N-­









member  1  (Kcnh1)  
Gallus  gallus   Mus  musculus   2   0   X-­ray   NC     
Ca2+-­bound  C-­
lobe  engages  the  












sapiens   2   0   NMR   NC   1-­4-­5-­14  
No  Ca2+  present  
in  the  structure;;  
225  nM  free  Ca2+  
in  the  NMR  
sample;;  the  
model  described  
in  the  manuscript  
has  2  Ca2+  ions  
bound  to  the  C-­
lobe  
very  shallow  N-­
lobe  pocket;;  Leu  












sapiens   0   N/A   NMR   C-­IQ     
No  N-­lobe  in  the  
structure   266  









helical  regions  of  
the  target  
NP  
152   5DBR   2017-­02-­22  
Sodium  channel  










target  while  the  
Ca2+-­bound  C-­
lobe  remains  free  
267  
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Method   Mode   FLMM  Tetrad  Engagement   Notes   Ref  







musculus   0   0   X-­ray   C-­IQ           57  







musculus   2   2   X-­ray   C   1-­5-­18  
Contains  IQ  motif  
   57  
156   5JTH   2017-­07-­19  






sapiens   2   2   X-­ray   C   1-­10-­14  
CaM  E67A  
   NP  
157   5JQA   2017-­10-­11  






sapiens   2   2   X-­ray   C   1-­10-­14      NP  
158   5NIN   2017-­12-­06  
A-­kinase  anchor  































forming  a  dimeric  
complex;;  SKS-­11  
269  

















forming  a  dimeric  
complex;;  SKS-­14  
269  






U   U   EM   C   apparently  1-­14  
Ca2+  not  
resolved;;  













0   0   EM   C-­IQ      ADP,  Mg
2+,  
phalloidin   271  









0   0   EM   C-­IQ      ADP,  Mg
2+,  state  
A   271  









0   0   EM   C-­IQ      ADP,  Mg
2+,  state  
B   271  
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Method   Mode   FLMM  Tetrad  Engagement   Notes   Ref  













regions  of  the  
target    
272  




norvegicus   0   0   X-­ray   C-­IQ           271  

















forming  a  dimeric  
complex;;  riluzole  
273  

















forming  a  dimeric  
complex;;  CyPPA  
273  













regions  of  the  
target  
274  









sapiens   0   2   X-­ray   NC     
Ca2+-­bound  N-­
lobe  and  Ca2+-­
free  C-­lobe  wrap  
around  distinct  
helical  regions  of  
the  target  
274  









sapiens   0   1   X-­ray   NC     
Ca2+-­bound  N-­
lobe  and  Ca2+-­
free  C-­lobe  wrap  
around  distinct  
helical  regions  of  
the  target    
274  













regions  of  the  
target;;  Mg2+;;  2.2  
Å  
274  













regions  of  the  
target;;  Mg2;;    
2.6  Å  
274  









sapiens   2   0   NMR   NC     
Ca2+-­bound  C-­
lobe  principally  
interacts  with  a  
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Method   Mode   FLMM  Tetrad  Engagement   Notes   Ref  










sapiens   0   0   EM   NC     
Ca2+-­free  C-­lobe  
engages  a  helical  
region  of  the  














sapiens   1   2   EM   NC     
The  C-­lobe  bound  
to  1  Ca2+  ion  
engages  a  helical  
region  while  the  
Ca2+-­bound  N-­
lobe  engages  a  














sapiens   1   2   EM   NC     
The  C-­lobe  bound  
to  1  Ca2+  ion  
engages  a  helical  
region  while  the  
Ca2+-­bound  N-­
lobe  engages  a  





















forming  a  dimeric  
complex  
276  

















forming  a  dimeric  
complex  
NP  














regions  of  the  
target  
NP  














regions  of  the  
target  
NP  










sapiens   1   2   X-­ray   C   1-­7-­10  


















sapiens   1   2   X-­ray   C   1-­7-­10  
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Method   Mode   FLMM  Tetrad  Engagement   Notes   Ref  
























cuniculus   2   1   EM   NC     
Ca2+-­bound  C-­
lobe  and  the  N-­










1.   Structures  for  which  co-­ordinates  are  available  as  of  12/2018  are  listed  in  order  of  release  date.  
Only  complexes  that  involve  wild-­type  CaM,  specific  mutants  or  truncated  variants  thereof,  have  
been   included.  Structures   such   as  PDB   ID:   6HCS   (release   date   2018-­12-­05)   that   contains   the  
unnatural  amino-­acid  p-­azido-­phenylalanine  (replacing  V108)  in  complex  with  CaMK2 CBD,  whose  
structure  has  been  previously  characterized,  have  not  been  included.  
2.   The  engagement  of  the  CaM  hydrophobic  pockets  defined  by  the  FLMM  tetrads  (F19,  L32,  M51,  
M71  in  the  N-­lobe,  FLMMN;;  F92,  L105,  M124,  M144  in  the  C-­lobe,  FLMMC)  has  been  defined  by  
the  spacing  between  the  key  hydrophobic  residues  on  the  target  relative  to  the  first  anchor.  Target  
hydrophobic  residues  that  lie  at  the  periphery  of  the  pockets  defined  by  the  FLMM  tetrads  are  in  
parentheses.  For  example,  a  1-­(5)-­8-­14  mode  suggests  the  key  residues  on  the  target  that  contact  
the  FLMM  tetrads  lie  at  the  5th,  8th  and  14th  position  with  respect  to  the  first,  with  a  deep  burial  of  
the  1st,  8th  and  14th  residues  and  peripheral  contact  with  the  5th.    
3.   Canonical  (denoted  by  “C”)  and  noncanonical  (denoted  by  “NC”)  structures  are  shaded  green  and  
blue,   respectively.   Definitions   of   “canonical”   and   “non-­canonical”   are   illustrated   in   Figure   1.2.  
Multimeric  structures  containing  both  canonical  and  noncanonical  binding  modes  are  shaded   in  
gray.  Structures  with  undefined  modes  of  binding  (denoted  by  “U”)  due  to  the  absence  of  one  of  
the   lobes   are   shaded   in   orange   (note   that   a   canonical   interaction   involving   an   IQ  motif   largely  
utilizes  one  lobe,  therefore  the  interaction  in  such  a  case  is  considered  canonical  even  if  one  lobe  
is  missing  e.  g.  2M5E,  #128).  Structures  with  seemingly  canonical  binding  modes  without  full  Ca2+  
saturation  are  shaded  in  pink  except  for  cases  in  which  the  CaM  can  only  bind  less  than  the  full  
complement   of   Ca2+   (e.g.   2LHI,   #100)   or   where  mutation   of   residues   that   are   in   the   Ca2+   co-­
ordination  sphere  prevent  Ca2+  binding  (e.g.  6DAD,  #183  or  6DAE,  #184).    
4.   An  interaction  is  considered  a  canonical  IQ  motif  interaction  (C-­IQ)  only  in  the  absence  of  Ca2+.  In  
some   cases,   IQ  motif   containing   sequences   also   interact  with  CaM   in   the   presence   of  Ca2+   in  
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canonical   fashion;;   these  are  classified  as   “C”   rather   than  C-­IQ.  The  presence  of  an   IQ  motif   is  
indicated  in  the  Notes  column.  
5.   If  different  PDB  IDs  involving  the  same  set  of  molecules  list  the  same  publication,  the  distinguishing  
features  between  the  structures  is  provided  e.g.  alternative  refinement  protocols,  additional  ligands,  
different  resolution,  different  states  etc.  
6.   NP  in  the  Reference  column  signifies  the  absence  of  a  published  manuscript  corresponding  to  a  
particular  PDB  entry.      
  
	  
	   148	  
References  
  
1.  Clapham  DE  (2007)  Calcium  signaling.  Cell  131:1047-­1058.  
2.  Bagur  R,  Hajnóczky  G  (2017)  Intracellular  Ca2+  sensing:  its  role  in  calcium  homeostasis  and  signaling.  
Mol.  Cell  66:780-­788.  
3.  Naraghi  M,  Neher  E  (1997)  Linearized  buffered  Ca2+  diffusion  in  microdomains  and  its  implications  for  
calculation  of  [Ca2+]  at  the  mouth  of  a  calcium  channel.  J.  Neurosci.  17:6961-­6973.  
4.  Chin  D,  Means  AR  (2000)  Calmodulin:  a  prototypical  calcium  sensor.  Trends  in  Cell  Biology  10:322-­328.  
5.  Persechini  A,  Stemmer  PM  (2002)  Calmodulin  is  a  limiting  factor  in  the  cell.  Trends  Cardiovasc.  Med.    
12:32-­37.  
6.  Zhang  M,  Abrams  C,  Wang  L,  Gizzi  A,  He  L,  Lin  R,  Chen  Y,  Loll  Patrick  J,  Pascal  John  M,  Zhang  J-­F  
(2012)  Structural  basis  for  calmodulin  as  a  dynamic  calcium  sensor.  Structure  20:911-­923.  
7.  Berchtold  MW,  Villalobo  A  (2014)  The  many  faces  of  calmodulin  in  cell  proliferation,  programmed  cell  
death,  autophagy,  and  cancer.  Biochim.  Biophys.  Acta  Mol.  Cell  Res.  1843:398-­435.  
8.   Villarroel   A,   Taglialatela   M,   Bernardo-­Seisdedos   G,   Alaimo   A,   Agirre   J,   Alberdi   A,   Gomis-­Perez   C,  
Soldovieri  MV,  Ambrosino  P,  Malo  C,  Areso  P  (2014)  The  ever  changing  moods  of  calmodulin:  how  
structural  plasticity  entails  transductional  adaptability.  J.  Mol.  Biol.  426:2717-­2735.  
9.  Babu  YS,  Sack  JS,  Greenhough  TJ,  Bugg  CE,  Means  AR,  Cook  WJ  (1985)  Three-­dimensional  structure  
of  calmodulin.  Nature  315:37-­40.  
10.  Babu  YS,  Bugg  CE,  Cook  WJ  (1988)  Structure  of  calmodulin  refined  at  2.2  Å  resolution.  J.  Mol.  Biol.  
204:191-­204.  
11.  Chou  JJ,  Li  S,  Klee  CB,  Bax  A  (2001)  Solution  structure  of  Ca2+–calmodulin  reveals  flexible  hand-­like  
properties  of  its  domains.  Nature  Struct.  Biol.  8:990-­997.  
12.  Kuboniwa  H,  Tjandra  N,  Grzesiek  S,  Ren  H,  Klee  CB,  Bax  A  (1995)  Solution  structure  of  calcium-­free  
calmodulin.  Nature  Struct.  Biol.  2:768-­776.  
13.  Yamniuk  AP,  Vogel  HJ  (2004)  Calmodulin’s  flexibility  allows  for  promiscuity  in  its  interactions  with  target  
proteins  and  peptides.  Mol.  Biotechnol.  27:33-­57.  
14.  Lewit-­Bentley  A,  Réty  S  (2000)  EF-­hand  calcium-­binding  proteins.  Curr.  Opin.  Struct.  Biol.  10:637-­643.  
15.  Gifford  JL,  Walsh  MP,  Vogel  HJ  (2007)  Structures  and  metal-­ion-­binding  properties  of  the  Ca2+-­binding  
helix-­loop-­helix  EF-­hand  motifs.  Biochem.  J.  405:199-­221.  
16.   Brokx   RD,   Lopez   MM,   Vogel   HJ,   Makhatadze   GI   (2001)   Energetics   of   target   peptide   binding   by  
calmodulin  reveals  different  modes  of  binding.  J.  Biol.  Chem.  276:14083-­14091.  
17.  Tidow  H,  Nissen  P  (2013)  Structural  diversity  of  calmodulin  binding  to  its  target  sites.  FEBS  J.  280:5551-­
5565.  
18.  Wu  X,  Bers  DM  (2007)  Free  and  bound  intracellular  calmodulin  measurements  in  cardiac  myocytes.  
Cell  Calcium  41:353-­364.  
	  
	   149	  
19.  Black  DJ,  Tran  Q-­K,  Persechini  A  (2004)  Monitoring  the  total  available  calmodulin  concentration  in  intact  
cells  over  the  physiological  range  in  free  Ca2+.  Cell  Calcium  35:415-­425.  
20.  Alaimo  A,  Alberdi  A,  Gomis-­Perez  C,  Fernández-­Orth  J,  Gómez-­Posada  JC,  Areso  P,  Villarroel  A  (2013)  
Cooperativity  between  calmodulin-­binding  sites  in  Kv7.2  channels.  J.  Cell  Sci.  126:244-­253.  
21.  Hoffman  L,  Chandrasekar  A,  Wang  X,  Putkey  JA,  Waxham  MN  (2014)  Neurogranin  alters  the  structure  
and  calcium-­binding  properties  of  calmodulin.  J.  Biol.  Chem.  289:14464-­14655.  
22.  Cheney  RE,  Mooseker  MS  (1992)  Unconventional  myosins.  Current  Opinion  in  Cell  Biology  4:27-­35.  
23.  Bähler  M,  Rhoads  A  (2001)  Calmodulin  signaling  via  the  IQ  motif.  FEBS  Lett.  513:107-­113.  
24.   Shen  M,   Zhang  N,   Zheng   S,   Zhang  W-­B,   Zhang  H-­M,   Lu   Z,   Su  QP,   Sun   Y,   Ye   K,   Li   X-­d   (2016)  
Calmodulin  in  complex  with  the  first  IQ  motif  of  myosin-­5a  functions  as  an  intact  calcium  sensor.  
Proc.  Natl.  Acad.  Sci.  U.S.A.  113:E5812-­E5820.  
25.  Ikura  M,  Clore  GM,  Gronenborn  AM,  Zhu  G,  Klee  CB,  Bax  A  (1992)  Solution  structure  of  a  calmodulin-­
target  peptide  complex  by  multidimensional  NMR.  Science  256:632-­638.  
26.  Rhoads  AR,  Friedberg  F  (1997)  Sequence  motifs  for  calmodulin  recognition.  FASEB  J.  11:331-­340.  
27.  Yap  KL,  Kim  J,  Truong  K,  Sherman  M,  Yuan  T,  Ikura  M  (2000)  Calmodulin  target  database.  J.  Struct.  
Funct.  Genom.  1:8-­14.  
28.  Ataman  ZA,  Gakhar  L,  Sorensen  BR,  Hell  JW,  Shea  MA  (2007)  The  NMDA  receptor  NR1  C1  region  
bound  to  calmodulin:  structural  insights  into  functional  differences  between  homologous  domains.  
Structure  15:1603-­1617.  
29.  Zhang  M,  Tanaka  T,  Ikura  M  (1995)  Calcium-­induced  conformational  transition  revealed  by  the  solution  
structure  of  apo  calmodulin.  Nature  Struct.  Biol.  2:758-­767.  
30.  Crivici  A,  Ikura  M  (1995)  Molecular  and  structural  basis  of  target  recognition  by  calmodulin.  Annu.  Rev.  
Biophys.  Biomol.  Struct.  24:85-­116.  
31.  Shoemaker  MO,  Lau  W,  Shattuck  RL,  Kwiatkowski  AP,  Matrisian  PE,  Guerra-­Santos  L,  Wilson  E,  Lukas  
TJ,  Van  Eldik  LJ,  Watterson  DM  (1990)  Use  of  DNA  sequence  and  mutant  analyses  and  antisense  
oligodeoxynucleotides   to   examine   the  molecular   basis   of   nonmuscle  myosin   light   chain   kinase  
autoinhibition,  calmodulin  recognition,  and  activity.  J.  Cell  Biol.  111:1107-­1125.  
32.  Soderling  TR  (1990)  Protein  kinases.  Regulation  by  autoinhibitory  domains.  J.  Biol.  Chem.  265:1823-­
1826.  
33.  Yokokura  H,  Picciotto  MR,  Nairn  AC,  Hidaka  H  (1995)  The  regulatory  region  of  calcium/calmodulin-­
dependent   protein   kinase   I   contains   closely   associated   autoinhibitory   and   calmodulin-­binding  
domains.  J.  Biol.  Chem.  270:23851-­23859.  
34.  Goldberg  J,  Nairn  AC,  Kuriyan  J  (1996)  Structural  basis  for  the  autoinhibition  of  calcium/calmodulin-­
dependent  protein  kinase  I.  Cell  84:875-­887.  
35.  Cohen  O,   Feinstein  E,   Kimchi   A   (1997)  DAP-­‐kinase   is   a  Ca2+/-­calmodulin-­‐dependent,   cytoskeletal-­‐
associated  protein  kinase,  with  cell  death-­‐inducing  functions  that  depend  on  its  catalytic  activity.  
EMBO  J.  16:998-­1008.  
	  
	   150	  
36.   Soderling   TR   (1999)   The   Ca2+–calmodulin-­dependent   protein   kinase   cascade.   Trends   Biochem.  
Sci.24:232-­236.  
37.   Corcoran   EE,   Means   AR   (2001)   Defining   Ca2+/calmodulin-­dependent   protein   kinase   cascades   in  
transcriptional  regulation.  J.  Biol.  Chem.  276:2975-­2978.  
38.  González  B,  Schell  MJ,  Letcher  AJ,  Veprintsev  DB,  Irvine  RF,  Williams  RL  (2004)  Structure  of  a  human  
inositol  1,4,5-­trisphosphate  3-­kinase:  Substrate  binding  reveals  why  it  is  not  a  phosphoinositide  3-­
kinase.  Mol.  Cell  15:689-­701.  
39.  Rosenberg  OS,  Deindl  S,  Sung  R-­J,  Nairn  AC,  Kuriyan  J  (2005)  Structure  of  the  autoinhibited  kinase  
domain  of  CaMKII  and  SAXS  analysis  of  the  holoenzyme.  Cell  123:849-­860.  
40.  Rellos  P,  Pike  ACW,  Niesen  FH,  Salah  E,   Lee  WH,   von  Delft   F,   Knapp  S   (2010)  Structure   of   the  
CaMKIIδ/calmodulin  complex  reveals  the  molecular  mechanism  of  CaMKII  kinase  activation.  PLOS  
Biology  8:e1000426.  
41.  Hashimoto  Y,  Perrino  BA,  Soderling  TR  (1990)  Identification  of  an  autoinhibitory  domain  in  calcineurin.  
J.  Biol.  Chem.  265:1924-­1927.  
42.  Perrino  BA,  Ng  LY,  Soderling  TR  (1995)  Calcium  regulation  of  calcineurin  phosphatase  activity  by  its  B  
subunit  and  calmodulin:  Role  of  the  autoinhibitory  domain.  J.  Biol.  Chem.  270:340-­346.  
43.  Harper  JF,  Hong  B,  Hwang  I,  Guo  HQ,  Stoddard  R,  Huang  JF,  Palmgren  MG,  Sze  H  (1998)  A  novel  
calmodulin-­regulated   Ca2+-­ATPase   (ACA2)   from   arabidopsis   with   an   N-­terminal   autoinhibitory  
domain.  J.  Biol.  Chem.  273:1099-­1106.  
44.   Stratton   MM,   Chao   LH,   Schulman   H,   Kuriyan   J   (2013)   Structural   studies   on   the   regulation   of  
Ca2+/calmodulin  dependent  protein  kinase  II.  Curr.  Opin.  Struct.  Biol.  23:292-­301.  
45.  Tjandra  N,  Kuboniwa  H,  Ren  H,  Bax  A  (1995)  Rotational  dynamics  of  calcium-­free  calmodulin  studied  
by  15N-­NMR  relaxation  measurements.  Eur.  J.  Biochem.  230:1014-­1024.  
46.  Shukla  D,  Peck  A,  Pande  VS  (2016)  Conformational  heterogeneity  of  the  calmodulin  binding  interface.  
Nature  Commun.  7:10910.  
47.  Chagot  B,  Chazin  WJ  (2011)  Solution  NMR  structure  of  apo-­calmodulin  in  complex  with  the  IQ  motif  of  
human  cardiac  sodium  channel  NaV1.5.  J.  Mol.  Biol.  406:106-­119.  
48.  Houdusse  A,  Gaucher  J-­F,  Krementsova  E,  Mui  S,  Trybus  KM,  Cohen  C  (2006)  Crystal  structure  of  
apo-­calmodulin  bound  to  the  first  two  IQ  motifs  of  myosin  V  reveals  essential  recognition  features.  
Proc.  Natl.  Acad.  Sci.  U.S.A.  103:19326-­19331.  
49.  Ishida  H,  Borman  MA,  Ostrander  J,  Vogel  HJ,  MacDonald  JA  (2008)  Solution  structure  of  the  calponin  
homology  (CH)  domain  from  the  smoothelin-­like  1  protein:  A  unique  apocalmodulin-­binding  mode  
and   the  possible   role  of   the  C-­terminal   type-­2  CH-­domain   in  smooth  muscle   relaxation.   J.  Biol.  
Chem.  283:20569-­20578.  
50.  Sorensen  BR,  Shea  MA  (1998)  Interactions  between  domains  of  apo  calmodulin  alter  calcium  binding  
and  stability.  Biochemistry  37:4244-­4253.  
	  
	   151	  
51.  Sorensen  BR,  Faga  LA,  Hultman  R,  Shea  MA  (2002)  An  interdomain  linker  increases  the  thermostability  
and  decreases  the  calcium  affinity  of  the  calmodulin  N-­domain.  Biochemistry  41:15-­20.  
52.   Putkey   JA,   Kleerekoper   Q,   Gaertner   TR,  Waxham  MN   (2003)   A   new   role   for   IQ  motif   proteins   in  
regulating  calmodulin  function.  J.  Biol.  Chem.  278:49667-­49670.  
53.  Kleerekoper  QK,  Putkey  JA  (2009)  PEP-­19,  an  intrinsically  disordered  regulator  of  calmodulin  signaling.  
J.  Biol.  Chem.  284:7455-­7464.  
54.  Hovey  L,  Fowler  CA,  Mahling  R,  Lin  Z,  Miller  MS,  Marx  DC,  Yoder  JB,  Kim  EH,  Tefft  KM,  Waite  BC,  
Feldkamp  MD,   Yu   L,   Shea  MA   (2017)  Calcium   triggers   reversal   of   calmodulin   on   nested   anti-­
parallel  sites  in  the  IQ  motif  of  the  neuronal  voltage-­dependent  sodium  channel  NaV1.2.  Biophys.  
Chem.  224:1-­19.  
55.  Linse  S,  Helmersson  A,  Forsén  S  (1991)  Calcium  binding  to  calmodulin  and  its  globular  domains.  J.  
Biol.  Chem.  266:8050-­8054.  
56.  Wang  C,  Chung  BC,  Yan  H,  Wang  H-­G,  Lee  S-­Y,  Pitt  GS   (2014)  Structural  analyses  of  Ca2+/CaM  
interaction   with   NaV   channel   C-­termini   reveal   mechanisms   of   calcium-­dependent   regulation.  
Nature  Commun.  5:4896.  
57.  Li  J,  Chen  Y,  Deng  Y,  Unarta  IC,  Lu  Q,  Huang  X,  Zhang  M  (2017)  Ca2+-­Induced  rigidity  change  of  the  
myosin  VIIa  IQ  motif-­single  α  helix  lever  arm  extension.  Structure  25:579-­591.e574.  
58.   Feldkamp  Michael  D,   Yu   L,   Shea  Madeline  A   (2011)   Structural   and   energetic   determinants   of   apo  
calmodulin  binding   to   the   IQ  motif   of   the  NaV1.2  voltage-­dependent   sodium  channel.  Structure  
19:733-­747.  
59.  Wu  G,  Berka  V,  Tsai  A-­L  (2011)  Binding  kinetics  of  calmodulin  with  target  peptides  of  three  nitric  oxide  
synthase  isozymes.  J.  Inorg.  Biochem.  105:1226-­1237.  
60.  Schumacher  MA,  Rivard  AF,  Bächinger  HP,  Adelman  JP  (2001)  Structure  of  the  gating  domain  of  a  
Ca2+-­activated  K+  channel  complexed  with  Ca2+/calmodulin.  Nature  410:1120-­1124.  
61.   Schumacher   MA,   Crum   M,   Miller   MC   (2004)   Crystal   structures   of   apocalmodulin   and   an  
apocalmodulin/SK  potassium  channel  gating  domain  complex.  Structure  12:849-­860.  
62.   Lee  C-­H,  MacKinnon  R   (2018)  Activation  mechanism  of   a   human  SK-­calmodulin   channel   complex  
elucidated  by  cryo-­EM  structures.  Science  360:508-­513.  
63.  Patel  N,  Stengel  F,  Aebersold  R,  Gold  MG  (2017)  Molecular  basis  of  AKAP79  regulation  by  calmodulin.  
Nature  Commun.  8:1681.  
64.  Drum  CL,  Yan  S-­Z,  Bard  J,  Shen  Y-­Q,  Lu  D,  Soelaiman  S,  Grabarek  Z,  Bohm  A,  Tang  W-­J  (2002)  
Structural   basis   for   the   activation   of   anthrax   adenylyl   cyclase   exotoxin   by   calmodulin.   Nature  
415:396-­402.  
65.  Rodríguez-­‐Castañeda  F,  Maestre-­‐Martínez  M,  Coudevylle  N,  Dimova  K,  Junge  H,  Lipstein  N,  Lee  D,  
Becker   S,   Brose   N,   Jahn   O,   Carlomagno   T,   Griesinger   C   (2010)   Modular   architecture   of  
Munc13/calmodulin  complexes:  dual  regulation  by  Ca2+  and  possible  function  in  short-­term  synaptic  
plasticity.  EMBO  J.  29:680-­691.  
	  
	   152	  
66.  Tavares  CDJ,  O’Brien  JP,  Abramczyk  O,  Devkota  AK,  Shores  KS,  Ferguson  SB,  Kaoud  TS,  Warthaka  
M,  Marshall  KD,  Keller  KM,  Zhang  Y,  Brodbelt  JS,  Ozpolat  B,  Dalby  KN  (2012)  Calcium/calmodulin  
stimulates   the   autophosphorylation   of   elongation   factor   2   kinase   on   Thr-­348   and   Ser-­500   to  
regulate  its  activity  and  calcium  dependence.  Biochemistry  51:2232-­2245.  
67.  Tavares  CDJ,  Giles  DH,  Stancu  G,  Chitjian  CA,  Ferguson  SB,  Wellmann  RM,  Kaoud  TS,  Ghose  R,  
Dalby  KN  (2017)  Signal  integration  at  elongation  factor  2  kinase:  The  roles  of  calcium,  calmodulin,  
and  Ser-­500  phosphorylation.  J.  Biol.  Chem.  292:2032-­2045.  
68.  Shen  Y,  Zhukovskaya  NL,  Guo  Q,  Florián  J,  Tang  WJ  (2005)  Calcium-­‐independent  calmodulin  binding  
and  two-­‐metal–ion  catalytic  mechanism  of  anthrax  edema  factor.  EMBO  J.  24:929-­941.  
69.  Lee  K,  Alphonse  S,  Piserchio  A,  Tavares  Clint  DJ,  Giles  David  H,  Wellmann  Rebecca  M,  Dalby  Kevin  N,  
Ghose  R   (2016)  Structural  basis   for   the   recognition  of  eukaryotic  elongation   factor  2  kinase  by  
calmodulin.  Structure  24:1441-­1451.  
70.  Will  N,  Lee  K,  Hajredini  F,  Giles  DH,  Abzalimov  RR,  Clarkson  M,  Dalby  KN,  Ghose  R  (2018)  Structural  
dynamics  of  the  activation  of  elongation  factor  2  kinase  by  Ca2+-­calmodulin.  J.  Mol.  Biol.  430:2802-­
2821.  
71.  de  Diego  I,  Kuper  J,  Bakalova  N,  Kursula  P,  Wilmanns  M  (2010)  Molecular  basis  of  the  death-­associated  
protein  kinase–calcium/calmodulin  regulator  complex.  Sci.  Signal.  3:ra6.  
72.   Piazza  M,   Futrega   K,   Spratt   DE,   Dieckmann   T,   Guillemette   JG   (2012)   Structure   and   dynamics   of  
calmodulin   (CaM)   bound   to   nitric   oxide   synthase   peptides:   Effects   of   a   phosphomimetic   cam  
mutation.  Biochemistry  51:3651-­3661.  
73.   Piazza   M,   Taiakina   V,   Guillemette   SR,   Guillemette   JG,   Dieckmann   T   (2014)   Solution   structure   of  
calmodulin   bound   to   the   target   peptide   of   endothelial   nitric   oxide   synthase   phosphorylated   at  
Thr495.  Biochemistry  53:1241-­1249.  
74.  Anthis  NJ,  Doucleff  M,  Clore  GM   (2011)   Transient,   sparsely   populated   compact   states   of   apo   and  
calcium-­loaded   calmodulin   probed   by   paramagnetic   relaxation   enhancement:   interplay   of  
conformational  selection  and  induced  fit.  J.  Am.  Chem.  Soc.  133:18966-­18974.  
75.  Anthis  NJ,  Clore  GM   (2013)   The   length   of   the   calmodulin   linker   determines   the   extent   of   transient  
interdomain  association  and  target  affinity.  J.  Am.  Chem.  Soc.  135:9648-­9651.  
76.  Liu  F,  Chu  X,  Lu  HP,  Wang  J  (2017)  Molecular  mechanism  of  multispecific  recognition  of  calmodulin  
through  conformational  changes.  Proc.  Natl.  Acad.  Sci.  U.S.A.  114:E3927-­E3934.  
77.  Nakai   J,  Ohkura  M,   Imoto  K   (2001)  A  high  signal-­to-­noise  Ca2+  probe  composed  of  a   single  green  
fluorescent  protein.  Nature  Biotechnol.  19:137-­141.  
78.  Tian  L,  Hires  SA,  Mao  T,  Huber  D,  Chiappe  ME,  Chalasani  SH,  Petreanu  L,  Akerboom  J,  McKinney  
SA,   Schreiter   ER,   Bargmann   CI,   Jayaraman   V,   Svoboda   K,   Looger   LL   (2009)   Imaging   neural  
activity  in  worms,  flies  and  mice  with  improved  GCaMP  calcium  indicators.  Nature  Methods  6:875-­
881.  
	  
	   153	  
79.  Fosque  BF,  Sun  Y,  Dana  H,  Yang  C-­T,  Ohyama  T,  Tadross  MR,  Patel  R,  Zlatic  M,  Kim  DS,  Ahrens  MB,  
Jayaraman   V,   Looger   LL,   Schreiter   ER   (2015)   Labeling   of   active   neural   circuits   in   vivo   with  
designed  calcium  integrators.  Science  347:755-­760.  
80.  Gao  XJ,  Riabinina  O,  Li  J,  Potter  CJ,  Clandinin  TR,  Luo  L  (2015)  A  transcriptional  reporter  of  intracellular  
Ca2+  in  Drosophila.  Nature  Neurosci.  18:917-­925.  
81.  Wang  W,  Wildes  CP,  Pattarabanjird  T,  Sanchez  MI,  Glober  GF,  Matthews  GA,  Tye  KM,  Ting  AY  (2017)  
A   light-­   and   calcium-­gated   transcription   factor   for   imaging   and  manipulating   activated   neurons.  
Nature  Biotechnol.  35:864-­871.  
82.  O’Neill  BK,  Laughlin  ST  (2018)  Neuronal  calcium  recording  with  an  engineered  TEV  protease.  ACS  
Chem.  Biol.  13:1159-­1164.  
83.  Korendovych   IV,  Kulp  DW,  Wu  Y,  Cheng  H,  Roder  H,  DeGrado  WF  (2011)  Design  of  a  switchable  
eliminase.  Proc.  Natl.  Acad.  Sci.  U.S.A.  108:6823-­6827.  
84.  Moroz  YS,  Dunston  TT,  Makhlynets  OV,  Moroz  OV,  Wu  Y,  Yoon  JH,  Olsen  AB,  McLaughlin  JM,  Mack  
KL,   Gosavi   PM,   van   Nuland   NAJ,   Korendovych   IV   (2015)   New   tricks   for   old   proteins:   single  
mutations  in  a  nonenzymatic  protein  give  rise  to  various  enzymatic  activities.  J.  Am.  Chem.  Soc.  
137:14905-­14911.  
85.  Gosavi   PM,   Jayachandran  M,  Rempillo   JJL,   Zozulia  O,  Makhlynets  OV,   Korendovych   IV   (2018)   A  
designed  enzyme  promotes  selective  post-­translational  acylation.  ChemBioChem  19:1605-­1608.  
86.  Cheung  WY  (1970)  Cyclic  3′,5′-­nucleotide  phosphodiesterase:  Demonstration  of  an  activator.  Biochem.  
Biophys.  Res.  Commun.  38:533-­538.  
87.  Kakiuchi  S,  Yamazaki  R  (1970)  Calcium  dependent  phosphodiesterase  activity  and  its  activating  factor  
(PAF)   from   brain:   Studies   on   cyclic   3′,5′-­nucleotide   phosphodiesterase   (III).   Biochem.   Biophys.  
Res.  Commun.  41:1104-­1110.  
88.  Nairn  AC,  Bhagat  B,  Palfrey  HC  (1985)  Identification  of  calmodulin-­dependent  protein  kinase  III  and  its  
major  Mr  100,000  substrate  in  mammalian  tissues.  Proc.  Natl.  Acad.  Sci.  U.S.A.  82:7939-­7943.  
89.  Nairn  AC,  Palfrey  HC  (1987)  Identification  of  the  major  Mr  100,000  substrate  for  calmodulin-­dependent  
protein  kinase  III  in  mammalian  cells  as  elongation  factor-­2.  J.  Biol.  Chem.  262:17299-­17303.  
90.  Proud  CG  (1992).  Protein  phosphorylation  in  translational  control.  Curr.  Top.  Cell.  Reg.  Academic  Press  
32:243-­369.  
91.  Wang  X,  Li  W,  Williams  M,  Terada  N,  Alessi  DR,  Proud  CG  (2001)  Regulation  of  elongation  factor  2  
kinase  by  p90RSK1  and  p70  S6  kinase.  EMBO  J.  20:4370-­4379.  
92.   Browne   GJ,   Proud   CG   (2002)   Regulation   of   peptide-­chain   elongation   in   mammalian   cells.   Eur.   J.  
Biochem.  269:5360-­5368.  
93.  Kenney  JW,  Moore  CE,  Wang  X,  Proud  CG  (2014)  Eukaryotic  elongation  factor  2  kinase,  an  unusual  
enzyme  with  multiple  roles.  Adv.  Biol.  Regul.  55:15-­27.  
94.  Ryazanov  AG,  Ward  MD,  Mendola  CE,  Pavur  KS,  Dorovkov  MV,  Wiedmann  M,  Erdjument-­Bromage  H,  
Tempst  P,  Parmer  TG,  Prostko  CR,  Germino  FJ,  Hait  WN  (1997)  Identification  of  a  new  class  of  
	  
	   154	  
protein  kinases  represented  by  eukaryotic  elongation  factor-­2  kinase.  Proc.  Natl.  Acad.  Sci.  U.S.A.  
94:4884-­4889.  
95.  Ryazanov  AG,  Pavur  KS,  Dorovkov  MV  (1999)  Alpha-­kinases:  a  new  class  of  protein  kinases  with  a  
novel  catalytic  domain.  Curr.  Biol.  9:R43-­R45.  
96.  Ryazanov  AG  (1987)  Ca2+/calmodulin-­dependent  phosphorylation  of  elongation  factor  2.  FEBS  Lett.  
214:331-­334.  
97.  Diggle  TA,  Seehra  CK,  Hase  S,  Redpath  NT   (1999)  Analysis  of   the  domain  structure  of  elongation  
factor-­2  kinase  by  mutagenesis.  FEBS  Lett.  457:189-­192.  
98.  Pavur  KS,  Petrov  AN,  Ryazanov  AG   (2000)  Mapping   the   functional   domains  of   elongation   factor-­2  
kinase.  Biochemistry  39:12216-­12224.  
99.  Pigott  Craig  R,  Mikolajek  H,  Moore  Claire  E,  Finn  Stephen  J,  Phippen  Curtis  W,  Werner  Jörn  M,  Proud  
Christopher  G  (2012)  Insights  into  the  regulation  of  eukaryotic  elongation  factor  2  kinase  and  the  
interplay  between  its  domains.  Biochem.  J.  442:105-­118.  
100.  Mittl  PRE,  Schneider-­Brachert  W  (2007)  Sel1-­like  repeat  proteins  in  signal  transduction.  Cell  Signal.  
19:20-­31.  
101.  Tavares  CDJ,  Ferguson  SB,  Giles  DH,  Wang  Q,  Wellmann  RM,  O'Brien  JP,  Warthaka  M,  Brodbelt  JS,  
Ren   P,   Dalby   KN   (2014)   The   molecular   mechanism   of   eukaryotic   elongation   factor   2   kinase  
activation.  J.  Biol.  Chem.  289:23901-­23916.  
102.  Usui  T,  Okada  M,  Hara  Y,  Yamawaki  H  (2011)  Exploring  calmodulin-­related  proteins,  which  mediate  
development   of   hypertension,   in   vascular   tissues   of   spontaneous   hypertensive   rats.   Biochem.  
Biophys.  Res.  Commun.  405:47-­51.  
103.  Usui  T,  Okada  M,  Hara  Y,  Yamawaki  H  (2013)  Eukaryotic  elongation  factor  2  kinase  regulates  the  
development  of  hypertension   through  oxidative  stress-­dependent   vascular   inflammation.  Am.  J.  
Physiol.  Heart  Circ.  305:H756-­H768.  
104.  Usui  T,  Nijima  R,  Sakatsume  T,  Otani  K,  Kameshima  S,  Okada  M,  Yamawaki  H  (2014)  Eukaryotic  
elongation  factor  2  kinase  controls  proliferation  and  migration  of  vascular  smooth  muscle  cells.  Acta  
Physiol.  213:472-­480.  
105.  Stouffer  GA,  Owens  GK  (1992)  Angiotensin  II-­induced  mitogenesis  of  spontaneously  hypertensive  rat-­
derived  cultured  smooth  muscle  cells  is  dependent  on  autocrine  production  of  transforming  growth  
factor-­beta.  Circ.  Res.  70:820-­828.  
106.   Touyz   RM   (2005)   Molecular   and   cellular   mechanisms   in   vascular   injury   in   hypertension:   role   of  
angiotensin  II  –  editorial  review.  Current  Opinion  in  Nephrology  and  Hypertension  14:125-­131.  
107.  Carretero  OA,  Oparil  S  (2000)  Essential  hypertension:  part  II:  treatment.  Circulation  101:446-­453.  
108.   Carretero   OA,   Oparil   S   (2000)   Essential   hypertension:   part   I:   definition   and   etiology.   Circulation  
101:329-­335.  
109.  Faxon  DP,  Creager  MA,  Smith  Jr  SC,  Pasternak  RC,  Olin  JW,  Bettmann  MA,  Criqui  MH,  Milani  RV,  
Loscalzo  J,  Kaufman  JA  (2004)  Atherosclerotic  vascular  disease  conference:  Executive  summary:  
	  
	   155	  
Atherosclerotic  vascular  disease  conference  proceeding  for  healthcare  professionals  from  a  special  
writing  group  of  the  American  Heart  Association.  Circulation  109:2595-­2604.  
110.   Khan   AA,   Dace   DS,   Ryazanov   AG,   Kelly   J,   Apte   RS   (2010)   Resveratrol   regulates   pathologic  
angiogenesis   by   a   eukaryotic   elongation   factor-­2   kinase-­regulated   pathway.   Am.   J.   Pathol.  
177:481-­492.  
111.  Zhang  P,  Riazy  M,  Gold  M,  Tsai  S-­H,  McNagny  K,  Proud  C,  Duronio  V  (2014)  Impairing  eukaryotic  
elongation   factor   2   kinase   activity   decreases   atherosclerotic   plaque   formation.  Can.   J.  Cardiol.  
30:1684-­1688.  
112.  Ryazanov  AG  (2002)  Elongation  factor-­2  kinase  and  its  newly  discovered  relatives.  FEBS  Lett.  514:26-­
29.  
113.  Ryazanov  AG,  Natapov  PG,  Shestakova  EA,  Severin  FF,  Spirin  AS  (1988)  Phosphorylation  of   the  
elongation   factor   2:   the   fifth   Ca2+/calmodulin-­dependent   system   of   protein   phosphorylation.  
Biochimie  70:619-­626.  
114.   Ryazanov   AG,   Davydova   EK   (1989)   Mechanism   of   elongation   factor   2   (EF-­2)   inactivation   upon  
phosphorylation.  Phosphorylated  EF-­2   is   unable   to   catalyze   translocation.  FEBS  Lett.   251:187-­
190.  
115.  Ryazanov  AG,  Shestakova  EA,  Natapov  PG  (1988)  Phosphorylation  of  elongation  factor  2  by  EF-­2  
kinase  affects  rate  of  translation.  Nature  334:170-­173.  
116.  Carlberg  U,  Nilsson  A,  Nygard  O  (1990)  Functional  properties  of  phosphorylated  elongation  factor  2.  
Eur.  J.  Biochem.  191:639-­645.  
117.   Dumont-­Miscopein   A,   Lavergne   JP,   Guillot   D,   Sontag   B,   Reboud   JP   (1994)   Interaction   of  
phosphorylated  elongation  factor  EF-­2  with  nucleotides  and  ribosomes.  FEBS  Lett.  356:283-­286.  
118.  Smith  EM,  Proud  CG  (2008)  Cdc2-­cyclin  B  regulates  eEF2  kinase  activity  in  a  cell  cycle-­  and  amino  
acid-­dependent  manner.  EMBO  J.  27:1005-­1016.  
119.  Sutton  MA,  Taylor  AM,  Ito  HT,  Pham  A,  Schuman  EM  (2007)  Postsynaptic  decoding  of  neural  activity:  
eEF2  as  a  biochemical  sensor  coupling  miniature  synaptic  transmission  to  local  protein  synthesis.  
Neuron  55:648-­661.  
120.  Park  S,  Park  JM,  Kim  S,  Kim  JA,  Shepherd  JD,  Smith-­Hicks  CL,  Chowdhury  S,  Kaufmann  W,  Kuhl  D,  
Ryazanov  AG,  Huganir  RL,  Linden  DJ,  Worley  PF  (2008)  Elongation  factor  2  and  fragile  X  mental  
retardation  protein  control  the  dynamic  translation  of  Arc/Arg3.1  essential  for  mGluR-­LTD.  Neuron  
59:70-­83.  
121.  Verpelli  C,  Piccoli  G,  Zibetti  C,  Zanchi  A,  Gardoni  F,  Huang  K,  Brambilla  D,  Di  Luca  M,  Battaglioli  E,  
Sala  C  (2010)  Synaptic  activity  controls  dendritic  spine  morphology  by  modulating  eEF2-­dependent  
BDNF  synthesis.  J.  Neurosci.  30:5830-­5842.  
122.  Gildish  I,  Manor  D,  David  O,  Sharma  V,  Williams  D,  Agarwala  U,  Wang  X,  Kenney  JW,  Proud  CG,  
Rosenblum  K  (2012)  Impaired  associative  taste  learning  and  abnormal  brain  activation  in  kinase-­
defective  eEF2K  mice.  Learn.  Mem.19:116-­125.  
	  
	   156	  
123.  Meric-­Bernstam  F,  Chen  H,  Akcakanat  A,  Do  KA,  Lluch  A,  Hennessy  BT,  Hortobagyi  GN,  Mills  GB,  
Gonzalez-­Angulo   AM   (2012)   Aberrations   in   translational   regulation   are   associated   with   poor  
prognosis  in  hormone  receptor-­positive  breast  cancer.  Breast  Cancer  Res.  14:R138.  
124.  Tekedereli  I,  Alpay  SN,  Tavares  CD,  Cobanoglu  ZE,  Kaoud  TS,  Sahin  I,  Sood  AK,  Lopez-­Berestein  
G,  Dalby  KN,  Ozpolat  B  (2012)  Targeted  silencing  of  elongation  factor  2  kinase  suppresses  growth  
and  sensitizes  tumors  to  doxorubicin  in  an  orthotopic  model  of  breast  cancer.  PloS  one  7:e41171.  
125.  Liu  XY,  Zhang  L,  Wu  J,  Zhou  L,  Ren  YJ,  Yang  WQ,  Ming  ZJ,  Chen  B,  Wang  J,  Zhang  Y,  Yang  JM  
(2013)   Inhibition  of   elongation   factor-­2   kinase  augments   the  antitumor   activity   of   temozolomide  
against  glioma.  PloS  one  8:e81345.  
126.  Li  X,  Alafuzoff  I,  Soininen  H,  Winblad  B,  Pei  JJ  (2005)  Levels  of  mTOR  and  its  downstream  targets  
4E-­BP1,  eEF2,  and  eEF2  kinase  in  relationships  with  tau  in  Alzheimer's  disease  brain.  FEBS  J.  
272:4211-­4220.  
127.  Ma  T,  Chen  Y,  Vingtdeux  V,  Zhao  H,  Viollet  B,  Marambaud  P,  Klann  E   (2014)   Inhibition  of  AMP-­
activated  protein  kinase  signaling  alleviates  impairments  in  hippocampal  synaptic  plasticity  induced  
by  amyloid  beta.  J.  Neurosci.  34:12230-­12238.  
128.  Kavalali  ET,  Monteggia  LM  (2012)  Synaptic  mechanisms  underlying  rapid  antidepressant  action  of  
ketamine.  Am.  J.  Physchiat.  169:1150-­1156.  
129.  Monteggia  LM,  Gideons  E,  Kavalali  ET  (2013)  The  role  of  eukaryotic  elongation   factor  2  kinase   in  
rapid  antidepressant  action  of  ketamine.  Biol.  Psychiatry  73:1199-­1203.  
130.  Horman  S,  Browne  G,  Krause  U,  Patel  J,  Vertommen  D,  Bertrand  L,  Lavoinne  A,  Hue  L,  Proud  C,  
Rider   M   (2002)   Activation   of   AMP-­activated   protein   kinase   leads   to   the   phosphorylation   of  
elongation  factor  2  and  an  inhibition  of  protein  synthesis.  Curr.  Biol.  12:1419-­1423.  
131.  Chan  AY,  Soltys  CL,  Young  ME,  Proud  CG,  Dyck  JR  (2004)  Activation  of  AMP-­activated  protein  kinase  
inhibits   protein   synthesis   associated   with   hypertrophy   in   the   cardiac   myocyte.   J.   Biol.   Chem.  
279:32771-­32779.  
132.   Soderling   TR,   Stull   JT   (2001)   Structure   and   regulation   of   calcium/calmodulin-­dependent   protein  
kinases.  Chem.  Rev.  101:2341-­2352.  
133.   Swulius   MT,   Waxham   MN   (2008)   Ca(2+)/calmodulin-­dependent   protein   kinases.   Cell   Mol.   Life  
Sci.65:2637-­2657.  
134.   Hoeflich   KP,   Ikura   M   (2002)   Calmodulin   in   action:   diversity   in   target   recognition   and   activation  
mechanisms.  Cell  108:739-­742.  
135.  Abramczyk  O,  Tavares  CDJ,  Devkota  AK,  Ryazanov  AG,  Turk  BE,  Riggs  AF,  Ozpolat  B,  Dalby  KN  
(2011)  Purification  and  characterization  of  tagless  recombinant  human  elongation  factor  2  kinase  
(eEF-­2K)  expressed  in  Escherichia  coli.  Protein  Expr.  Purif.  79:237-­244.  
136.  Schägger  H  (2006)  Tricine–SDS-­PAGE.  Nature  Protocols  1:16-­22.  
137.  Delaglio  F,  Grzesiek  S,  Vuister  GW,  Zhu  G,  Pfeifer  J,  Bax  A  (1995)  NMRPipe:  A  multidimensional  
spectral  processing  system  based  on  UNIX  pipes.  J.  Biol.  NMR  6:277-­293.  
	  
	   157	  
138.   Johnson  BA.  Using  NMRView   to  Visualize   and  Analyze   the  NMR  Spectra   of  Macromolecules.   In:  
Downing  AK,  Ed.  (2004)  Protein  NMR  Techniques.  Humana  Press,  Totowa,  NJ,  pp.  313-­352.  
139.  Sattler  M,  Schleucher  J,  Griesinger  C  (1999)  Heteronuclear  multidimensional  NMR  experiments  for  
the  structure  determination  of  proteins   in   solution  employing  pulsed   field  gradients.  Prog.  Nucl.  
Magn.  Reson.  Spectrosc.  34:93-­158.  
140.   Alphonse   S,   Bhattacharya   S,   Wang   H,   Ghose   R   (2015)   Methyl   relaxation   measurements   reveal  
patterns  of  fast  dynamics  in  a  viral  RNA-­directed  RNA  polymerase.  Biochemistry  54:5828-­5838.  
141.  Ikura  M,  Marion  D,  Kay  LE,  Shih  H,  Krinks  M,  Klee  CB,  Bax  A  (1990)  Heteronuclear  3D  NMR  and  
isotopic   labeling   of   calmodulin:   Towards   the   complete   assignment   of   the   1H   NMR   spectrum.  
Biochem.  Pharmacol.  40:153-­160.  
142.  Habeck  M,  Rieping  W,  Linge  JP,  Nilges  M.  NOE  Assignment  With  ARIA  2.0.   In:  Downing  AK,  Ed.  
(2004)  Protein  NMR  Techniques.  Humana  Press,  Totowa,  NJ,  pp.  379-­402.  
143.  Engh  RA,  Huber  R  (1991)  Accurate  bond  and  angle  parameters  for  X-­ray  protein  structure  refinement.  
Acta  Cryst.  A  47:392-­400.  
144.  Shen  Y,  Delaglio   F,  Cornilescu  G,  Bax  A   (2009)   TALOS+:   a   hybrid  method   for   predicting   protein  
backbone  torsion  angles  from  NMR  chemical  shifts.  J.  Biol.  NMR  44:213-­223.  
145.  Linge  JP,  Williams  MA,  Spronk  CAEM,  Bonvin  AMJJ,  Nilges  M  (2003)  Refinement  of  protein  structures  
in  explicit  solvent.  Proteins:  Struct.,  Funct.,  Bioinf  50:496-­506.  
146.   Schwieters  CD,   Kuszewski   JJ,   Tjandra  N,  Marius  Clore  G   (2003)   The   Xplor-­NIH  NMR  molecular  
structure  determination  package.  J.  Mag.  Res.  160:65-­73.  
147.   Laskowski   RA,   Rullmannn   JA,   MacArthur   MW,   Kaptein   R,   Thornton   JM   (1996)   AQUA   and  
PROCHECK-­NMR:  programs  for  checking  the  quality  of  protein  structures  solved  by  NMR.  J.  Biol.  
NMR  8:477-­486.  
148.  Vriend  G  (1990)  WHAT   IF:  a  molecular  modeling  and  drug  design  program.  J.  Mol.  Graph.  Model    
8:52-­56.  
149.   Koradi   R,   Billeter   M,   Wüthrich   K   (1996)   MOLMOL:   A   program   for   display   and   analysis   of  
macromolecular  structures.  J.  Mol.  Graph.  14:51-­55.  
150.  Pettersen  EF,  Goddard  TD,  Huang  CC,  Couch  GS,  Greenblatt  DM,  Meng  EC,  Ferrin  TE  (2004)  UCSF  
Chimera—A   visualization   system   for   exploratory   research   and   analysis.   J.   Comput.   Chem.  
25:1605-­1612.  
151.  Rückert  M,  Otting  G  (2000)  Alignment  of  biological  macromolecules  in  novel  nonionic  liquid  crystalline  
media  for  NMR  experiments.  J.  Am.  Chem.  Soc.  122:7793-­7797.  
152.  Ottiger  M,  Delaglio  F,  Bax  A   (1998)  Measurement   of   J   and  dipolar   couplings   from  simplified   two-­
dimensional  NMR  spectra.  J.  Mag.  Res.  131:373-­378.  
153.   Zweckstetter   M   (2008)   NMR:   prediction   of   molecular   alignment   from   structure   using   the   PALES  
software.  Nature  Protocols  3:679-­690.  
	  
	   158	  
154.  Cornilescu  G,  Marquardt  JL,  Ottiger  M,  Bax  A  (1998)  Validation  of  protein  structure  from  anisotropic  
carbonyl  chemical  shifts  in  a  dilute  liquid  crystalline  phase.  J.  Am.  Chem.  Soc.  120:6836-­6837.  
155.  Tolman  JR,  Al-­Hashimi  HM,  Kay  LE,  Prestegard  JH  (2001)  Structural  and  dynamic  analysis  of  residual  
dipolar  coupling  data  for  proteins.  J.  Am.  Chem.  Soc.  123:1416-­1424.  
156.  Alaimo  A,  Malo  C,  Areso  P,  Aloria  K,  Millet  O,  Villarroel  A.  The  use  of  dansyl-­calmodulin   to  study  
interactions  with  channels  and  other  proteins.  In:  Gamper  N,  Ed.  (2013)  Ion  Channels:  Methods  
and  Protocols.  Humana  Press,  Totowa,  NJ,  pp.  217-­231.  
157.   Zuiderweg   ERP   (2002)   Mapping   protein-­protein   interactions   in   solution   by   NMR   spectroscopy.  
Biochemistry  41:1-­7.  
158.  Akerfeldt  KS,  Coyne  AN,  Wilk  RR,  Thulin  E,  Linse  S  (1996)  Ca2+-­binding  stoichiometry  of  calbindin  
D28k   as   assessed   by   spectroscopic   analyses   of   synthetic   peptide   fragments.   Biochemistry  
35:3662-­3669.  
159.  Biekofsky  RR,  Martin  SR,  Browne  JP,  Bayley  PM,  Feeney  J  (1998)  Ca2+  coordination  to  backbone  
carbonyl  oxygen  atoms  in  calmodulin  and  other  EF-­hand  proteins:  15N  chemical  shifts  as  probes  
for  monitoring  individual-­site  Ca2+  coordination.  Biochemistry  37:7617-­7629.  
160.  Atreya  HS,  Chary  KV  (2002)  New  chemical  shift  signatures  of  bound  calcium  in  EF-­hand  proteins.  
Curr.  Sci.  83:1240-­1245.  
161.  Chang  S-­L,  Szabo  A,  Tjandra  N  (2003)  Temperature  dependence  of  domain  motions  of  calmodulin  
probed  by  NMR  relaxation  at  multiple  fields.  J.  Am.  Chem.  Soc.  125:11379-­11384.  
162.  Pandey  K,  Dhoke  RR,  Rathore  YS,  Nath  SK,  Verma  N,  Bawa  S,  Ashish  (2014)  Low  pH  overrides  the  
need  of  calcium  ions  for  the  shape-­function  relationship  of  calmodulin:  resolving  prevailing  debates.  
J.  Phys.  Chem.  B  118:5059-­5074.  
163.  Theoharis  NT,  Sorensen  BR,  Theisen-­Toupal  J,  Shea  MA  (2008)  The  neuronal  voltage-­dependent  
sodium   channel   type   II   IQ   motif   lowers   the   calcium   affinity   of   the   C-­domain   of   calmodulin.  
Biochemistry  47:112-­123.  
164.   Valeyev   NV,   Bates   DG,   Heslop-­Harrison   P,   Postlethwaite   I,   Kotov   NV   (2008)   Elucidating   the  
mechanisms   of   cooperative   calcium-­calmodulin   interactions:   a   structural   systems   biology  
approach.  BMC  Syst.  Biol.2:48.  
165.  Moore  CEJ,  Mikolajek  H,  Regufe  da  Mota  S,  Wang  X,  Kenney  JW,  Werner  JM,  Proud  CG  (2015)  
Elongation  factor  2  kinase  is  regulated  by  proline  hydroxylation  and  protects  cells  during  hypoxia.  
Mol.  Cell.  Biol.  MCB-­01457.  
166.  Alberts  B,  Bray  D,  Lewis  J,  Raff  M,  Roberts  K,  Watson  JD  (1994)  Mol.  Biol.  Cell  (Garland,  New  York),  
pp.  907-­982.  
167.  Lewin  B  (1997).  genes  VII.  2000.  New  York:  Oxford  University  Press.  
168.  Jackson  DA,  Pombo  ANA,  Iborra  F  (2000)  The  balance  sheet  for  transcription:  an  analysis  of  nuclear  
RNA  metabolism  in  mammalian  cells.  FASEB  J.  14:242-­254.  
	  
	   159	  
169.  Louis  M,  Holm  L,  Sánchez  L,  Kaufman  M  (2003)  A  theoretical  model  for  the  regulation  of  sex-­lethal,  a  
gene   that   controls   sex   determination   and   dosage   compensation   in   Drosophila   melanogaster.  
Genetics  165:1355-­1384.  
170.  Buszczak  M,  Signer  RAJ,  Morrison  Sean  J  (2014)  Cellular  differences  in  protein  synthesis  regulate  
tissue  homeostasis.  Cell  159:242-­251.  
171.  Yamaguchi  H,  Matsushita  M,  Nairn  AC,  Kuriyan  J  (2001)  Crystal  structure  of  the  atypical  protein  kinase  
domain  of  a  TRP  channel  with  phosphotransferase  activity.  Mol.  Cell  7:1047-­1057.  
172.   Ye  Q,   Crawley   SW,   Yang   Y,   Côté   GP,   Jia   Z   (2010)   Crystal   structure   of   the   α-­kinase   domain   of  
dictyostelium  myosin  heavy  chain  kinase  A.  Sci.  Signal.  3:ra17.  
173.  Yang  Y,  Ye  Q,  Jia  Z,  Côté  GP  (2015)  Characterization  of  the  catalytic  and  nucleotide  binding  properties  
of   the   alpha-­kinase   domain   of   dictyostelium   myosin-­II   heavy   chain   kinase   A.   J.   Biol.   Chem.  
290:23935-­23946.  
174.  Ye  Q,  Yang  Y,  van  Staalduinen  L,  Crawley  SW,  Liu  L,  Brennan  S,  Côté  GP,  Jia  Z  (2016)  Structure  of  
the  dictyostelium  myosin-­II  heavy  chain  kinase  A  (MHCK-­A)  α-­kinase  domain  apoenzyme  reveals  
a  novel  autoinhibited  conformation.  Sci.  Rep.  6:26634.  
175.   Ollerenshaw   JE,   Tugarinov   V,   Kay   LE   (2003)   Methyl   TROSY:   explanation   and   experimental  
verification.  Mag.  Reson.  Chem.  41:843-­852.  
176.  Amero  C,  Schanda  P,  Durá  MA,  Ayala  I,  Marion  D,  Franzetti  B,  Brutscher  B,  Boisbouvier  J  (2009)  Fast  
two-­dimensional  nmr  spectroscopy  of  high  molecular  weight  protein  assemblies.  J.  Am.  Chem.  Soc.  
131:3448-­3449.  
177.  Tugarinov  V,  Kay  LE  (2004)  An  isotope  labeling  strategy  for  methyl  trosy  spectroscopy.  J.  Biol.  NMR  
28:165-­172.  
178.  Siivari  K,  Zhang  M,  Palmer  AG,  Vogel  HJ  (1995)  NMR  studies  of   the  methionine  methyl  groups   in  
calmodulin.  FEBS  Lett.  366:104-­108.  
179.  Gellman  SH  (1991)  On  the  role  of  methionine  residues  in  the  sequence-­independent  recognition  of  
nonpolar  protein  surfaces.  Biochemistry  30:6633-­6636.  
180.   Gifford   JL,   Ishida   H,   Vogel   HJ   (2011)   Fast   methionine-­based   solution   structure   determination   of  
calcium-­calmodulin  complexes.  J.  Biol.  NMR  50:71-­81.  
181.  Dorovkov  MV,  Pavur  KS,  Petrov  AN,  Ryazanov  AG  (2002)  Regulation  of  elongation  factor-­2  kinase  by  
pH.  Biochemistry  41:13444-­13450.  
182.  Xie  J,  Mikolajek  H,  Pigott  CR,  Hooper  KJ,  Mellows  T,  Moore  CE,  Mohammed  H,  Werner  JM,  Thomas  
GJ,  Proud  CG  (2015)  Molecular  mechanism  for  the  control  of  eukaryotic  elongation  factor  2  kinase  
by  pH;;  a  role  in  cancer  cell  survival.  Mol.  Cell.  Biol.  MCB-­00012.  
183.  Liao  S-­M,  Du  Q-­S,  Meng  J-­Z,  Pang  Z-­W,  Huang  R-­B  (2013)  The  multiple  roles  of  histidine  in  protein  
interactions.  Chem.  Cent.  J.7:44.  
184.  Leppla  SH  (1982)  Anthrax  toxin  edema  factor:  a  bacterial  adenylate  cyclase  that  increases  cyclic  AMP  
concentrations  of  eukaryotic  cells.  Proc.  Natl.  Acad.  Sci.  U.S.A.  79:3162-­3166.  
	  
	   160	  
185.   Dempsey   DR,   Jiang   H,   Kalin   JH,   Chen   Z,   Cole   PA   (2018)   Site-­specific   protein   labeling   with   N-­
hydroxysuccinimide-­esters  and   the  analysis  of  ubiquitin   ligase  mechanisms.  J.  Am.  Chem.  Soc.  
140:9374-­9378.  
186.  Tolbert  TJ,  Wong  C-­H  (2002)  New  methods  for  proteomic  research:  Preparation  of  proteins  with  N-­
terminal  cysteines  for  labeling  and  conjugation.  Angew.  Chem.  114:2275-­2278.  
187.  Yi  L,  Sun  H,  Itzen  A,  Triola  G,  Waldmann  H,  Goody  RS,  Wu  Y-­W  (2011)  One-­pot  dual-­labeling  of  a  
protein  by  two  chemoselective  reactions.  Angew.  Chem.  123:8437-­8440.  
188.  Meador  WE,  Means  AR,  Quiocho  FA  (1992)  Target  enzyme  recognition  by  calmodulin:  2.4  A  structure  
of  a  calmodulin-­peptide  complex.  Science  257:1251-­1255.  
189.   Meador   WE,   Means   AR,   Quiocho   FA   (1993)   Modulation   of   calmodulin   plasticity   in   molecular  
recognition  on  the  basis  of  x-­ray  structures.  Science  262:1718-­1721.  
190.  Wall  ME,  Clarage  JB,  Phillips  GN  (1997)  Motions  of  calmodulin  characterized  using  both  Bragg  and  
diffuse  X-­ray  scattering.  Structure  5:1599-­1612.  
191.  Mirzoeva  S,  Weigand  S,  Lukas  TJ,  Shuvalova  L,  Anderson  WF,  Watterson  DM  (1999)  Analysis  of  the  
functional   coupling   between   calmodulin's   calcium   binding   and   peptide   recognition   properties.  
Biochemistry  38:3936-­3947.  
192.  Osawa  M,  Tokumitsu  H,  Swindells  MB,  Kurihara  H,  Orita  M,  Shibanuma  T,  Furuya  T,  Ikura  M  (1999)  
A   novel   target   recognition   revealed   by   calmodulin   in   complex   with   Ca2+-­calmodulin-­dependent  
kinase  kinase.  Nature  Struct.  Biol.  6:819-­824.  
193.  Elshorst  B,  Hennig  M,  Försterling  H,  Diener  A,  Maurer  M,  Schulte  P,  Schwalbe  H,  Griesinger  C,  Krebs  
J,  Schmid  H,  Vorherr  T,  Carafoli  E  (1999)  NMR  solution  structure  of  a  complex  of  calmodulin  with  
a  binding  peptide  of  the  Ca2+  pump.  Biochemistry  38:12320-­12332.  
194.  Kurokawa  H,  Osawa  M,  Kurihara  H,  Katayama  N,  Tokumitsu  H,  Swindells  MB,  Kainosho  M,  Ikura  M  
(2001)  Target-­induced  conformational  adaptation  of  calmodulin  revealed  by  the  crystal  structure  of  
a  complex  with  nematode  Ca2+/calmodulin-­dependent  kinase  kinase  peptide.  J.  Mol.  Biol.  312:59-­
68.  
195.  Shen  Y,  Lee  YS,  Soelaiman  S,  Bergson  P,  Lu  D,  Chen  A,  Beckingham  K,  Grabarek  Z,  Mrksich  M,  
Tang  WJ  (2002)  Physiological  calcium  concentrations  regulate  calmodulin  binding  and  catalysis  of  
adenylyl  cyclase  exotoxins.  EMBO  J.  21:6721-­6732.  
196.  Clapperton  JA,  Martin  SR,  Smerdon  SJ,  Gamblin  SJ,  Bayley  PM  (2002)  Structure  of  the  complex  of  
calmodulin   with   the   target   sequence   of   calmodulin-­dependent   protein   kinase   I:     Studies   of   the  
kinase  activation  mechanism.  Biochemistry  41:14669-­14679.  
197.  Aoyagi  M,  Arvai  AS,  Tainer  JA,  Getzoff  ED  (2003)  Structural  basis  for  endothelial  nitric  oxide  synthase  
binding  to  calmodulin.  EMBO  J.  22:766-­775.  
198.  Yamauchi  E,  Nakatsu  T,  Matsubara  M,  Kato  H,  Taniguchi  H  (2003)  Crystal  structure  of  a  MARCKS  
peptide  containing  the  calmodulin-­binding  domain  in  complex  with  Ca2+-­calmodulin.  Nature  Struct.  
Biol.  10:226-­231.  
	  
	   161	  
199.  Yap  KL,  Yuan  T,  Mal  TK,  Vogel  HJ,  Ikura  M  (2003)  Structural  basis  for  simultaneous  binding  of  two  
carboxy-­terminal  peptides  of  plant  glutamate  decarboxylase  to  calmodulin.  J.  Mol.  Biol.  328:193-­
204.  
200.  Shen  Y,  Zhukovskaya  NL,  Zimmer  MI,  Soelaiman  S,  Bergson  P,  Wang  C-­R,  Gibbs  CS,  Tang  W-­J  
(2004)  Selective  inhibition  of  anthrax  edema  factor  by  adefovir,  a  drug  for  chronic  hepatitis  B  virus  
infection.  Proc.  Natl.  Acad.  Sci.  U.S.A.  101:3242-­3247.  
201.  Shen  Y,  Guo  Q,  Zhukovskaya  NL,  Drum  CL,  Bohm  A,  Tang  W-­J  (2004)  Structure  of  anthrax  edema  
factor–calmodulin–adenosine   5′-­(α,β-­methylene)-­triphosphate   complex   reveals   an   alternative  
mode  of  ATP  binding  to  the  catalytic  site.  Biochem.  Biophys.  Res.  Commun.  317:309-­314.  
202.  Guo  Q,  Shen  Y,  Zhukovskaya  NL,  Florián  J,  Tang  W-­J  (2004)  Structural  and  kinetic  analyses  of  the  
interaction  of  anthrax  adenylyl  cyclase  toxin  with  reaction  Products  cAMP  and  pyrophosphate.  J.  
Biol.  Chem.  279:29427-­29435.  
203.   Contessa   GM,   Orsale  M,  Melino   S,   Torre   V,   Paci   M,   Desideri   A,   Cicero   DO   (2005)   Structure   of  
calmodulin   complexed   with   an   olfactory   CNG   channelfragment   and   role   of   the   central   linker:  
Residual  dipolar  couplingsto  evaluate  calmodulin  binding  modes  outside  the  kinase  family.  J.  Biol.  
NMR  31:185-­199.  
204.  Ménétrey   J,   Bahloul   A,  Wells   AL,   Yengo  CM,  Morris   CA,   Sweeney   HL,   Houdusse   A   (2005)   The  
structure  of  the  myosin  VI  motor  reveals  the  mechanism  of  directionality  reversal.  Nature  435:779-­
785.  
205.  Guo  Q,  Shen  Y,  Lee  YS,  Gibbs  CS,  Mrksich  M,  Tang  WJ  (2005)  Structural  basis  for  the  interaction  of  
Bordetella  pertussis  adenylyl  cyclase  toxin  with  calmodulin.  EMBO  J.  24:3190-­3201.  
206.   Van   Petegem   F,   Chatelain   FC,   Minor   JDL   (2005)   Insights   into   voltage-­gated   calcium   channel  
regulation   from  the  structure  of   the  CaV1.2   IQ  domain–Ca2+/calmodulin  complex.  Nature  Struct.  
Mol.  Biol.  12:1108-­1115.  
207.   Fallon   JL,   Halling   DB,   Hamilton   SL,   Quiocho   FA   (2005)   Structure   of   calmodulin   bound   to   the  
hydrophobic  IQ  domain  of  the  cardiac  Cav1.2  calcium  channel.  Structure  13:1881-­1886.  
208.  Ye  Q,  Li  X,  Wong  A,  Wei  Q,  Jia  Z  (2006)  Structure  of  calmodulin  bound  to  a  calcineurin  peptide:    A  
new  way  of  making  an  old  binding  mode.  Biochemistry  45:738-­745.  
209.  Liu  J,  Taylor  DW,  Krementsova  EB,  Trybus  KM,  Taylor  KA  (2006)  Three-­dimensional  structure  of  the  
myosin  V  inhibited  state  by  cryoelectron  tomography.  Nature  442:208-­211.  
210.  Simonovic  M,  Zhang  Z,  Cianci  CD,  Steitz  TA,  Morrow  JS  (2006)  Structure  of  the  calmodulin  αII-­spectrin  
complex  provides  insight  into  the  regulation  of  cell  plasticity.  J.  Biol.  Chem.  281:34333-­34340.  
211.  Maximciuc  AA,  Putkey  JA,  Shamoo  Y,  MacKenzie  KR  (2006)  Complex  of  calmodulin  with  a  ryanodine  
receptor  target  reveals  a  novel,  flexible  binding  mode.  Structure  14:1547-­1556.  
212.  Ménétrey  J,  Llinas  P,  Cicolari  J,  Squires  G,  Liu  X,  Li  A,  Sweeney  HL,  Houdusse  A  (2008)  The  post-­‐
rigor  structure  of  myosin  VI  and  implications  for  the  recovery  stroke.  EMBO  J.  27:244-­252.  
	  
	   162	  
213.  Gsponer   J,   Christodoulou   J,   Cavalli   A,   Bui   JM,   Richter   B,   Dobson  CM,   Vendruscolo  M   (2008)   A  
coupled  equilibrium  shift  mechanism  in  calmodulin-­mediated  signal  transduction.  Structure  16:736-­
746.  
214.   Ye   Q,  Wang   H,   Zheng   J,  Wei   Q,   Jia   Z   (2008)   The   complex   structure   of   calmodulin   bound   to   a  
calcineurin  peptide.  Proteins:  Struct.,  Funct.,  Bioinf.73:19-­27.  
215.  Halling  DB,  Georgiou  DK,  Black  DJ,  Yang  G,  Fallon  JL,  Quiocho  FA,  Pedersen  SE,  Hamilton  SL  (2009)  
Determinants   in  CaV1   channels   that   regulate   the  Ca2+   sensitivity   of   bound   calmodulin.   J.   Biol.  
Chem.  284:20041-­20051.  
216.  Kim  EY,  Rumpf  CH,  Fujiwara  Y,  Cooley  ES,  Van  Petegem  F,  Minor  DL  (2008)  Structures  of  CaV2  
Ca2+/CaM-­IQ   domain   complexes   reveal   binding   modes   that   underlie   calcium-­dependent  
inactivation  and  facilitation.  Structure  16:1455-­1467.  
217.  Fallon  JL,  Baker  MR,  Xiong  L,  Loy  RE,  Yang  G,  Dirksen  RT,  Hamilton  SL,  Quiocho  FA  (2009)  Crystal  
structure   of   dimeric   cardiac   L-­type   calcium   channel   regulatory   domains   bridged   by   Ca2+·  
calmodulins.  Proc.  Natl.  Acad.  Sci.  U.S.A.  106:5135-­5140.  
218.  Majava  V,  Kursula  P  (2009)  Domain  swapping  and  different  oligomeric  states  for  the  complex  between  
calmodulin  and  the  calmodulin-­binding  domain  of  calcineurin  A.  PloS  one  4:e5402.  
219.  Ishida  H,  Rainaldi  M,  Vogel  HJ  (2009)  Structural  studies  of  soybean  calmodulin  isoform  4  bound  to  
the  calmodulin-­binding  domain  of  tobacco  mitogen-­activated  protein  kinase  phosphatase-­1  provide  
insights  into  a  sequential  target  binding  mode.  J.  Biol.  Chem.  284:28292-­28305.  
220.  Xia  C,  Misra   I,   Iyanagi  T,  Kim  JJP   (2009)  Regulation  of   interdomain   interactions  by  calmodulin   in  
inducible  nitric  oxide  synthase.  J.  Biol.  Chem.  284:30708-­30717.  
221.  Mukherjea  M,  Llinas  P,  Kim  H,  Travaglia  M,  Safer  D,  Ménétrey  J,  Franzini-­Armstrong  C,  Selvin  PR,  
Houdusse  A,  Sweeney  HL   (2009)  Myosin  VI   dimerization   triggers   an   unfolding   of   a   three-­helix  
bundle  in  order  to  extend  its  reach.  Mol.  Cell  35:305-­315.  
222.  Juranic  N,  Atanasova  E,  Filoteo  AG,  Macura  S,  Prendergast  FG,  Penniston  JT,  Strehler  EE  (2010)  
Calmodulin  wraps  around  its  binding  domain  in  the  plasma  membrane  Ca2+  pump  anchored  by  a  
novel  18-­1  motif.  J.  Biol.  Chem.  285:4015-­4024.  
223.  Ishida  H,  Vogel  HJ  (2010)  The  solution  structure  of  a  plant  calmodulin  and  the  CaM-­binding  domain  
of  the  vacuolar  calcium-­ATPase  BCA1  reveals  a  new  binding  and  activation  mechanism.  J.  Biol.  
Chem.  285:38502-­38510.  
224.  Kim  EY,  Rumpf  CH,  Van  Petegem  F,  Arant  RJ,  Findeisen  F,  Cooley  ES,  Isacoff  EY,  Minor  DL  (2010)  
Multiple   C-­‐terminal   tail   Ca2+/CaMs   regulate   CaV1.   2   function   but   do   not   mediate   channel  
dimerization.  EMBO  J.  29:3924.  
225.  Pylypenko  O,  Song  L,  Squires  G,  Liu  X,  Zhong  AB,  Houdusse  A,  Sweeney  HL  (2011)  Role  of  insert  I  
of  myosin  VI  in  modulating  nucleotide  affinity.  J.  Biol.  Chem.  286:11716-­11723.  
226.  Köster  S,  Pavkov-­Keller   T,  Kühlbrandt  W,  Yildiz  Ö   (2011)  Structure   of   human  Na+/H+  exchanger  
NHE1  regulatory  region  in  complex  with  calmodulin  and  Ca2+.  J.  Biol.  Chem.  286:40954-­40961.  
	  
	   163	  
227.  Zhang  Y,  Li  Z,  Sacks  DB,  Ames  JB  (2012)  Structural  basis  for  Ca2+-­induced  activation  and  dimerization  
of  estrogen  receptor  α  by  calmodulin.  J.  Biol.  Chem.  287:9336-­9344.  
228.  Sarhan  MF,  Tung  C-­C,  Van  Petegem  F,  Ahern  CA  (2012)  Crystallographic  basis  for  calcium  regulation  
of  sodium  channels.  Proc.  Natl.  Acad.  Sci.  U.S.A.  109:3558-­3563.  
229.  Viswanath  S,  Bonomi  M,  Kim  SJ,  Klenchin  VA,  Taylor  KC,  Yabut  KC,  Umbreit  NT,  Van  Epps  HA,  
Meehl  J,  Jones  MH,  Russel  D,  Velazquez-­Muriel  JA,  Winey  M,  Rayment  I,  Davis  TN,  Sali  A,  Muller  
EG,  Bloom  KS  (2017)  The  molecular  architecture  of  the  yeast  spindle  pole  body  core  determined  
by  Bayesian  integrative  modeling.  Mol.  Biol.  Cell  28:3298-­3314.  
230.  Liu  Z,  Vogel  H  (2012)  Structural  basis   for   the  regulation  of  L-­type  voltage-­gated  calcium  channels:  
interactions   between   the   N-­terminal   cytoplasmic   domain   and   Ca2+-­calmodulin.   Front.   Mol.  
Neurosci.  5:38.  
231.   Gifford   JL,   Ishida   H,   Vogel   HJ   (2012)   Structural   insights   into   calmodulin   regulated   L-­selectin  
ectodomain  shedding.  J.  Biol.  Chem.  287:26513-­26527.  
232.  Wang  C,  Chung  Ben  C,  Yan  H,  Lee  S-­Y,  Pitt  Geoffrey  S  (2012)  Crystal  structure  of  the  ternary  complex  
of   a   NaV   C-­terminal   domain,   a   fibroblast   growth   factor   homologous   factor,   and   calmodulin.  
Structure  20:1167-­1176.  
233.  Ogura  K,  Kumeta  H,  Takahasi  K,  Kobashigawa  Y,  Yoshida  R,  Itoh  H,  Yazawa  M,  Inagaki  F  (2012)  
Solution  structures  of  yeast  Saccharomyces  cerevisiae  calmodulin  in  calcium-­  and  target  peptide-­
bound  states  reveal  similarities  and  differences  to  vertebrate  calmodulin.  Genes  Cells  17:159-­172.  
234.   Lau   S-­Y,   Procko   E,  Gaudet   R   (2012)   Distinct   properties   of   Ca2+–calmodulin   binding   to   N-­and  C-­
terminal  regulatory  regions  of  the  TRPV1  channel.  J.  Gen.  Physiol.  140:541-­555.  
235.   Zhang  M,   Pascal   JM,   Schumann  M,   Armen  RS,   Zhang   J-­F   (2012)   Identification   of   the   functional  
binding  pocket   for   compounds   targeting   small-­conductance  Ca2+-­activated  potassium  channels.  
Nature  Commun.  3:1021.  
236.  Ménétrey  J,  Isabet  T,  Ropars  V,  Mukherjea  M,  Pylypenko  O,  Liu  X,  Perez  J,  Vachette  P,  Sweeney  HL,  
Houdusse  Anne  M  (2012)  Processive  steps  in  the  reverse  direction  require  uncoupling  of  the  lead  
head  lever  arm  of  myosin  VI.  Mol.  Cell  48:75-­86.  
237.  Tidow  H,  Poulsen  LR,  Andreeva  A,  Knudsen  M,  Hein  KL,  Wiuf  C,  Palmgren  MG,  Nissen  P  (2012)  A  
bimodular  mechanism  of  calcium  control  in  eukaryotes.  Nature  491:468-­472.  
238.  Liu  Y,  Zheng  X,  Mueller  GA,  Sobhany  M,  DeRose  EF,  Zhang  Y,  London  RE,  Birnbaumer  L  (2012)  
Crystal  structure  of  calmodulin  binding  domain  of  Orai1  in  complex  with  Ca2+/calmodulin  displays  
a  unique  binding  mode.  J.  Biol.  Chem.  287:43030-­43041.  
239.  Xu  Q,  Chang  A,  Tolia  A,  Minor  DL  (2013)  Structure  of  a  Ca2+/CaM:Kv7.4  (KCNQ4)  B-­helix  complex  
provides  insight  into  M  current  modulation.  J.  Mol.  Biol.  425:378-­394.  
240.  Grishaev  A,  Anthis  NJ,  Clore  GM  (2012)  Contrast-­matched  small-­angle  X-­ray  scattering  from  a  heavy-­
atom-­labeled   protein   in   structure   determination:   Application   to   a   lead-­substituted   calmodulin–
peptide  complex.  J.  Am.  Chem.  Soc.  134:14686-­14689.  
	  
	   164	  
241.  Kumar  V,  Chichili  VPR,  Zhong  L,  Tang  X,  Velazquez-­Campoy  A,  Sheu  F-­S,  Seetharaman  J,  Gerges  
NZ,   Sivaraman   J   (2013)   Structural   basis   for   the   interaction   of   unstructured   neuron   specific  
substrates  neuromodulin  and  neurogranin  with  calmodulin.  Sci.  Rep.  3:1392.  
242.   Zhang   M,   Pascal   JM,   Zhang   J-­F   (2013)   Unstructured   to   structured   transition   of   an   intrinsically  
disordered  protein  peptide  in  coupling  Ca2+-­sensing  and  SK  channel  activation.  Proc.  Natl.  Acad.  
Sci.  U.S.A.  110:4828-­4833.  
243.  Gruschus  JM,  Yap  TL,  Pistolesi  S,  Maltsev  AS,  Lee  JC  (2013)  NMR  structure  of  calmodulin  complexed  
to  an  N-­terminally  acetylated  α-­synuclein  peptide.  Biochemistry  52:3436-­3445.  
244.  Reichow  SL,  Clemens  DM,  Freites  JA,  Németh-­Cahalan  KL,  Heyden  M,  Tobias  DJ,  Hall  JE,  Gonen  T  
(2013)  Allosteric  mechanism  of  water-­channel  gating  by  Ca2+–calmodulin.  Nature  Struct.  Mol.  Biol.  
20:1085-­1092.  
245.  Chichili   VPR,  Xiao  Y,   Seetharaman   J,  Cummins   TR,   Sivaraman   J   (2013)   Structural   basis   for   the  
modulation  of  the  neuronal  voltage-­gated  sodium  channel  NaV1.6  by  calmodulin.  Sci.  Rep.  3:2435.  
246.  Ye  Q,  Feng  Y,  Yin  Y,  Faucher  F,  Currie  MA,  Rahman  MN,  Jin  J,  Li  S,  Wei  Q,  Jia  Z  (2013)  Structural  
basis  of  calcineurin  activation  by  calmodulin.  Cell  Signal.  25:2661-­2667.  
247.  Irene  D,  Huang  J-­W,  Chung  T-­Y,  Li  F-­Y,  Tzen  JTC,  Lin  T-­H,  Chyan  C-­L  (2013)  Binding  orientation  and  
specificity  of  calmodulin  to  rat  olfactory  cyclic  nucleotide-­gated  ion  channel.  J.  Biomol.  Struct.  Dyn.  
31:414-­425.  
248.  Shuman  H,  Greenberg  MJ,  Zwolak  A,  Lin  T,  Sindelar  CV,  Dominguez  R,  Ostap  EM  (2014)  A  vertebrate  
myosin-­I  structure  reveals  unique  insights  into  myosin  mechanochemical  tuning.  Proc.  Natl.  Acad.  
Sci.  U.S.A.  111:2116-­2121.  
249.  Vlach  J,  Samal  AB,  Saad  JS  (2014)  Solution  structure  of  calmodulin  bound  to  the  binding  domain  of  
the  HIV-­1  matrix  protein.  J.  Biol.  Chem.  289:8697-­8705.  
250.  Münnich  S,  Taft  MH,  Manstein  DJ  (2014)  Crystal  structure  of  human  myosin  1c—the  motor  in  GLUT4  
exocytosis:  Implications  for  Ca2+  regulation  and  14-­3-­3  binding.  J.  Mol.  Biol.  426:2070-­2081.  
251.  Chen  L-­T,  Liang  W-­X,  Chen  S,  Li  R-­K,  Tan  J-­L,  Xu  P-­F,  Luo  L-­F,  Wang  L,  Yu  S-­H,  Meng  G,  Li  KK,  Liu  
T-­X,  Chen  Z,  Chen  S-­J   (2014)   Functional   and  molecular   features   of   the   calmodulin-­interacting  
protein  IQCG  required  for  haematopoiesis  in  zebrafish.  Nature  Commun.  5:3811.  
252.  Zhang  M,  Meng  X-­Y,  Cui  M,  Pascal  JM,  Logothetis  DE,  Zhang  J-­F  (2014)  Selective  phosphorylation  
modulates  the  PIP2  sensitivity  of  the  CaM–SK  channel  complex.  Nature  Chem.  Biol.  10:753-­759.  
253.   Franco-­Echevarría   E,   Baños-­Sanz   Jose  I,   Monterroso   B,   Round   A,   Sanz-­Aparicio   J,   González   B  
(2014)   A   new   calmodulin-­binding   motif   for   inositol   1,4,5-­trisphosphate   3-­kinase   regulation.  
Biochem.  J.  463:319-­328.  
254.  Dunlap  TB,  Guo  H-­F,  Cook  EC,  Holbrook  E,  Rumi-­Masante  J,  Lester  TE,  Colbert  CL,  Vander  Kooi  
CW,  Creamer  TP  (2014)  Stoichiometry  of  the  calcineurin  regulatory  domain–calmodulin  complex.  
Biochemistry  53:5779-­5790.  
	  
	   165	  
255.  Sachyani  D,  Dvir  M,  Strulovich  R,  Tria  G,  Tobelaim  W,  Peretz  A,  Pongs  O,  Svergun  D,  Attali  B,  Hirsch  
Joel  A   (2014)   Structural   basis   of   a   Kv7.1   potassium   channel   gating   module:   studies   of   the  
intracellular  C-­terminal  domain  in  complex  with  calmodulin.  Structure  22:1582-­1594.  
256.  Gabelli  SB,  Boto  A,  Kuhns  VH,  Bianchet  MA,  Farinelli  F,  Aripirala  S,  Yoder  J,  Jakoncic  J,  Tomaselli  
GF,   Amzel   LM   (2014)   Regulation   of   the   NaV1.5   cytoplasmic   domain   by   calmodulin.   Nature  
Commun.  5:5126.  
257.  Zhang  Y,  Matt  L,  Patriarchi  T,  Malik  ZA,  Chowdhury  D,  Park  DK,  Renieri  A,  Ames  JB,  Hell  JW  (2014)  
Capping  of   the  N-­‐terminus  of  PSD-­‐95  by  calmodulin   triggers   its  postsynaptic   release.  EMBO  J.  
33:1341-­1353.  
258.  Llinas  P,  Isabet  T,  Song  L,  Ropars  V,  Zong  B,  Benisty  H,  Sirigu  S,  Morris  C,  Kikuti  C,  Safer  D,  Sweeney  
HL,  Houdusse  A  (2015)  How  actin  initiates  the  motor  activity  of  myosin.  Dev.  Cell  33:401-­412.  
259.  Keller  J  (2017)  Solution  of  the  structure  of  a  calmodulin-­peptide  complex  in  a  novel  configuration  from  
a  variably  twinned  data  set.  Acta  Cryst.  D  73:22-­31.  
260.   Whicher   JR,   MacKinnon   R   (2016)   Structure   of   the   voltage-­gated   K+   channel   Eag1   reveals   an  
alternative  voltage  sensing  mechanism.  Science  353:664-­669.  
261.  Chen  Y,  Clarke  OB,  Kim  J,  Stowe  S,  Kim  Y-­K,  Assur  Z,  Cavalier  M,  Godoy-­Ruiz  R,  von  Alpen  DC,  
Manzini  C,  Blaner  WS,  Frank  J,  Quadro  L,  Weber  DJ,  Shapiro  L,  Hendrickson  WA,  Mancia  F  (2016)  
Structure  of  the  STRA6  receptor  for  retinol  uptake.  Science  353:aad8266.  
262.  Ropars  V,  Yang  Z,  Isabet  T,  Blanc  F,  Zhou  K,  Lin  T,  Liu  X,  Hissier  P,  Samazan  F,  Amigues  B,  Yang  
ED,  Park  H,  Pylypenko  O,  Cecchini  M,  Sindelar  CV,  Sweeney  HL,  Houdusse  A  (2016)  The  myosin  
X  motor  is  optimized  for  movement  on  actin  bundles.  Nature  Commun.  7:12456.  
263.  Strulovich  R,  Tobelaim  WS,  Attali  B,  Hirsch  JA  (2016)  Structural  insights  into  the  M-­channel  proximal  
C-­terminus/calmodulin  complex.  Biochemistry  55:5353-­5365.  
264.  Marques-­Carvalho  Maria  J,  Oppermann  J,  Muñoz  E,  Fernandes  Andreia  S,  Gabant  G,  Cadene  M,  
Heinemann   Stefan  H,   Schönherr   R,   Morais-­Cabral   João  H   (2016)   Molecular   insights   into   the  
mechanism  of  calmodulin  inhibition  of  the  EAG1  potassium  channel.  Structure  24:1742-­1754.  
265.  Piazza  M,  Dieckmann  T,  Guillemette  JG  (2016)  Structural  studies  of  a  complex  between  endothelial  
nitric  oxide  synthase  and  calmodulin  at  physiological  calcium  concentration.  Biochemistry  55:5962-­
5971.  
266.  Wang  X,  Putkey  JA  (2016)  PEP-­19  modulates  calcium  binding  to  calmodulin  by  electrostatic  steering.  
Nature  Commun.  7:13583.  
267.  Johnson  CN,  Potet  F,  Thompson  MK,  Kroncke  BM,  Glazer  AM,  Voehler  MW,  Knollmann  BC,  George  
AL,  Jr.,  Chazin  WJ  (2018)  A  mechanism  of  calmodulin  modulation  of  the  human  cardiac  sodium  
channel.  Structure  26:683-­694.  
268.   Sun   J,   MacKinnon   R   (2017)   Cryo-­EM   Structure   of   a   KCNQ1/CaM   complex   reveals   insights   into  
congenital  long  QT  syndrome.  Cell  169:1042-­1050.  
	  
	   166	  
269.  Nam  Y-­W,  Orfali  R,  Liu  T,  Yu  K,  Cui  M,  Wulff  H,  Zhang  M  (2017)  Structural  insights  into  the  potency  
of  SK  channel  positive  modulators.  Sci.  Rep.  7:17178.  
270.  Gurel  PS,  Kim  LY,  Ruijgrok  PV,  Omabegho  T,  Bryant  Z,  Alushin  GM  (2017)  Cryo-­EM  structures  reveal  
specialization  at  the  myosin  VI-­actin  interface  and  a  mechanism  of  force  sensitivity.  eLife  6:e31125.  
271.  Mentes  A,  Huehn  A,  Liu  X,  Zwolak  A,  Dominguez  R,  Shuman  H,  Ostap  EM,  Sindelar  CV  (2018)  High-­
resolution  cryo-­EM  structures  of  actin-­bound  myosin  states  reveal  the  mechanism  of  myosin  force  
sensing.  Proc.  Natl.  Acad.  Sci.  U.S.A.  115:1292-­1297.  
272.  Bernardo-­Seisdedos  G,  Nuñez  E,  Gomis-­Perez  C,  Malo  C,  Villarroel  Á,  Millet  O  (2018)  Structural  basis  
and  energy  landscape  for  the  Ca2+  gating  and  calmodulation  of  the  Kv7.  2  K+  channel.  Proc.  Natl.  
Acad.  Sci.  U.S.A.  115:2395-­2400.  
273.  Cho  LTY,  Alexandrou  AJ,  Torella  R,  Knafels  J,  Hobbs  J,  Taylor  T,  Loucif  A,  Konopacka  A,  Bell  S,  
Stevens  EB,  Pandit  J,  Horst  R,  Withka  JM,  Pryde  DC,  Liu  S,  Young  GT  (2018)  An   intracellular  
allosteric   modulator   binding   pocket   in   SK2   ion   channels   is   shared   by   multiple   chemotypes.  
Structure  26:533-­544.  
274.  Chang  A,  Abderemane-­Ali  F,  Hura  GL,  Rossen  ND,  Gate  RE,  Minor  DL  (2018)  A  calmodulin  C-­lobe  
Ca2+-­dependent  switch  governs  Kv7  channel  function.  Neuron  97:836-­852.  
275.   Bokhovchuk   FM,   Bate   N,   Kovalevskaya   NV,   Goult   BT,   Spronk   CAEM,   Vuister   GW   (2018)   The  
structural   basis   of   calcium-­dependent   inactivation   of   the   transient   receptor   potential   vanilloid   5  
channel.  Biochemistry  57:2623-­2635.  
276.  Nam  Y-­W,  Baskoylu  SN,  Gazgalis  D,  Orfali  R,  Cui  M,  Hart  AC,  Zhang  M  (2018)  A  V-­to-­F  substitution  
in  SK2  channels  causes  Ca2+  hypersensitivity  and  improves  locomotion  in  a  C.  elegans  ALS  model.  
Sci.  Rep.  8:10749.  
277.  Wang  K,  Holt  C,  Lu  J,  Brohus  M,  Larsen  KT,  Overgaard  MT,  Wimmer  R,  Van  Petegem  F   (2018)  
Arrhythmia  mutations  in  calmodulin  cause  conformational  changes  that  affect  interactions  with  the  
cardiac  voltage-­gated  calcium  channel.  Proc.  Natl.  Acad.  Sci.  U.S.A.  115:E10556-­E10565.  
278.  Hughes  TET,  Pumroy  RA,  Yazici  AT,  Kasimova  MA,  Fluck  EC,  Huynh  KW,  Samanta  A,  Molugu  SK,  
Zhou   ZH,   Carnevale   V,   Rohacs   T,   Moiseenkova-­Bell   VY   (2018)   Structural   insights   on   TRPV5  
gating  by  endogenous  modulators.  Nature  Commun.  9:4198.  
  
